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1. Introduction 
 
1.1 General introduction 
Metal catalyzed allylic substitution has been demonstrated to be a versatile and important tool 
in organic synthesis
1-8
. Through this reaction, the formation of many types of bonds such as 
C-C, C-N, C-O, C-S and C-P is possible. Furthermore, depending on the conditions, different 
chemo-, regio- and stereoselectivities can be achieved. Palladium has been widely used and is 
a well-studied metal in allylic substitution. Moreover, palladium complexes have proven to be 
useful compounds with a broad range of applications.  
The first π-allyl-palladium complex was reported by Smidt and Hafner9 in 1959 when they 
described the discovery of a [Pd(allyl)Cl]2 complex. Less than 10 years after this article, in 
1965, Tsuji et al.
10
 presented the first C-C bond formation using the same π-allylpalladium 
complex in stoichiometric amount. In 1970, the discovery that zero-valent palladium 
complexes are active catalysts in catalytic amount was found by chemists from Toray 
Industries in Japan and from the Union Carbide Corporation Chemicals and Plastics
11,12
. 
Three years later, Trost et al. started to investigate the field and were the first group to achieve 
stoichiometric enantioselective allylic substitutions
13
 and, in 1977, catalytic enantioselective 
allylic substitutions
14
. Nowadays, this field is still an interesting research area where the 
search for new chiral ligands and new applications for the reaction has raised an increased 
interest.  
 
1.2 Palladium catalyzed enantioselective allylic substitution 
Performing a palladium catalyzed enantioselective allylic substitution involves taking 
different factors into account, such as catalyst, ligand, nucleophile etc. Depending on the 
substrate, several changes are needed to optimize the reaction conditions and to get the 
desired product in high enantioselectivity.  
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1.2.1 Catalytic cycle 
The generally accepted mechanism for palladium-catalyzed allylic substitutions with “soft” 
nucleophiles imply as the first step, the coordination of the low valent palladium(0) catalyst to 
the double bond of substrate 1 into a η2-complex 2 (step A scheme 1). An oxidative addition 
follows which affords the η3-π-allylpalladium complex 3 (step B)15. This activated substrate is 
then attacked by a nucleophile to form a η2-complex 4 (step C). Decomplexation of the Pd 
complex releases the palladium and the desired product 5 (step D) 
Scheme 1: Catalytic cycle 
 
1.2.2 Catalysts and Ligands 
Different sources of palladium catalysts are known, Pd2(dba)3
16
 (dba = dibenzylidene acetone) 
and [Pd(allyl)Cl]2 being the most frequently employed. With these catalysts, complexes are 
generated in situ by combination with the desired ligand. [Pd(allyl)Cl]2 is in oxidation sate +2 
but is reduced to the activated Pd(0) by nucleophilic attack on the allyl group
17
. 
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In the 1970’s, a broad range of different ligands have been developed to improve the 
enantioselectivity of palladium catalyzed reactions. In 1972, the first C2-symmetric chiral 
ligand was introduced by Kagan
18
 with the DIOP ligand. Since then, several C2-symmetric 
ligands
19
 were developed and excellent results were obtained in hydrogenation with chelating 
diphosphines, i.e. Chiraphos
20,21
 and Binap
22,23 
(scheme 2). Unfortunately transferring these 
ligands into allylic substitution resulted into deceiving results probably due to the fact that in 
the allylic substitution the nucleophilic attack is taking place outside the coordination sphere 
of the complex which is not the case in hydrogenations
3,24
. Consequently, in 1986, 
Hayashi
25,26 
developed optically active ferrocenylphosphine ligands containing a side chain 
capable of interacting with the nucleophile and allowing the direction of the attack on a 
specific allylic terminus. Nevertheless, in the early 1990, two groups demonstrated that high 
enantioselectivites could also be achieved with a C2-symmetric ligand: The Pfaltz group with 
bisoxazolidines
27-29
 and the Trost group
30
 with new types of diphosphines.  
 
Scheme 2: First ligands used in allylic substitution 
 
Since then, the Trost ligands based on 2-(diphenylphosphino)benzoic acid (DPPBA), scheme 
3, have been applied in several allylic alkylation reactions and were involved in a number of 
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applications
31-32
. The configuration of these ligands generates Pd fragments with large bite 
angles which allow the palladium-ligand complex to embrace the allyl function of the 
substrate forming a chiral pocket (scheme 4). With this concept, Trost developed a model 
which allows predicting the product stereochemistry depending on the DPPBA chiral ligand 
used
33
. In this model, the asymmetric induction is established on steric interactions between 
the “wall” (phenyl substitutents of the chiral ligand) and the incoming nucleophile. 
Depending on how the ligand “sits” on the allyl substrate, one terminus should be favored for 
nucleophilic attack. However, in recent research it has been demonstrated that these ligands 
are forming oligomers making the reaction mechanism difficult to elucidate
34-36
. In 2009, 
Lloyd-Jones et al.
37
 elucidated the monomeric forms of the cationic Pd-η3-allyl complexes 
bearing the trans-cyclohexylenediamine-based Trost ligand ((R,R)-standard, scheme 3) 
through NMR, isotopic labeling and computation. They identified that hydrogen-bond 
interaction of one N-H unit in Pd-ligand complex allowed to accelerate ionization and 
nucleophile attack. This new model may be helpful in the interpretation of the selectivity in 
allylic subsitution reactions catalyzed by Pd complexes of Trost ligands. 
 
 
Scheme 3:  Different DPPBA Trost ligands 
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Scheme 4: Model developed by Trost 
 
In 1993, non-C2 symmetric P,N-phosphinooxazoline ligands, so called PHOX ligands 
(scheme 5), were developed independently by three different groups, Pfaltz
38
, Helmchen
39
 and 
Williams
40
. These ligands adopt the concept of electronic differentiation with the combination 
of hard, N, and soft P donor. Electronic as well as steric properties created useful ligands for 
allylic substitutions enabling high enantioselectivity. These ligands were particularly 
appropriate for substrates such as 1,3-diarylallylacetate and 1,3-diisopropylacetate and 
illustrated high enantioselectivity, a result which was not demonstrated with the Trost ligands. 
The use of an appropriate ligand for a specific substrate is not straightforward and is reflected 
by the vast number of ligands developed. 
 
Scheme 5: PHOX ligands 
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1.2.3 Substrates 
1.2.3.1  Symmetrically substituted allyl systems 
Non-functionalized substrates such as 1 which go through a symmetrical complex 6 are 
frequently used as test substrates for the design of new ligands.  
 
 
Scheme 6: Allylic substitution through a symmetrically substituted allyl system  
In such a system, the substitution proceeds via a symmetrical palladium-allylic-complex 6
3,7 
(scheme 6). Therefore, coordination and oxidative addition leads to the same intermediate 
resulting in no stereoselective differenciation on the substrate. The regioselectivity of the 
nucleophilic attack determines the enantioselectivity of the reaction. To exemplify the 
concept: if an achiral ligand is used, the allyl complex is achiral and the allylic termini 
enantiotopic providing a racemic product. On the other hand, the termini are 
diastereoisotropic with the use of a chiral ligand and a differentiated nucleophilic attack 
enables obtaining either enantiomer 7 or ent-7. 
These substrates present the advantage of achieving a theoretic quantitative yield which is not 
always the case for asymmetric substrates especially if no dynamic kinetic asymmetric 
transformation (DYKAT) can be achieved from the reaction
41-43
. 
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1.2.3.2 Meso-substrates 
Meso-substrates are another class of compounds in which the chirality is introduced in the 
oxidative addition step
3,44
.  Meso-cycloalkene substrates exemplify this concept (scheme 7). 
In that case, the Pd complex coordinates to the allyl function opposite to the leaving group 
and differentiation between the two leaving groups leads to control of the stereochemistry.  
The regioselectivity of the nucleophile attack on the chiral allyl intermediate is determined by 
the less hindered position.  
Kinetic resolution applied to the desymmetrization of meso-compounds provides high yield 
and high enantiomeric enrichement of a single product. 
 
 
Scheme 7: Allylic substitution on meso-substrate 
 
1.2.4 Leaving groups 
Besides the standard acetate, alternative leaving groups such as halides, carbonates,  
sulfonates or phosphates have been used in enantioselective allylic substitutions (scheme 8)
45
. 
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Scheme 8: Different leaving groups used in allylic subsitutions 
 
The nature of the leaving group can play an important role in the enantioselectivity of the 
reaction if the enantioselective step is the oxidative addition of the allylic substrate into the 
Pd(0) complex
46
. 
 
 
Scheme 9: First step of the palladium catalyzed allylic substitution  
 
The complexation and the oxidative addition are both reversible steps as demonstrated by 
Amatore et al.
47-49
 (scheme 9). In the course of the reaction, the concentration of leaving 
group anion increases. If the nucleophilic attack is slow, the ionized leaving group may itself 
behave as a nucleophile whic may result in a rearrangement of the allyl substrate. Therefore, a 
good leaving group should be a poor nucleophile and should favor the complexation and 
oxidative addition steps.  
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Carbonate leaving groups offer the advantage of decarboxylation during the process rendering 
the formation of the Pd-allyl-complex irreversible (scheme 10)
50-51
. The formed alkoxide can 
also act as a base and deprotonate the nucleophile, another benefit of such a leaving group.  
Tsuji et al.
52
 also presented this method with allylic carbamates which could be employed 
under neutral conditions, without addition of a base.  
 
Scheme 10: Decarboxylation with the carbonate leaving group 
1.2.5 π-σ-π isomerization 
During the reaction, a well-known mechanism of isomerism along the allyl complexes is 
possible which involves a π-σ-π isomerization1,3,7. The mechanism involves the rotation 
around the σ-(C-C) bond which leads to a syn-anti interconversion. The syn and anti 
dispositions are relative to the central hydrogen (subsitutent at C2 as shown in scheme 11). 
The mechanism is explained in scheme 11: starting from the syn-isomer η3-π-allyl-complex I 
the palladium complex react to a η1-intermediate II which allows rotation around the σ-(C-C) 
bond affording III. At that point, the substituent R has switched from the syn to the anti 
position, after a change of coordination from a η1-σ to a η3-π-complex, anti-isomer IV is 
obtained. 
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Scheme 11: Mechanism of π-σ-π isomerization 
 
The syn-isomer is sterically favored and therefore more stable then the anti isomer. 
Depending on the steric hindrance applied by a ligand, the anti-isomer can be preferentially 
formed
53-55. Since the σ-complex is coordinatively unsaturated, the presence of halides or the 
nature of nucleophile and solvent can influence the π-σ-π isomerization56-57.  
The syn-anti isomerization happens before the nucleophile attack and is dependent on the 
reaction conditions. If the rate of the isomerization is fast compared to the nucleophilic attack, 
an equilibrium can be formed where both syn and anti isomer are present. Scheme 12 
illustrates an example where starting from a pure trans- or cis-isomer, the same ratio of trans- 
and cis-product is obtained due to the π-σ-π isomerization occuring before the nucleophilic 
attack.  
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Scheme 12: π-σ-π isomerization leading to cis/trans isomerization 
The emergence of π-σ-π isomerization is dependant on the type of substrate used and on the 
reaction conditions. 
 
1.2.6 Nucleophile 
In Pd-catalyzed allylic substitutions, a differentiation between two classes of nucleophiles is 
done: “Soft” and “hard” nucleophiles. It is an empirical classification which allows 
distinguishing between a reaction with retention of configuration and a reaction with 
inversion of configuration
3,58
. The so-called “soft” nucleophiles are stabilized carbanions and 
most heteroatom nucleophiles with a pKa below 25. “Hard” nucleophiles are nonstabilized 
carbanions and some heteroatom nucleophiles with pKa above 25
31
.  
Scheme 13 illustrates the differentiation between the two groups. For both classes, during the 
oxidative addition, the leaving group is ionized with inversion of configuration i.e. the Pd 
complex approaches from the opposite side of the leaving group. With “soft” nucleophiles, 
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the nucleophile attacks outside the coordination sphere of the Pd complex to give overall 
substitution with retention of configuration. On the other hand, “hard” nucleophiles bind at 
the metal and attack the allylic moiety from the same side of the Pd complex to give overall 
substitution with inversion of configuration.   
 
Scheme 13: Mechanism for retention and inversion of configuration 
A wide range of nucleophiles are known to react under retention of configuration such as 
dimethyl malonate, benzylamine, phthalimides, phenols or p-TolSO2Na
59-61
. In contrast, 
reactions with hard nucelophiles have seen much less success and a few examples with 
organozinc or Grignard reagents are known
44
. Most reports on allylic substitutions with hard 
nucleophiles employ Ni
62-63
 or Cu
64-65 
complexes as the catalyst. 
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1.2.7 β-hydride elimination 
β-hydride elimination describes the transfer of a hydride from the beta-position on a substrate 
to the metal center. In the case of an allylic substitution, the absence of nucleophile or the 
poor character of a nucleophile as well as the type of substrate can create an environment 
favorable for β-hydride elimination66. Scheme 14 illustrates the loss of hydrogen to form a 
diene.  
 
  
Scheme 14: Mechanism of β-hydride elimination 
 
In 1978, Tsuji et al.
67
 published an article where he reported the formation of diene products 
by elimination with a palladium catalyst (scheme 15). The reaction proceeds under mild 
reaction conditions but temperature and addition of a base can favor the elimination product.  
 
 
Scheme 15: Diene formation
67 
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2. Purpose of this work 
 
Enantioselective palladium catalyzed allylic substitutions reactions have been subject to 
numerous improvements since 1977. Nowadays, they are an important tool in organic 
synthesis. 
Various substrates have been used in this reaction, most of them having two different 
substituents at each end. However, racemic allylic derivatives with two identical substituents 
have been widely used especially for the design of new ligands and the understanding of the 
mechanism specific to each ligand. The advantage of substrates proceeding via symmetrical 
allyl systems is that quantitative yield and true enantioselective conversion can be obtained 
from the reaction. Until now, these symmetrical substrates were all synthesized with 
unfunctionalized substitutents such as aryl- or alkyl-groups. For that reason, the synthetic 
application after the enantioselective substitution was rather limited.  
Therefore the purpose of this thesis was: 
1) To synthesize new kind of substrates with a symmetrical allyl system possessing 
functionalized substituents (scheme 16). The idea was to use functional groups such as esters 
or ethers which after substitution can easily be transformed into useful and interesting 
compounds.  
 
Scheme 16: Ester and ether substrates 
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2) To perform an enantioselective allylic substitution and improve the yield and 
enantioselectivity of the reaction through different screenings, for instance leaving groups, 
catalysts, ligands, bases, nucleophiles, temperature or solvents. In addition, these experiments 
could lead to a better understanding of the reaction (scheme 17).  
 
Scheme 17: Allylic substitution on symmetrically substituted allyl ester- and ether systems 
 
3) To synthesize new useful and interesting compounds from the enantio-enriched products 
obtained after allylic substitution. 
 
If successful, this strategy with bifunctional substrates should be extended to dimeric meso-
substrate where the particularity of the substrate resides in the ionization of the enantiotopic 
leaving group. For this purpose, compounds 37 and 38 (scheme 18) should be synthesized and 
used as substrates for enantioselective allylic substitutions. Coordination of the Pd complex 
would induce the decarboxylation of the leaving group and a presumably regioselective 
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nucleophilic attack on the less hindered position (scheme 19). The functionalized substituents 
form a particularly attractive substrate which after allylic substitution would allow the 
synthesis of interesting compounds. 
 
Scheme 18: Dimeric meso ester- and ether substrates 
 
Scheme 19: Allylic substitutions on dimeric meso ester- and ether substrates
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3. Results and Discussions 
 
3.1 Di-Ester substrates 
Di-ester compounds such as 41 would be interesting systems to study in an enantioselective 
allylic substitution. The symmetry of the transition state theoretically would allow a full 
conversion to product with potentially high enantioselectivity (scheme 20). The obtained 
product 43 could be used as a valuable chiral substrate which could further be transformed 
into different interesting compounds through hydrolysis, epoxidation, dihydroxylation etc.   
 
 
Scheme 20: Nucleophilic allylic substitution on di-ester compound 41 
 
Even though the synthesis of such di-ester molecules looks easy on paper, the preparation 
poses a challenging task. 
 
3.1.1 Substrate synthesis  
3.1.1.1 Coupling of ethyl propiolate to ethyl glyoxalate 
Several synthetic routes can be imagined to obtain diester compounds 41. One of them, is the 
formation of compound 46 through the coupling of commercially available ethyl propiolate 
(44) to glyoxylic acid ethyl ester (45) using nBuLi and 2,2,6,6-tetramethylpiperidine 
(LTMP)
68
 to activate the triple bond (scheme 21). Ethyl glyoxalate is commercially available 
as a solution in a concentration of ~50 % in toluene, partly in polymerized form. The reaction 
proved to be difficult due to the polymerization of the aldehyde at lower temperature, which 
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was problematic due to the fact that the reaction was conducted at -78 °C. The ratio of 
monomer and polymer in the ethyl glyoxalate solution was analyzed by NMR before adding it 
to the solution of activated propiolate. The amount of monomer was found to be 
approximately 6 % at 0 °C. Therefore, different attempts to avoid the polymerization and to 
obtain a reasonable amount of monomer were tried, such as refluxing the ethyl glyoxalate 
solution, working under dilute conditions or applying an excess of the aldehyde. After 
refluxing in toluene during 1h under diluted conditions, 58 % of (45) was present in its 
monomeric form, calculated from the NMR spectra (other byproducts were observed after 2h 
under reflux). Nevertheless, no satisfactory results were obtained from the reaction and a 
mixture of products was observed. 
 
Another strategy was to perform the reaction at 0 °C but in that case the deprotonated ethyl 
propiolate (44) turned out to be unstable. 
 
 
Scheme 21: Addition of ethyl propiolate (44) to ethyl glyoxalate (45) 
 
Due to these issues, encountered in the synthesis of alkyne compound 46, other synthetic 
approaches were needed. 
 
3.1.1.2 Reduction of dimethyl 2-oxoglutaconate 
After the unsuccessful coupling attempts, ketone reduction to alcohol 48 was envisaged 
starting from commercially available dimethyl 2-oxoglutaconate (47) (scheme 22). Different 
reducing agents were tested such as L-Selectride
69
, Luche reduction reagent
70
 and also a 
metal-catalyzed transfer reduction with Ru catalyst
71
. Unfortunately, decomposition was 
observed in a reduction attempt with L-Selectride and also under Luche reduction conditions. 
No reaction occurred with Ru(p-cymen)(TsDPEN) in a transfer hydrogenation. After the 
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failed reduction attempts and taking into account that compound (47) is highly sensitive to 
moisture and undergoes acetal formation with MeOH, the molecule was to be found 
unsuitable and another synthesis strategy had to be found. 
 
 
Scheme 22: Reduction of dimethyl 2-oxoglutaconate (47) 
 
3.1.1.3 Bromination 
Reduction of (47) being troublesome, another approach was followed starting with an allylic 
bromination of commercially available diethylglutaconate (49) to give compound 51 (scheme 
23). The first attempt was the allylic bromination using NBS as reagent
72
. Besides 
monobrominated product, different dibromo products were also observed on LC-MS. After 
running a chromatography column, a mixture of 75:25 of vinyl 50 to allyl 51 monobrom was 
isolated in 12% yield.  
An attempt to push the equilibrium to the allyl product with the help of a base (5% cat 
NaOMe) was unsuccessful, the vinyl product being thermodynamically more favorable.  
 
 
Scheme 23: Allylic bromination of diethylglutaconate (49) 
 
Instead of an allylic bromination, a dibromination of the double bond and subsequent 
elimination to obtain the allylic compound 51 was tested (scheme 24). Compound 52 was 
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readily synthesized from (49) with Br2 in 73% yield
73
. For the following reaction, different 
bases such as Et3N, imidazol, pyridine were tried. Starting with the weakest base pyridine, no 
reaction was observed. Reaction with the strongest base, triethylamine, showed different 
byproducts, one of them being the dimerization to a cyclic compound 53 but the desired 
product was not isolated. Imidazole turned out to be a relatively good base, favouring 
elimination and yielding the vinyl/allyl 50/51 mixture in the same ratio (75:25) as for the NBS 
reaction. Attempts to obtain the desired di-ester compound being difficult, even though 
different pathways were tested; a change in the molecule was required. 
 
 
 
Scheme 24: Dibromination of diethylglutaconate (49) followed by elimination with 3 different bases 
pyridine, Et3N and imidazol 
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3.1.1.4 Allylic substitution on vinyl/allyl monobromide 
From the previous results using mixtures of vinyl/allyl isomers 50 and 51, it seems that a 
dynamic equilibrium between the two isomers is taking place. If the dynamic equilibrium 
between vinyl and allyl bromide is fast enough compared to the nucleophile attack, then an 
allylic substitution could be envisaged (scheme 25). Therefore, an allylic substitution was 
performed on the mixture of 75:25 vinyl/allyl bromide with Pd2(dba)3·CHCl3 (0.03eq) as 
catalyst, PPh3 (0.12eq) as  ligand, BnNH2 (2.2 eq) as nucleophile and toluol as solvent at rt. 
The reaction provided a mixture of products. Unfortunately, the desired product could not be 
identified nor isolated from the product mixture. 
 
Scheme 25: Dynamic equilibrium between 50 and 51 with subsequent allylic substitution  
 
3.1.1.5 Quantum Mechanic Study 
To understand why such relatively simple compounds could not be isolated, a quantum 
mechanics calculation of the different isomer energies was performed. The calculation was 
completed with Turbomole DFT/BP86 and the in vacuo calculated energies (in kcal/mol) are 
given relative to the lowest form. The results are shown in scheme 26. 
 Results and Discussions 
___________________________________________________________________________ 
- 28 - 
 
 
Scheme 26: QM calculated energies (underlined and in kcal/mol) 
In general, the data shows that the vinyl forms 56a, 57a, 58a and 59a are thermodynamically 
more favorable then the allyl forms 56b, 57b, 58b and 59b. The enol-forms c have a 
significantly higher energy than the other forms, thus the probability to observe this form is 
low and should not be considerate.  
This calculation is in accordance with the previously observed experimental data for the 
bromination products where the equilibrium is in favor of the vinyl form.  
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The calculations of series 57 take into account a substrate bearing a methyl carbonate as a 
leaving group. In that case as well, the calculation shows the vinyl form to be 
thermodynamically more favorable.  
The energies of amide compounds 58 and 59 bearing a methyl carbonate- and a nitro leaving 
group respectively, were calculated in order to predict if the same effect would be observed as 
for the other substrates. It turned out that again the vinyl forms 58a and 59a are 
thermodynamically more stable than the allyl isomers 58b and 59b. 
According to the calculations, the vinyl form seems to be the preferred configuration. A 
possible, keto-enol tautomerization of the alcohol to the ketone as shown in scheme 27 could 
then be imagined.  The thermodynamically more stable vinyl form could isomerize to the keto 
form which would annihilate the prospect of an allylic substitution. 
 
Scheme 27: Keto-enol tautomerization 
These calculations combined with the theoretical considerations prompted us to skip the di-
ester substrates and to concentrate on di-ether substrates. 
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3.2 Dibenzylether substrates 
Dibenzylether substrates represent a more stable system and their synthesis is straightforward. 
In such a system, keto-enol tautomerization does not take place and the chiral product after 
substitution bears an allylic ether which allows differentiation between both ether functions. 
Provided good yield and enantioselectivity can be achieved with these substrates, subsequent 
selective functionalization of the products should be possible and would allow the synthesis 
of interesting compounds. 
In the literature, alkoxy substituents are not commonly used in palladium catalyzed 
substitution since it could theoretically play the role of a leaving group
74
. Nevertheless, some 
studies on regioselectivity using asymmetric substrates with an alkoxy group were already 
reported
75
 but none of them passing a symmetrical transition state as shown in scheme 28.   
 
 
Scheme 28: Allylic substitution on dibenzylether substrates 
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3.2.1  Substrate synthesis  
3.2.1.1 (E)-Dibenzylether substrates 
The (E)-Dibenzylether substrates (compounds 69-72) were prepared as following (scheme 
29): The reaction between the lithium salt of commercially available 2-propyn-1-ol (64) and 
2-benzyloxy-acetaldehyde (66) gave 67 (72% yield). 67 was reduced with LiAlH4
76
 to obtain 
the (E) allylic alcohol 68 (68% yield) as a common intermediate. Compound 67 has a new 
structure not described in the literature, whereas the (S)-enantiomer of compound 68 is 
already known
77
. The introduction of the different leaving groups for the preparation of 
compounds 69-72 was achieved as follows: the carbonate derivatives 69 and 70 were 
prepared by treatment of 68 with ethyl-chloroformate
78
 (85% yield) and methyl-
chloroformate
78
 (63% yield) respectively (scheme 30). Alternatively, 68 was treated with 
benzylisocyanate
79
 to obtain the benzylcarbamate derivative, 71 (83% yield). Finally, the 
chloroacetate derivative 72 was prepared by reaction of 68 with chloroacetylchloride
78
 (94% 
yield). 
 
 
Scheme 29: Synthesis of compound 68 
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Scheme 30: Synthesis of the (E)-Dibenzylether substrates from compound 68  
 
3.2.1.2 (Z)-Dibenzylether substrates 
The (Z)-Dibenzylether substrates were synthesized according to scheme 31. First the leaving 
groups were introduced to compound 67 affording ethylcarbonate compound 73 (68% yield) 
and methylcarbonate compound 74 (70% yield)
78
. The introduction of the leaving group 
before hydrogenation was important to this heterogeneous reaction. Hydrogenation of 67 was 
not selective and mixture of the desired alkene and the fully hydrogenated product was 
obtained which were difficult to separate. The steric hindrance of the leaving group combined 
with the use of a poisoned catalyst (Pd on barium sulfate) with 2,2’-Bipyridyl allowed 
selective hydrogenation to obtain the (Z)-alkene in good yields. As reported by Hirota et al.
80
, 
the use of 2,2’-Bipyridyl suppresses the hydrogenolysis of the benzyl ethers. Hydrogenation 
of 73 and 74 with Pd/BaSO4, 2,2’-Bipyridyl, H2 afforded 75  (89% yield) respectively 76 
(99% yield). 
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Scheme 31: Synthesis of (Z)-Dibenzylehter substrates  
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3.3 Allylic substitutions on dibenzylether substrates 
3.3.1 Leaving group screening 
The first step of the Tsuji-Trost reaction involves the coordination of the Pd(0)-catalyst to the 
allylic system of the substrate 61 (scheme 32) which forms a η2-allyl complex 77 
(complexation step). An oxidative addition follows during which the leaving group is 
expelled (also called ionization step) leading to a η3-allyl complex 62. The choice of a good 
leaving group is an important factor in the reaction and can play a non negligible role in 
inducing enantioselectivity. Therein the effect of different leaving groups was studied to 
choose the best suited one for this system.  
 
Scheme 32: First step of the Tsuji-Trost reaction: complexation and ionization to η3-allyl 
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3.3.1.1 Ethyl carbonate substrates 
In allylic substitution, carbonate leaving groups are well known and frequently used. In a 
general way, allylic carbonates have the advantage of decarboxylating after the oxidative 
addition forming alkoxides which are able to deprotonate the nucleophile (scheme 33)
45
. 
Furthermore, according to a kinetic study of Amatore
47
, the carbonates are good leaving 
groups since the ionization step is faster than the complexation step. Therefore our first 
experiments were performed using ethyl carbonate as leaving groups. Using these substrates, 
allylic substitutions of both the (E)- and (Z)-allyl carbonates were studied. 
 
Scheme 33: Allylic carbonates decarboxylation and nucleophile deprotonation  
 
3.3.1.1.1 (E)-Ethyl carbonate substrate (compound 69) 
Allylic substitutions using the (E)-substrate with the ethylcarbonate leaving group (compound 
69) were performed under standard reaction conditions using BnNH2 as the nucleophile, at rt 
in dichloromethane (scheme 34).  
 
Scheme 34: Allylic subsitution on (E)-Ethyl carbonate-substrate 69 with benzylamine 
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The results are summarized in table 1. The first reaction was a non-enantioselective 
substitution with PPh3 as a ligand and [Pd2(dba)3]·CHCl3  as a catalyst (entry 1, table 1). The 
racemic product showed an Z:E ratio of 25:75, even though the starting material comprised 
>97% of the E-isomer. Approximately the same proportion of E/Z isomers was obtained as 
product in the case of the enantioselective substitution with (R,R)-Trost DACH Phenyl as 
ligand  (entry 2 and 3, table 1), indicating that an equilibration is established either during the 
complex formation (catalyst/ligand coordination to the allyl system) and/or during the 
substitution reaction (nucleophilic attack). Entry 2 and entry 3 (table 1) show a comparison of 
the two different catalysts frequently used in allylic substitution: Pd(0) = [Pd2(dba)3]·CHCl3 
and the in situ generated Pd(0) from Pd(II) = [Pd(allyl)Cl]2. Both are almost equivalent in 
terms of yield and Z/E isomerization with a better ee for Pd(0). Unfortunately, both reactions 
were not complete leading to poor yield and moderate ee. 
 
Table 1: Allylic substitutions on (E)-Ethylcarbonate substrate (compound 69) 
Entry Catalyst Ligand Time Yield
4
 Z/E ratio ee
6
 
1 Pd(0)
1
 PPh3 5h30 48% 25 : 75
5
 - 
2 Pd(0)
1
 Trost(1)
3
 4 days 34% 14 : 86
6
 80% (Z) 70% (E) 
3 Pd(II)
2
 Trost(1)
3
 6 days 40%  20 : 80
6
 50% (Z) 26% (E) 
Reaction conditions: Pd catalyst (0.08 eq.), ligand (0.24 eq.), BnNH2 (2 eq.), rt; 
1 [Pd2(dba)3]CHCl3 ; 
2 [Pd(allyl)Cl]2 ; 
3 (R,R)-
Trost DACH Phenyl; 4 isolated yield after chromatography;  5 calculated on 1H NMR; 6 determined by HPLC (Chiralpak AD-
H) 
 
Entry 3 (table 1) was followed by HPLC on a chiral stationary phase to get an insight into the 
reaction. The evolution of the reaction was monitored with a chiral column (Chiralpak AD-H, 
eluent: 6% iPrOH 94% n-hexane). Before each injection on the column, a probe of the 
reaction mixture was filtered over a short pad of silica and the solvent evaporated under 
reduced pressure. The sample was then diluted in a mixture of 6% iPrOH and 94% n-hexane 
to work under isocratic conditions. The results are summarized in table 2. The Z/E ratio was 
constant over time. The enantioselectivity decreased with time which could be the effect of a 
competing side reaction or due to the (Z)-(E) isomerization and the π-σ-π interconversion as 
explained in section 3.3.2. 
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Table 2: Reaction followed by Chiral HPLC 
Time Conversion Yield
1
 Z/E ratio
2
 ee
2
 
1h 89% SM  11% Product  18:82               49% (E) 
2h 82% SM  18% Product  18:82               45% (E) 
4h 71% SM  29% Product  20:80 67% (Z) 47% (E) 
6h 69% SM  31% Product  20:80 64% (Z) 45% (E) 
1 day 57% SM  43% Product  25:75 59% (Z) 37% (E) 
5 days 46% SM  54% Product  24:76 50% (Z) 27% (E) 
6 days 47% SM  53% Product  25:75 48% (Z) 28% (E) 
6 days  40% 20:80 50% (Z) 26% (E) 
Reaction conditions: [Pd(allyl)Cl]2  (0.08 eq.), (R,R)-Trost DACH Phenyl (0.24 eq.), BnNH2 (2 eq.), rt; 
1 isolated yield after 
chromatography;  2 determined by HPLC (Chiralpak AD-H) 
 
3.3.1.1.2 (Z)-Ethyl carbonate substrate (compound 75) 
Since isomerization to the (Z)-product was observed when the reaction was conducted with 
the (E)-substrate, the application of the (Z) substrate could help to get information about the 
influence the configuration has on the reaction and to better understand the reaction 
mechanism. 
Therefore, allylic substitution on (Z)-Ethyl carbonate substrate (compound 75) was 
investigated under the reaction conditions of benzylamine as nucleophile, dichloromethane as 
solvent and at room temperature (scheme 35). The results are summarized in table 3.  
 
 
 Scheme 35: Allylic substitution on (Z)-Ethylcarbonate-substrate 75 with benzylamine 
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Table 3: Allylic substitutions on (Z)-Ethylcarbonate substrate (compound 75) 
Entry Catalyst Ligand Time Yield
3
 Z/E ratio
4
 ee
5
 
1 Pd(0)
1
 PPh3 4h 64% 30:70 - 
2 Pd(0)
1
 Trost(1)
2
 24h 36% 10:90 76% (Z) 64% (E)  
Reaction conditions: Ligand (0.24 eq.), BnNH2 (2 eq.), rt; 
1 [Pd2(dba)3]·CHCl3 (0.08 eq.); 
2 (R,R)-Trost DACH Phenyl; 3 
isolated yield after chromatography;  4 calculated on 1H NMR; 5 determined by HPLC (Chiralpak AD-H) 
 
Approximately the same Z/E ratio was surprisingly observed with (E)-product as major 
compound as in the previous results starting from the (E)-substrate. This result again indicated 
the presence of an equilibrium where the (E)-isomer of the product is preferably formed as 
compared to the (Z)-product. The enantioselectivity is better for the (Z)-product than for the 
(E)-product. The E/Z isomerization is disscussed in more detail in section 3.3.2. 
 
 
3.3.1.2 Methyl carbonate substrates 
At the same time, since the yield and the ee of the ethyl carbonate substrates were not 
satisfactory, another somehow similar but more labile leaving group was tested. Methyl 
carbonate was introduced and evaluated in allylic substitutions.  
 
3.3.1.2.1 (E)-Methyl carbonate substrate (compound 70) 
Different reaction conditions were tested with the (E)-Methyl carbonate substrate (scheme 36) 
and the results are summarized in table 4. Concerning the Z/E isomerization, the same 
observation was noticed as for the ethyl carbonate with approximately 20:80 Z:E 
isomerization. Further explanation and experiments are given in section 3.3.2. 
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Scheme 36: Allylic substitution on (E)-Methyl carbonate substrate 70 with benzylamine 
 
Entry 2 and 3 (table 4) shows the same reaction with different catalyst: [Pd2(dba)3]·CHCl3 
respectively [Pd(allyl)Cl]2. In terms of ee, similar results were found but reactions with 
[Pd(allyl)Cl]2 were completed leading to a better yield and in a shorter reaction time. 
Therefore, this catalyst was further used in this reaction with this substrate.  
The temperature was lowered to see if the ee could be improved and a slight amelioration was 
observed but it was not significant (entry 4, table 4). 
 
Since promising results were observed with this substrate, a solvent screening was performed: 
toluene (entry 5, table 4) showed similar results as CH2Cl2 but with a lower ee for the (E)-
product. Reaction in THF was not completed and afforded only low enantioselectivity (entry 
6, table 4). Reaction in more polar solvent such as CH3CN was rapid with good yield but 
unfortunately the ee was low (entry 7, table 4). Dioxane (entry 8, table 4) proved to be an 
unsuitable solvent for this system. In summary, dichloromethane showed the best results 
when combining yield and enantioselectivity. 
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Table 4: Allylic substitutions on (E)-Methyl carbonate substrate (compound 70) 
Entry Catalyst Ligand Solvent T  Time Yield
4
 Z/E ratio
5,6
 ee
6
 
1 Pd(0)
1
 PPh3 CH2Cl2 rt 24h 55% 18:82
5
 - 
2 Pd(0)
1
 Trost(1)
3
 CH2Cl2 rt 24h 56% 23:77
5
  
18:82
6
 
81% (Z)  
59% (E) 
3 Pd(II)
2
 Trost(1)
3
 CH2Cl2 rt 4h 90% 16:84
6
 79% (Z) 
51% (E) 
4 Pd(II)
2
 Trost(1)
3
 CH2Cl2 0°C  5h 75% 17:83
5,6
 75% (Z) 
45% (E) 
5 Pd(II)
2
 Trost(1)
3
 Toluene rt 2h30 89% 22:78
6
 76% (Z) 
22% (E) 
6 Pd(II)
2
 Trost(1)
3
 THF rt 24h 50% 15:85
5,6
 53% (Z) 
11% (E) 
7 Pd(II)
2
 Trost(1)
3
 CH3CN rt 1h 91% 16:84
6
 60% (Z) 
20% (E) 
8 Pd(II)
2
 Trost(1)
3
 Dioxane rt 
 
72h 64%  22:78
56
 35% (Z) 
7% (E) 
Reaction conditions: Pd catalyst (0.08 eq.), ligand (0.24 eq.), BnNH2 (2 eq.); 
1 [Pd2(dba)3]CHCl3 ; 
2 [Pd(allyl)Cl]2 ; 
3 (R,R)-
Trost DACH Phenyl; 4 isolated yield after chromatography;  5 calculated on 1H NMR; 6 determined by HPLC (Chiralpak AD-
H) 
 
 
3.3.1.2.2 (Z)-Methyl carbonate substrate (compound 76) 
Allylic substitutions were performed with (Z)-Methyl carbonate substrate (compound 76) to 
observe and confirm if the same trend could be noticed than for the (Z)-Ethyl carbonate 
(scheme 37). The results of the (Z)-substrate (table 5) in terms of yield and enantioselectivity 
were poor and isomerization to the (E) product occurred the same way as for (Z)-Ethyl 
carbonate indicating that substitutions on the (Z)-species are not very promising. Therefore, 
the (Z)-forms of the other substrates were not synthesized.  
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Scheme 37: Allylic substitution on (Z)-Methylcarbonate substrate 76 with benzylamine 
 
Table 5: Allylic substitutions on (Z)-Methylcarbonate substrate (compound 76) 
Entry Ligand Solvent Time yield
2
 Z/E ratio
3
 ee
3
 
1 PPh3 CH2Cl2 24h 75% 33:67 - 
2 Trost(1)
1
 CH2Cl2 24h 33% 17:83 66% (Z) 32% (E) 
3 Trost(1)
1
 Toluene 72h 13% 21:79 77% (Z) 34% (E) 
4 Trost(1)
1
 THF 72h 13% 22:78 57% (Z) 9% (E) 
5 Trost(1)
1
 ACNL 72h 57% 22:78 31% (Z) 2% (E) 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), BnNH2 (2 eq.), rt ; 
1 (R,R)-Trost DACH Phenyl; 2 isolated 
yield after chromatography; 3 determined by HPLC (Chiralpak AD-H) 
 
 
3.3.1.3 Benzylcarbamate substrate 
As reported by Tsuji, benzylcarbamates were found to be good leaving groups with C-
nucleophile under neutral reaction conditions (without addition of a base)
51,81
. In 2005, Tunge 
et al.
82
, described reactions with carbamate leaving groups where decarboxylation lead to the 
formation of amine reactive intermediate. In his thesis, Claude Schärer
83
 observed high 
enantioselectivity using benzylcarbamate as leaving group in an asymmetric allylic 
substitution. The advantage of such leaving groups is the catalytic decarboxylative allylic 
amination which represents an interesting reaction due to its good atom economy and mild 
reaction conditions. Therefore, reactions with this leaving group were performed.  
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As a first attempt, allylic substitutions with benzylamine as the nucleophile were carried out 
to see which influence it would have on the reaction (scheme 38).  The results are 
summarized in table 6. The major isomer being the (E) form, only the ee’s of the (E)-isomers 
were compared. The best ee’s are correlated to CH2Cl2 as solvent but toluene gave the best 
yield. A dramatic drop of ee was observed with toluene at 40°C. Poor results were obtained 
with dioxane (entry 3, table 6) and DMF (entry 6, table 6) as solvents. Furthermore, the 
reaction was never completed leading to poor yields and recovery of starting material. The 
decarboxylation preceding the substitution could not be observed making the substrate 
unsuitable for reaction such as described by Tunge et al. From the poor results summarized in 
table 6 and compared to the carbonate leaving group, benzylcarbamate was found an 
unsuitable leaving group for our system.  
 
Scheme 38: Allylic substitution on (E)-Benzylcarbamate substrate 71 with benzylamine 
 
Table 6: Allylic substitutions on (E)-Benzylcarbamate substrate (compound 71) 
Entry Ligand Solvent T  Yield
2
 Z/E ratio
3
 ee
3
 
1 PPh3 CH2Cl2 rt 31% 29:71 - 
2 Trost(1)
1
 CH2Cl2 rt 29% 17:83 77% (Z) 49% (E) 
3 Trost(1)
1
 Dioxane rt 16% 11:89 44% (Z)   8% (E) 
4 Trost(1)
1
 Toluene rt 54% 22:78 79% (Z) 32% (E) 
5 Trost(1)
1
 Toluene 40 °C 38% 27:73 41% (Z)    7% (E) 
6 Trost(1)
1
 DMF rt 33% 12:88
 
42% (Z) 32% (E) 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), BnNH2 (3 eq.) ; 
1 (R,R)-Trost DACH Phenyl;  1 isolated yield 
after chromatography; 2 determined by HPLC (Chiralpak AD-H) 
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3.3.1.4 Chloracetate substrate 
In general, allylic carbonates are more reactive than acetates due to decarboxylation of 
carbonate (see section 3.3.1.1). Nevertheless, from the previous results, allyl carbonates 
seemed to be less suitable leaving groups in our system. In the literature, chloracetate is a 
known leaving group for allylic substitutions
78
 and therefore, it was also tested as leaving 
group in this thesis (scheme 39). The results are summarized in table 7.  
 
 
Scheme 39: Allylic substitution on (E)-Chloracetate-substrate 72 with benzylamine 
 
 
Table 7: Allylic substitutions on (E)-Chloracetate substrate (compound 72) 
Entry Catalyst Solvent T  Time Yield
3
 Z/E ratio
4,5
 ee 
5
 
1 Pd(0)
1
 CH2Cl2 rt 
 
36h 48% 20:80
5
 
17:83
4
 
76% (Z)  52% (E) 
2 Pd(II)
2
 CH2Cl2 rt  3h30 84% 16:84
5
 78% (Z)  47% (E) 
3 Pd(II)
2
 CH2Cl2 0°C 
 
24h 80%  19:81
5
 
16:84
4
 
78% (Z)  50% (E) 
 
4 Pd(II)
2
 Toluene rt 
 
36h 69% 25:75
5
 
24:76
4
 
78% (Z)  41% (E) 
Reaction conditions: Pd catalyst (0.08 eq.), (R,R)-Trost DACH Phenyl (0.24 eq.), BnNH2 (2 eq.) ; 
1 [Pd2(dba)3]·CHCl3 ; 
2[Pd(allyl)Cl]2 ; 
3 isolated yield after chromatography;  4 calculated on 1H NMR; 5 determined by HPLC (Chiralpak AD-H) 
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Since the choice of the catalyst seems to depend on the substrate and the leaving group, the 
same reaction with [Pd2(dba)3]·CHCl3  or [Pd(allyl)Cl]2  (entry 1 and 2, table 7) was 
performed. With a better yield and similar ee, [Pd(allyl)Cl]2 was chosen as the catalyst and 
was used as a standard for the next reaction. Lowering the temperature, slightly improved the 
ee. Reaction in toluene (entry 4, table 7) gave moderate results. With a short reaction time and 
good yields, chloracetate was identified to be a promising leaving group for further 
improvement of the reaction conditions. 
 
3.3.2 E/Z isomerization 
E/Z isomerization is frequently observed in palladium catalyzed allylic substitution. One 
explanation for this effect is given by the π-σ-π isomerization which results from syn-anti 
interconversion around the σ-(C-C) bond. In our system, E/Z isomerization leads to the same 
ratio, either starting from (Z) or (E)-substrate. A possible explanation for this effect is the σ-
interconversion during complexation of the palladium-ligand
84-85
. Scheme 40 illustrates a 
possible mechanism involving our substrate. The oxidative addition, where Pd-ligand 
complex coordinates to the substrate and the leaving group is released, leads to a steric 
hindrance in case of the (Z)-compound 82 bringing the palladium to interconvert in a σ-bond 
which allows the molecule to rotate into a more stable (E)-conformation 84. The Pd-ligand 
then interconvert again into the more stable π-complex 85, which allows the nucleophilic 
attack. Starting either from the (Z) or the (E) substrate, the equilibrium arising during the 
coordination of Pd complex to the substrate affords the same (E)/(Z) ratio of product.  
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Scheme 40: π-σ-π isomerization  
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3.3.3 Ligand screening with (E)-Chloracetate substrate (compound 72) 
Chiral ligands play a crucial role in allylic subsitutions since the ligand-substrate interactions 
induce enantioselectivity on the substrate. Several ligands have been designed for this 
reaction including different concepts. The C2-symmetric diphosphine ligands developed by 
Trost, are ligands which create a chiral space enveloping the allyl substrate. The increase of 
the bite angle, which corresponds to the P-Pd-P angle, improves the chiral cavity which 
embraces the allyl moiety by extending the chiral environnment toward the allyl fragments. 
Chiral phosphinooxazoline (PHOX) ligands were developed independently at the same time 
by Pfaltz, Helmchen and Williams and compared to the C2-symmetrical ligands control the 
selectivity based on electronic effects
86
.  
In our system, the starting substrate is a racemic mixture of compound 72 containing two 
identical substituents at the allylic termini, which are converted to the same symmetrical 
intermediate. In that case, the enantioselectivity is determined during the nucleophilic 
addition to the allyl system. Controlling which terminus of the allyl group is attacked would 
determine which enantiomer is formed
87
. Using Trost ligands would induce enantioselectivity 
from sterical hindrance of the phenyl group attached to the ligand. In addition, hydrogen-bond 
interactions of one N-H unit in the Pd-coordinated Trost complex may help the ionization and 
nucleophile attack
37
. On the other hand, PHOX ligands discriminates the allylic terminus by 
electronic effects of the P, N heteroatoms located on the ligand but also by sterical effects of 
the substitutents attached to the ligand. 
These two chiral ligand concepts have been investigated in our system. Three different PHOX 
ligands (scheme 41) were tested as well as four different Trost ligands (scheme 42). Table 8 
summarizes the results. 
Good yields were obtained with all three PHOX ligands (entry 1-3, table 8) but unfortunately 
the ee’s were poor and long reaction times were needed to complete the reaction. It is 
interesting to note that PHOX ligands only showed little isomerization to the (Z)-product 
probably due to a stronger binding to the allyl system. In general, PHOX ligands are known to 
be good ligands for larger substrates. On the other hand, the results obtained for the Trost 
ligands showed moderate to good yields and in the case of Trost (1) and Trost (2) moderate 
ee’s (entry 4 and 5, table 8). No reaction to the desired product could be observed with Trost 
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(3) (entry 6, table 8). Fortunately, promising results were obtained with Trost (4) chiral ligand 
(entry 7, table 8) where isomerization was reduced so that less than 5 % (Z)-product was 
observed. This was probably due to the larger bite angle of this ligand allowing a better 
“envelopment” or control of the substrate with good yield and a high ee.  
From a general observation, the Z/E isomerization is dependent on the ligand and probably on 
the way the Pd-ligand complex binds to the substrate. PHOX ligands are sterically less 
demanding than Trost ligands and probably have a stronger binding access to the substrate, 
minimizing isomerization to the less stable (Z)-isomer. If however, Trost (1) and Trost (4) are 
compared, a closer look has to be taken on the bite angle (scheme 43). Trost (1) has a small 
bite angle compared to Trost (4). As consequence, the phenyl groups of Trost (1) ligand could 
be the cause of sterical hindrance with the substrate forcing it to change conformation. On the 
other hand, Trost (4) has a larger bite angle which could allow the substrate to fit into the 
“cavity” of the ligand and therefore minimizing isomerization to the (Z)-isomer (scheme 43) 
With the enantioselectivity being improved as well as the Z/E isomerization being 
substantially minimized, chiral ligand (R,R)-Trost ANDEN was chosen as the ligand of choice 
for further screenings.  
 
  
 
Scheme 41: PHOX ligands: PHOX (1) = (S)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-
oxazoline; PHOX (2) = (S)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline; PHOX (3) 
= (S)-4-tert-butyl-2-[2-(Diphenylphosphino)phenyl]-2-oxazoline 
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Scheme 42: Trost ligands: Trost (1) = (R,R)- Trost DACH Phenyl; Trost (2) = (R,R)- Trost DACH 
Naphtyl; Trost (3) = (R,R)-Trost Pyridyl; Trost (4) = (R,R)-Trost ANDEN 
 
 
Table 8: Ligands screening with (E)-Chloracetate substrate (compound 72) 
Entry Ligand Time Yield
1
 Z/E ratio
2
 ee
3
 
1 (S)-PHOX(1) 7 days 84% 6:94
 
11% (Z)   40% (E) 
2 (S)-PHOX(2) 7 days 84% 7:93
 
  4% (Z)   33% (E) 
3 (S)-PHOX(3) 7 days 88% 6:94
 
  3% (Z)   66% (E) 
4 (R,R)-Trost (1) 3h 84% 15:85
 
78% (Z)   47% (E) 
5 (R,R)-Trost (2) 2 days 63%  14:86
   
30% (Z)     4% (E) 
6 (R,R)-Trost (3) - - - - 
7 (R,R)-Trost (4) 4h 71% < 5% (Z) 78% (E) 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), BnNH2 (2 eq.), rt; 
1 isolated yield after chromatography;  
2 calculated on 1H NMR; 3 determined by HPLC (Chiralpak AD-H) 
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Scheme 43:  Bite angle comparison
6 
 
3.3.4 Solvent screening with (E)-Chloracetate substrate (compound 72) 
The choice of solvent is another parameter which has to be taken into account
88
, when 
performing an allylic substitution since it sometimes strongly influences the rate of the 
reaction and the ee. The typical solvents used in this reaction are toluene, dichloromethane or 
more polar solvents such as THF and DMF. 
Using the (E)-Chloracetate substrate (compound 72), a solvent screening from non-polar 
solvents such as toluene to more polar ones like DMF was conducted. Six different solvents 
were screened: toluene, THF, α,α,α-trifluorotoluene, dichloromethane, DMF, acetonitrile. The 
results are summarized in table 9.  
 
Table 9: Solvent screening on (E)-Chloracetate substrate (compound 72) 
Entry Solvent Time Yield
1
 Z/E ratio
2
 ee
2
 
1 Toluene 2h30 63% 3:97 90% (E) 
2 THF 7 days 32% 6:94 35% (E) 
3 PhCF3 1 day 55% 2 :98 89% (E) 
4 CH2Cl2 4h 71%  < 5% (Z) 78% (E) 
5 DMF 6 days 49% 8:92 53% (E) 
6 CH3CN 2 days 52% 5:95 66% (E) 
 Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), (R,R)-Trost ANDEN (0.24 eq.), BnNH2 (2 eq.), rt; 
1 isolated yield after 
chromatography; 2 determined by HPLC (Chiralpak AD-H) 
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Results obtained from the polar solvents, CH3CN and DMF (entry 5 and 6, table 9), were 
moderate with moderate yield and moderate to low ee’s, demonstrating that these solvent are 
not suitable to our system. Low yield and low ee was observed with THF as solvent (entry 2, 
table 9). PhCF3 is a relatively new class of solvent used in allylic substitution. It is slightly 
more polar than THF and slightly less polar then dichloromethane
89
. Improvements of the ee 
were obtained with PhCF3 (entry 3, table 9) and toluene (entry 1, table 9) but the yields were 
moderate, probably due to some solubility issues. The solubility in dichloromethane was 
better than in toluene and the yield was slightly increased compared to toluene with a good ee 
(entry 4, table 9). Because of solubility issues, dichloromethane was chosen as a standard 
solvent even though toluene and PhCF3 showed good results. It is noteworthy that the solvent 
has only a low influence in the Z/E isomerization keeping it below 10%. 
 
3.3.5 Base screening with (E)-Chloracetate substrate (compound 72) 
Different bases with different basicity (DMAP, Et3N, EDIPA, DBU, BSA) were compared 
under standard reaction conditions and results are summarized in table 10. BSA is frequently 
used in allylic substitutions. In our case, results (entry 1, table 10) showed moderate yield, 
moderate ee but low isomerization. Tertiary, non-nucleophilic bases such as N-
Ethyldiisopropylamine (entry 2, table 10) improved the reaction with shorter reaction time, 
good yield, high ee and low isomerization. Since the reaction was fast, an experiment at 0°C 
(entry 3, table 10) was performed to improve the ee and succeeded giving 92% ee. Good 
results were also obtained with 4-DMAP (entry 4, table 10) but the yield was slightly lower. 
Similar to EDIPA but slightly less hindered and slightly less basic, results from Et3N (entry 5, 
table 10) were as good as those from EDIPA. DBU is a stronger base with a pKa of 12.7 
90
. 
The results with DBU (entry 6, table 10) showed a low yield with moderate ee probably due 
to its higher basicity.  
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Table 10: Base screening on (E)-Chloracetate substrate (compound 72) 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), (R,R)-Trost ANDEN (0.24 eq.), BnNH2 (2 eq.) , CH2Cl2 ; 
1 BSA (2 eq.), 
NaOAc (0.032 eq.); 2 base (1 eq.) ; 3 isolated yield after chromatography;  4 calculated on 1H NMR; 5 determined by HPLC 
(Chiralpak AD-H) 
 
From the results summarized in table 10, EDIPA was chosen as the best base for our allylic 
substitution. To find the best condition for our system and to understand which role the base 
plays, a screening with different amount of base was performed and is summarized in table 
11.  With 0.2 eq. of EDIPA, the reaction needs more time and the ee is as good as without the 
base. Addition of 2 eq. of base, gave results similar to addition of 1 eq. of EDIPA. Therefore 
1 eq. of EDIPA was chosen as standard for our system. 
 
 
Table 11: Base amount screening on (E)-Chloracetate substrate (compound 72) 
Entry Base Time Yield
1
 Z/E ratio
2
 ee
2
 
1 EDIPA (0.2 eq.) 4h 75% 1 :99 74% (E) 
2 EDIPA (1 eq.) 1h30 75% 2 :98 85% (E) 
3 EDIPA (2 eq.) 1h30 82% 2 :98 80% (E) 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), (R,R)-Trost ANDEN (0.24 eq.), BnNH2 (2 eq.), CH2Cl2,  rt; 
1 isolated yield 
after chromatography;  2 determined by HPLC (Chiralpak AD-H) 
Entry Base  Time T Yield
3
 Z/E ratio ee
5
 
1 BSA/NaOAc
1
  36h rt 67% 2 :98
4,5
 74% (E) 
2 EDIPA
2
  1h30 rt 75% 2 :98
5
 85% (E) 
3 EDIPA
2
 2h 0°C 70% 1 :99
4,5
 92% (E) 
4 4-DMAP
2
  1 day 0°C 59% only (E)
4,5
 89% (E) 
5 Et3N
2
 3h 0°C 93% only (E)
4,5
 89% (E) 
6 DBU
2
 4 days 0°C to rt 32% 5 :95
4
 
6 :94
5
 
74% (E) 
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As seen in the results obtained above, base addition plays an important role in the allylic 
substitution, shortening the reaction time, improving yield and ee. In the literature, the use of 
BSA and its role in allylic substitution to generate anionic nucleophile from the conjugated 
acid in situ with dimethyl malonate is well known
91-92
. This method was invented by Trost
22
 
and improved the selectivity of the reaction as well as the rate of reaction.  
One possible effect the leaving group could have on the reaction is that the acetate ion may 
play an active role in the catalytic process acting as nucleophile and therefore competing with 
the poor or stabilized nucleophile (scheme 44)
47
. The low yield without the base could be 
explained by the fact that the chloracetate ion reacts faster with the cationic palladium system 
than the nucleophile. Addition of the base would quench the reversibility of the reaction 
avoiding the leaving group to attack before the nucleophile. 
 
 
Scheme 44: Reversibility during ionization process 
 
 
3.3.6 Catalyst 
To get an insight into our system, stoichiometric allylic substitutions experiments were 
performed and followed by NMR measurements which allow the observation of the system in 
situ. Each step of the reaction was analyzed to get an outline of the mechanism.  
For this NMR study, 
1
H NMR spectra were recorded and the region belonging to the allylic 
system of the molecule was analyzed (figure 1). Before starting the experiment, spectra of 
[Pd(allyl)Cl]2 (blue line) and (R,R)-Trost ANDEN (dark green line, figure 1) and (E)-
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Chloracetate substrate (pink line, figure 1) were recorded separately. Addition of the catalyst 
to the ligand, showed the formation of the Pd complex with disappearance of characteristic 
peak belonging to ligand and catalyst and with formation of a new set of peaks (grey line, 
figure 1).  Addition of the substrate to the Pd complex after 15min, showed no significant 
binding of the Pd complex to the allyl system. The allyl system of the substrate and the 
additional peak belonging to the Pd complex stayed unchanged (light yellow line, figure 1). 
After addition of EDIPA, the same was observed and no significant change of the substrate 
could be noticed (light blue line, figure 1). A modification occurred only when BnNH2 was 
added to the system. A new set of peaks appeared between 5 and 5.25 ppm and new peaks in 
the allylic region corresponding to product (red line, figure 1). As described in the literature, 
activation of the palladium-ligand system and coordination of the complex to the substrate 
occurred only after addition of the nucleophile.  
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Figure 1: 
1
H NMR experiments in CDCl3, at rt and with BnNH2 (2 eq.), [Pd(allyl)Cl]2 (0.5 eq.), (R,R)-
Trost ANDEN (0.72 eq.) 
 
It is known from the literature that [Pd(allyl)Cl]2 in oxidation state +2 is reduced, in situ, to 
the active catalyst with oxidation state 0 by addition of ligand and nucleophile. Scheme 45 
illustrates the mechanism. The halogen-bridged dimer is relatively non-electrophilic
93
 and 
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palladium-ligand complex has first to be formed to increase the electrophilic character of the 
allyl system. Nucelophile attack allows the formation of the active Pd(0) which is then able to 
coordinate with the substrate. In our reaction, after formation of the palladium-ligand complex 
the nucleophile reacts with the allyl group and forms the N-Allylbenzylamine hydrochloride. 
The reactive palladium-ligand is then able to react and form the η3-allyl complex with the 
substrate which allows the substitution to occur.  
 
 
 
Scheme 45: Activation of the Pd complex through the nucleophile 
 
To prove this mechanism, other NMR (
1
H and 
13
C) experiments were performed where 
BnNH2 was first added to [Pd(allyl)Cl]2 in stoichiometric amount. After 1h, the ligand was 
added to this mixture and an NMR spectrum was measured (figure 2 and 3). 
No significant change on the NMR pattern only a shift of the peaks was observed when 
benzylamine was added to the catalyst indicating no reaction. This was to expect due to the 
non-electrophilic character of the halogen-bridged dimer. After addition of (R,R)-Trost 
DACH Phenyl ligand, the complex was formed as well as the same set of peaks between 5-5.5 
ppm which probably correspond to the allyl system of N-allylbenzylamine. Furthermore, 3h 
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after addition of the ligand, the NMR tube turned black indicating the presence of elemental 
palladium. Scheme 46 illustrates a possible mechanism. 
To confirm our hypothesis, comparison between our reaction mixture after addition of BnNH2 
and commercially available N-Allylbenzylamine was performed on 
1
H NMR (figure 4). The 
similarity between the spectra comfirms our assumption and N-Allylbenzylamine can be 
listed as a byproduct in our reaction. 
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Figure 2: 
1
H NMR with BnNH2 (2 eq.) and [Pd(allyl)Cl]2 (0.5 eq.) then addition of (R,R)-Trost 
DACH Phenyl (1 eq.) 
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Figure 3: 
13
C NMR with BnNH2 (2 eq.) and [Pd(allyl)Cl]2 (0.5 eq.) then addition of (R,R)-Trost 
DACH Phenyl (1 eq.) 
 
 
 
 
Scheme 46: Formation of N-Allyl-Benzylamine hydrochloride after formation of Pd complex 
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Figure 4: Comparison between reaction mixture and N-Allylbenzylamine 
 
 
3.3.7 Catalyst Loading screening with (E)-Chloracetate substrate (compound 72) 
On industrial level, a low catalyst loading reduces waste and cost
84
. Nevertheless, even 
though initial cost of palladium is high, recovery and recycling is possible and easily made. 
Several experiments on catalyst loading were performed on our system using different 
conditions (solvent screening and base addition). Toluene, PhCF3 and CH2Cl2, our three best 
solvents, were tested under different catalyst loadings starting from 1 mol% up to 8 mol% 
with 3 times the amount of ligand respectively. The results are summarized in table 12. In 
toluene, comparable ee’s were observed for 8, 4 and 1 mol % catalyst loading but the yield 
dropped when 1 mol% was used (entry 1, 2 and 4, table 12). As comparison, Pd(0) was also 
tested with 4 mol% in toluene and almost exactly the same results were obtained (entry 3, 
table 12). The screening gave similar results for PhCF3 regarding ee and yield (entry 5, 6 and 
7, table 12). At 1.25 mol% and with addition of EDIPA, a drop in the yield was observed. In 
CH2Cl2, the same tendency is observed with a drop of yield but also of ee with 1.25 mol%. 
The threshold appears to be reached below 2.5 mol%.  In our case, the optimal reaction 
condition in terms of time, yield and ee was given with CH2Cl2 and 8 mol% catalyst.  
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Table 12: Catalyst loading screening with (E)-Chloracetate substrate (compound 72) 
Entry Catalyst
1
 Base Solvent T [°C]     
/Time 
Yield
3
 Z/E 
ratio
4
 
ee
4
 
1 Pd(II)
 
8 mol%
 
- Toluol rt/2h30 63% 3:97 90% (E) 
2 Pd(II)
 
4 mol%
 
- Toluol rt/24h 53% 3:97 85% (E) 
3 Pd(0) 4 mol% - Toluol rt/24h 55% 4:96 84% (E) 
4 Pd(II)
 
1 mol%
 
- Toluol rt/6 days 35% 2:98 89% (E) 
5 Pd(II)
 
8 mol%
 
- PhCF3 rt/24h 55% 2 :98 89% (E) 
6 Pd(II)
 
4 mol%
 
- PhCF3 rt/24h 59% 1:99 91% (E) 
7 Pd(II)
 
2.5mol%
 
- PhCF3 rt/48h 60% 2:98 91% (E) 
8 Pd(II) 1.25 mol% EDIPA
2 
PhCF3 rt/72h 40% 2 :98 88% (E) 
9 Pd(II)
 
8 mol%
 
EDIPA
2 
CH2Cl2 0/4h30 92% no (Z) 89% (E) 
10 Pd(II) 1.25 mol% EDIPA
2 
CH2Cl2 0/72h 26% no (Z) 69% (E) 
Reaction conditions:, (R,R)-Trost ANDEN (0.08 eq.), BnNH2 (2 eq.); 
1 Pd(II) = [Pd(allyl)Cl]2 and Pd(0) = 
[Pd2(dba)3]·CHCl3 ; 
2 (1 eq.); 3 isolated yield; 4 determined by HPLC (Chiralpak AD-H) 
 
 
3.3.8 Nucleophile scope with (E)-Chloracetate substrate (compound 72) 
A broad scope of different nucleophiles can be used in allylic substitutions depending on the 
desired product. Nevertheless, the nucleophiles are often divided into two different classes of 
nucleophiles, the soft (“stabilized”) - and hard (“unstabilized”) nucelophile. The former are 
derived from conjugate acids with pKa < 25 and the latter from pKa > 25
31
. Normally, overall 
retention of stereochemistry is observed with soft nucleophiles which add to the allyl system 
at the opposite side of the metal. On the other hand, inversion of stereochemistry is observed 
with hard nucleophiles since they undergo a transmetallation where the nucleophile attacks 
the metal center. In our case, we performed experiments using soft nucleophiles of three 
different classes: nitrogen, oxygen and carbon (N-, O-and C-nucleophiles).  
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3.3.8.1 C-nucleophiles 
C-nucleophiles were the first to be tested for C-C bond forming substitution reactions. 
Dimethylmalonate is a standard nucleophile and our first C-nucleophile tried on our system 
(scheme 47). Results are summarized in table 13. With dimethylmalonate as nucleophile, C2-
symmetrical Trost ligands were found to be unsuitable ligands since no reaction was observed 
with Trost (1) and only traces of product with Trost (4) (entry 2 and 3, table 13). The reaction 
worked only in the presence of PHOX ligands. The PHOX (2) ligand worked with the best 
yield and ee when heating at 40°C in CH2Cl2 and toluene (entry 5 and 6, table 13). Otherwise 
the reaction was too slow and incomplete (entry 4, table 13).  The reactions with PHOX (1) 
were faster with good yield but moderate ee’s. To improve the ee, the temperature was 
lowered to 0°C but no significant change could be observed. Different solvents like CF3Ph 
and THF were tried but only a drop of the yield could be detected (entry 9 and 10, table 13). 
Finally, PHOX (3) was tested and the reaction was fast with excellent yield but again 
moderate ee. Standard reaction conditions with dimethylcarbonate use BSA/NaOAc as base. 
Reaction with EDIPA (entry 12, table 13) was performed but no reaction could be observed. 
It is interesting to note that in all cases, no Z/E isomerization could be observed. 
 
 
Scheme 47: Allylic subsitution with dimethylmalonate affording compound 94 
 
Other C-nucleophiles such as Meldrum’s acid, 1,3-Cyclopentanedione, Dimethyl 
methylmalonate were tested but no reaction was observed under racemic reaction conditions. 
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Table 13: Screening with dimethylmalonate 
Entry Ligand Base Solvent T / Time Yield
3
 Z/E ratio
5
 ee
5
 
1 PPh3 BSA/NaOAc
1
 MED rt/6h 90% onyl (E) - 
2 Trost (4) BSA/NaOAc
1
 MED rt/24h - - - 
3 Trost (1) BSA/NaOAc
1
 MED rt/24h - - - 
4 PHOX(2) BSA/NaOAc
1
 MED rt/6 days 32% 
4
 - - 
5 PHOX(2) BSA/NaOAc
1
 MED 40°C/24h 91% onyl (E) 71% 
6 PHOX(2) BSA/NaOAc
1
 Toluene 40°C/48h 81%
 4
 onyl (E) 77% 
7 PHOX(1) BSA/NaOAc
1
 MED rt/5h30 88% onyl (E) 64% 
8 PHOX(1) BSA/NaOAc
1
 MED 0 °C/ 24h 92% onyl (E) 65% 
9 PHOX(1) BSA/NaOAc
1
 PhCF3 0°C to rt/48h 61% 
4
 onyl (E) 65% 
10 PHOX(1) BSA/NaOAc
1
 THF 0°C/72h 46% 
4
 onyl (E) 66% 
11 PHOX(3) BSA/NaOAc
1
 MED rt/3h30 95% onyl (E) 61% 
12 PHOX(3) EDIPA
2
 MED rt /24h - - - 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), compound 72 (1 eq.); 
1 BSA (2 eq.), NaOAc (0.032 eq.);        
2 EDIPA (1 eq.); 3 isolated yield; 4 HPLC conversion; 5 determined by HPLC on a chiral stationary phase 
 
 
3.3.8.2 N-nucleophiles 
The enantioselective allylic amination is a well-established process and several examples 
using primary and secondary amines are well-known
94
. The obtained allylic amine and 
derivatives are interesting compounds for further functionalization and are key steps for 
amino sugars, pyrroles etc. A wide range of different N-nucleophiles was used in our system: 
primary and secondary aryl amines, primary and secondary alkyl amines etc. leading to a vast 
library of different allylic amine products in good yield and acceptable ee.  
A first range of six different N-nucleophiles, BnNH2, aniline, m-anisidine, piperidine, 
diethylamine and butylamine, was screened under different conditions with the three best 
solvents CH2Cl2, toluene and PhCF3 to afford the desired products (scheme 48). The results 
are summarized in table 14.  
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Scheme 48: Products from allylic substitutions with different N-nucleophiles 
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Table 14: First N-nucleophiles screening  
Entry Nucleophile Solvent Time Yield
2
 Z/E ratio
4
 ee
4
 
1 BnNH2 CH2Cl2 4h30 92% only  (E) 89% (E) 
2 BnNH2
1
 CH2Cl2 72h 72% 2:98 82% (E) 
3 BnNH2 Toluene 3h 88% 3 :97 86% (E) 
4 BnNH2 CF3Ph 20min 93% 1:99 91% (E) 
5 Aniline CH2Cl2 45min 95% only (E) 89% (E) 
6 Aniline
1
 CH2Cl2 24h 84% 3:97 40% (E) 
7 Aniline Toluene 20min 92% only (E) 86% (E) 
8 Aniline CF3Ph 15min quant only (E) 93% (E) 
9 p-Anisidin CH2Cl2 20min 97% only (E) 88% (E) 
10 p-Anisidin
1
 CH2Cl2 1h 90% 4:96  26% (E) 
11 p-Anisidin Toluene 10min 99% 6:94 87% (E) 
12 p-Anisidin CF3Ph 10min quant 1:99 92% (E) 
13 Piperidine CH2Cl2 1h 82% <2% (Z) 47% (E) 
14 Piperidine Toluene 7h 65% only (E)  81%(E) 
15 Piperidine CF3Ph 29h 51% 
3
  only (E) 28% (E) 
16 Butylamine CH2Cl2 24h 21% only (E) 74% (E) 
17 Butylamine Toluene 1h30 90% 3:97  88% (E) 
18 Butylamine CF3Ph 20min 86% only (E)  88%(E) 
19 Diethylamine CH2Cl2 3h 86% 2:98  19% (E) 
20 Diethylamine Toluene 6h30 64% 4:96  88% (E) 
21 Diethylamine CF3Ph 20min 69% 2:98 41% (E) 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), (R,R)-Trost ANDEN (0.24 eq.), compound 72 (1 eq.),  EDIPA (1 eq.), 0°C;  
1without base and at rt; 3 25% yield of byproduct 100; 4 determined by HPLC on a chiral stationary phase 
 
Excellent results were obtained with primary aryl amines such as benzylamine, aniline, p-
anisidine with excellent yields and good to excellent ee (entry 1-12, table 14).  Noteworthy, in 
reactions without a base (entry 2, 6 and 10, table 14) the conversion was complete but the ee 
dropped dramatically underlining the role of the base in the enantioselective process. 
Reactions with piperidine gave moderate ee in CH2Cl2 and PhCF3 (entry 13 and 15, table 14) 
 Results and Discussions 
___________________________________________________________________________ 
- 63 - 
 
but good ee in toluene (entry 14, table 14). Good results were obtained from alkyl amines 
such as butylamine in toluene and CF3Ph (entry 17 and 18, table 14) but the yield decreased 
when the reaction was performed in CH2Cl2 (entry 16, table 14). Diethylamine worked best in 
toluene (entry 20, table 14) while CH2Cl2 and PhCF3 showed a decrease in ee (entry 19 and 
21, table 14). 
The substitution with benzylamine as a nucleophile in dichloromethane as solvent was 
repeated on a 2g scale resulting in the same result in terms of ee and yield as on a small scale.  
During the allylic substitution with piperidine, chloracetate reacted with piperidine to afford 
byproduct 100 (scheme 49 and entry 15, table 14) which was isolated and characterized.  
 
 
 
Scheme 49: Byproduct 100 
 
 
Results from the initial N-nucleophile screening showed that the primary aryl amines are good 
nucleophiles for our system. Therefore a second set of screening was performed with different 
aryl nucleophiles bearing electron withdrawing groups or electron donating groups and with 
an increased sterical demand. Results are summarized in scheme 50. 
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Scheme 50: Secondary aryl amine screening with the reaction conditions of [Pd(allyl)Cl]2 (0.08 eq.), 
(R,R)-Trost ANDEN (0.24 eq.), compound 72 (1 eq.),  EDIPA (1 eq.), 0°C, CH2Cl2 
 
 
For all these N-nucleophiles, excellent ee’s and yields were obtained except for (2,6-
diisopropylphenyl)amine which is probably due to the steric hindrance caused by the 
isopropyl group next to the amine.  
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During allylic substitution with 3,4,5-trimethoxyaniline, byproduct 111 was isolated (scheme 
51). Depending on the nucleophile, the corresponding N-allyl products were then identified on 
LC-MS during allylic substitutions.  
 
Scheme 51: Byproduct 111 
 
3.3.8.2.1 Benzimidazole, Indole and Me-indole as N-Nucleophiles 
Allylic substitutions with a new class of N-nucleophiles were performed: benzimidazole,  
indole and Me-indole (scheme 52). The results are summarized in table 15. Reactions with 
such aromatic hetereocycles worked only with benzimidazole (entry 1-3, table 15) but with 
poor yield and ee (entry 2 and 3, table 15). Reaction of entry 3 was performed in CF3Ph and 
side product 113 (scheme 53) was isolated in 11% yield. It is noteworthy that Z/E 
isomerization was minimized when (R,R)-Trost ANDEN was used compared to PPh3 as 
ligand. Unfortunately, no reactions were observed with indole and Me-indole (entry 3 and 4, 
table 15) and the starting materials were recovered. Nevertheless, such products are 
interesting compounds and improvement of the reaction might be possible in future.  
 
Scheme 52: Allylic substitution on compound 72 with benzimidazole as nucleophile. 
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Table 15: Screening with benzimidazole, indole and 2-methylindole as nucleophile and (E)-
Chloracetate substrate (compound 72) 
Entry Nucleophile Ligand Time Yield
3
 Z/E ratio
4
 ee
4
 
1 Benzimidazole PPh3 24h 88% 26:74 - 
2 Benzimidazole Trost(4) 5 days 42% 4:96 32% 
3
1
 Benzimidazole Trost(4) 5 days 36% 5:95 10% 
4
2
 Indole PPh3 72h - - - 
5
2
 2-methylindole PPh3 72h - - - 
Reaction conditions: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), EDIPA (1 eq.), CH2Cl2, rt; 
1 reaction conducted in CF3Ph;     
2 recovery of starting material; 3 yield after chromatography columns; 4 determined by HPLC (Chiralpak AD-H ) 
 
 
Scheme 53:  Byproduct 113 
 
3.3.8.3 O-Nucleophiles 
Oxygen nucleophiles are not commonly used in allylic substitutions since they are poor 
nucleophiles. However, aryloxides have been used as nucleophiles for the Tsuji-Trost 
reaction. Methods for the asymmetric installation of C-O bonds and the allylic ether products 
which are obtained are therefore very interesting. We investigated the allylic subsitution of 
several aryloxides on our system and the results are summarized in scheme 54. 
In terms of yield and ee, nice results were obtained with 3,4-dimethoxyphenol and its 
“homologues” 3,4-(methylendioxy)phenol and 4-methoxyphenol. Yields for 3,5-
dimethoxyphenol, 2,5-dimethoxphenol, 2-tert-butyl-4-hydroxyanisole, and 2,6-
dimethoxyphenol were moderate but good ee’s were obtained. Steric hindrance, combined 
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with poor nucleophilicity may be the cause of these results. Reactions with 3,4,5-
trimethoxyphenol and 2,6-di-tert-butyl-4-methoxyphenol were unsuccessful probably due to 
steric hindrance and low nucleophilicity. Nevertheless, these results show that in general 
phenolic O-nucleophiles are suitable on this system.  
 
Scheme 54: O-nucleophile screening with the reaction conditions of [Pd(allyl)Cl]2 (0.08 eq.), (R,R)-
Trost ANDEN (0.24 eq.), compound 72 (1 eq.),  EDIPA (1 eq.), 0°C, CH2Cl2 
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During allylic substitutions with 2,5-dimethoxyphenole, byproduct 123 was isolated (scheme 
55).  Depending on the nucleophile, the corresponding O-allyl products were then identified 
on LC-MS during allylic substitutions.  
 
 
 
Scheme 55: Byproduct 123 
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3.4 Determination of the absolute configuration 
To determine the absolute configuration of our allylic amine products, derivatization to a 
known compound was necessary. For each obtained allylic amine, the oily-liquid consistency 
was troublesome and several crystallization attempts were unsuccessful. Fortunately, a way 
was found to overcome this problem. In the literature, N-(1,5-dihydroxypenta-2-yl)benzamide 
is known and has been characterized
95-96
. Therefore, our substitution product was derivatized 
into compound 125 (scheme 56). The synthesis started from the hydrogenation of 
benzylamine substitution product 80 with H2, Pd(C) in EtOH to afford 124 (42% yield) which 
was followed by coupling with benzoyl chloride to afford the crystalline compound 125 (60% 
yield) 
 
 
Scheme 56: Substitution product derivatization to compound 125 
 
At the same time, optically pure compounds were synthesized according to scheme 57 and 58 
Starting from commercially available H-D-glu(OMe)-OMe·HCl (126) (scheme 57) 
respectively H-L-glu(OMe)-OMe·HCl (129) (scheme 58), coupling with benzoyl chloride 
afforded the carbamate compounds 127 (93% yield) and 130 (93% yield) respectively.  
Desired products 128 and 131 were obtained by reduction with LiAlH4 in 63% yield 
respectively 21% yield. Optical rotation as well as assignment of the HPLC peaks of the 
enantiomers was made possible with the optically pure compounds. The comparison of the 
results allowed us to determine the absolute configuration of our major enantiomer from the 
allylic substitution which was defined as (R), see table 16 and figure 5. The absolute 
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configurations of the other allylic amines were not determined experimentally. However, 
supposing an analoguous mechanism of the reaction they were assumed to be (R). 
 
 
Scheme 57: Synthesis of optically pure (R)-N-(1,5-dihydroxypenta-2-yl)benzamide 128 
 
 
 
Scheme 58: Synthesis of optically pure (S)-N-(1,5-dihydroxypenta-2-yl)benzamide 131 
 
 
Table 16: Optical activity and melting point of N-benzoyl-Glu-(OCH3) 
 
 Compound 
125 
N-Benzoyl-D- 
Glu-(OCH3) 
N-Benzoyl-L- 
Glu-(OCH3) 
[α]20D  (c=0.01,MeOH) +27 +33 -34.5 
mp [°C] 104.4 - 106.2 106.4 – 109.4 106.5 – 107.4 
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Figure 5: Chromatogram of compound 125 
 
A comparison of the reaction with different ligands is summarized in table 17. All products 
with the different (S)-PHOX ligands were determined as (R). Absolute configurations from 
products with (R,R)-Trost (1) and (R,R)-Trost (2) were established as (S). Products from 
(R,R)-Trost (4) were of the (R)-configuration.  
 
Table 17: Comparison of the absolute configurations with different ligands 
Ligand Yield
2 
ee
3
 Abs. conf.
4
 
(S)-PHOX(1) 84% 40% (E)  (R) 
(S)-PHOX(2) 84% 33% (E)  (R) 
(S)-PHOX(3) 88% 66% (E)  (R) 
(R,R)-Trost(1) 84% 47% (E)  (S) 
(R,R)-Trost(2) 63%    4% (E)  (S) 
(R,R)-Trost(4)
1
 92% 89% (E)  (R) 
Reaction condition: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), BnNH2 (2 eq.), CH2Cl2, rt; 
1
 with EDIPA (1 eq.), 
0°C; 
2
 isolated yield; 
3
 determined by HPLC on chiral stationary phase;
 4
 determined by derivatization 
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To see if O-nucleophiles react in an analogous manner as N- and C-nucleophiles, an 
experiment was performed with the (R,R)-Trost DACH Phenyl and compared with (R,R)-
Trost ANDEN experiment. Results are summarized in table 18. HPLC analyses showed that 
the major enantiomers from (R,R)-DACH Phenyl and (R,R)-Trost ANDEN, are of opposite 
configuration. The same result was obtained with BnNH2 as nucleophile. Therefore, the 
reaction behavior being similar between N- and O-nucleophiles and based on the mechanism 
of the reaction, an analogy could be envisaged for the absolute configuration. 
 
Table 18: Absolute configuration comparison between N- and O-nucleophile 
Entry Ligand Nucleophile Yield
4
 ee
5
 
Abs.  
conf.
6
 
Comment 
1
1
 (R,R)-Trost(1) BnNH2 58% 52% (E) (S) 
major enantiomer 
opposite to entry 2 
2
1
 (R,R)-Trost(4) BnNH2 92% 89% (E) (R) 
major enantiomer 
opposite to entry 1 
3
2
 (R,R)-Trost(1) 
p-methoxy 
-phenol 
33% 18% - 
major enantiomer 
opposite to entry 4 
4
3
 (R,R)-Trost(4) 
p-methoxy- 
phenol 
86% 89% - 
major enantiomer 
opposite to entry 3 
Reaction condition: [Pd(allyl)Cl]2 (0.08 eq.), ligand (0.24 eq.), BnNH2 (2 eq.), EDIPA ( 1 eq.), CH2Cl2; 
1
 at 0°C; 
2
at rt; 
3
0°C to rt; 
4
 isolated yield; 
5
 determined by HPLC on chiral stationary phase;
 6
 determined by derivatization 
 
 
3.4.2 Reaction of (E)-Chloracetate compound 72 with (S,S)-Trost ANDEN                  
and BnNH2 as N-nucleophile  
 
The advantage of the Trost ligands is that the (R,R)- and (S,S)-forms are commercially 
available. Therefore, (R,R) or (S,S) Trost ligands can be used leading to the synthesis of 
corresponding enantiomers. A reaction with (S,S)-Trost ANDEN as ligand was performed 
under the same reaction conditions as with (R,R)-Trost ANDEN as ligand to synthesize the 
opposite enantiomere. The following reaction conditions were used: BnNH2 (2 eq.) as 
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nucleophile, [Pd(allyl)Cl]2 (0.08 eq.) as catalyst, (S,S)-Trost ANDEN (0.24 eq.) as ligand, 
EDIPA (1 eq.) as base, CH2Cl2 as solvent and at 0°C. The product was isolated in 97% yield 
with 86 % ee (E) with (S)-product as major enantiomere. This results confirms that under the 
same reaction conditions as with (R,R)-Trost ANDEN (entry 3, table 18) the opposite 
enantiomere was isolated with similar yield and ee. 
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3.5 Allylic substitutions on dimeric substrates 
Palladium catalyzed asymmetric allylic substitution on meso or racemo compounds such as 
132 (scheme 59) and 135 (scheme 60) enable to obtain products such as 134 and 137 which 
offer the possibility to be derivatized into a broad range of different target compounds. The 
idea was to perform a palladium catalyzed allylic substitution on a symmetric system where 
the leaving group enables to differentiate the double bonds and where the chirality of the Pd-
ligand complexe induces the enantioselective nucleophilic substitution. As illustrated in 
scheme 59 and 60, the coordination of palladium to the allylic system, opens the cyclic 
carbonate (leaving group), inducing decarboxylation. The regioselectivity of the nucleophilic 
attack would be determined by the palladium-ligand complex.  
In 2006, Trost et al.
97
 published the asymmetric allylic alkylation of meso and dl-1,2-
divinylethylene carbonate and observed a palladium catalyzed DYKAT (dynamic catalytic 
asymmetric transformation) yielding one stereoisomer product in excellent ee
98-99
. These good 
results encouraged us to deepen the study on allylic substitution to our compound bearing 
functionalized groups on each end of the molecule. In our study, four different substrates were 
synthesized: A meso compound bearing ester- and benzylether functional groups and racemo 
compounds bearing ester- and benzylether functional groups. 
 
Scheme 59: Allylic substitution on meso compounds  
 
Scheme 60: Allylic substitution on racemo compounds  
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3.5.1 Meso diester compound 
 
3.5.1.1 Substrate synthesis 
The meso diester compound 144 was synthesized according to scheme 61. Commercially 
available meso-tartaric acid monohydrate (138) was converted into dimethyl ester with 
Amberlyst 15
100
 in MeOH to obtain compound 139 in 92% yield. Diol 139 was protected with 
2,2-Dimethoxypropane and p-toluensulfonic acid monohydrate
101
 to afford compound 140 in 
81% yield. Compound 142 was obtained from compound 140 by reduction with DIBAL 
followed by a Horner-Wardsworth-Emmons reaction in one pot reaction
102
 and in 59% yield. 
142 was deprotected with HCl
103
 to afford 143 in 80% yield. The cyclic carbonate product 
144 was obtained in 99% yield from reaction of compound 143 with trisphosgene
104
 in MED. 
 
 
Scheme 61: Synthesis of meso diester compound 144 
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3.5.1.2 Allylic substitutions on meso diester (compound 144) 
Allylic substitutions with substrate 144 were performed under different reaction conditions 
(table 19) with different ligands, nucleophiles and bases. In almost all cases, elimination 
product 145 (scheme 62) was observed. This product is not stable and decomposes after a 
while. In one case, with (R,R)-Trost naphtyl ligand (entry 4, table 19), no reaction and 
recovery of starting material was observed. In entry 5 and 7 (table 19), the reaction was 
performed without nucleophile, with and without base, and elimination product was detected 
indicating that β-hydride elimination occurred without participation of the nucleophile. On the 
other hand, no elimination was observed without palladium-ligand complex and with 
nucleophile (entry 12, table 19), some carbamate was also formed, indicating that the 
substrate is not very stable. Some byproducts were detected on HR-MS which were oligomers 
such as shown in scheme 63.  
The ester functionality could be the reason for the instability of the substrate but β-hydride 
elimination product probably occurs due to the meso conformation of the cyclic carbonate 
unit and due to the presence of the palladium catalyst. Scheme 64 shows a possible 
mechanism of the elimination reaction. Kang et al.
105
 noticed a similar behavior of 
palladium(0) on cyclic carbonates which undergo elimination to form dienols. These results 
could explain why in our system, β-hydride elimination is observed.  
 
 
 
Scheme 62: Elimination product 145 
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Table 19: Allylic substitutions on meso diester substrate (compound 144) 
Entry Ligand Pd source Nucleophile Base Comment 
1 (R,R)-Trost(1) [Pd(allyl)Cl]2 Dimethylmalonate BSA/NaOAc elimination 
2 (R,R)-Trost(1) [Pd(allyl)Cl]2 p-Methoxyphenol Na2CO3 elimination 
3 (R,R)-Trost(1) [Pd(allyl)Cl]2 Phthalimide Cs2CO3 elimination 
4 (R,R)-Trost(2) [Pd(allyl)Cl]2 Phthalimide Na2CO3 no reaction 
5 (R,R)-Trost(1) [Pd(allyl)Cl]2 - Cs2CO3 elimination 
6 (R,R)-Trost(1) [Pd(allyl)Cl]2 BnNH2 - elimination 
7 (R,R)-Trost(1) [Pd(allyl)Cl]2 - - elimination 
8
1
 PHOX(2) [Pd(allyl)Cl]2 BnNH2 - elimination 
9 PPh3 [Pd(allyl)Cl]2 Phthalimide Na2CO3 elimination 
10 PPh3 [Pd(allyl)Cl]2 Aniline - elimination 
11 PPh3 [Pd(allyl)Cl]2 BnNH2 - elimination 
12 - - BnNH2 - recovery SM + 
some carbamate 
Reaction conditions: Pd catalyst (0.08 eq.), ligand (0.24 eq.), nucleophile (2 eq.), base (1 eq.), CH2Cl2, rt 
 
 
 
Scheme 63: Oligomers detected by HR-MS and possible structures 
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Scheme 64: β-hydride elimination on the meso diester substrate (compound 144) 
 
 
3.5.2 Racemo diester compound 
 
3.5.2.1 Substrate synthesis 
To overcome the β-hydride elimination, racemo dimeric ester substrate 156 was synthesized 
(scheme 65). The procedure was the same as for the meso diester compound 144 except that 
(+)-dimethyl 2,3-O-isopropylidene-D-tartrate (152) is commercially available. Reduction with 
DIBAL followed by Horner-Wardsworth-Emmons reaction afforded compound 154 in 62%. 
Diol deprotection afforded compound 155 in 88% yield. Protection with trisphosgene gave 
compound 156 in 95% yield. 
 
 Results and Discussions 
___________________________________________________________________________ 
- 79 - 
 
 
Scheme 65: Synthesis of racemo diester substrate (compound 156) 
 
3.5.2.2 Allylic substitutions on racemo diester (compound 156) 
Allylic substitutions under various reaction conditions were performed and the results are 
summarized in table 20. By LC-MS, product formation could be detected, but isolation of the 
product was difficult and decomposition was observed (entry 1-3, table 20). The carbamate 
product 157 (scheme 66) was isolated with only BnNH2 (entry 4, table 20) in 59% yield. The 
formation of the carbamate 157 was also detected with Trost (4) as ligand and 
Pd2(dba)3·CHCl3 as catalyst (entry 5, table 20) but the formation was slow. The ester groups 
probably have a destabilizing effect but no elimination product could be detected (scheme 
67). 
 
Scheme 66: Byproduct 157 
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Table 20: Allylic substitutions on racemo-ester (compound 156) 
Entry Ligand Pd source Nucleophile Base Comment 
1 PPh3 [Pd(allyl)Cl]2 BnNH2 - Product but 
decomposition 
2 PPh3 [Pd(allyl)Cl]2 BnNH2 EDIPA
2 
Product but 
decomposition 
3
1
 PPh3 [Pd2(dba)3]·CHCl3 BnNH2 - Product but 
decomposition 
4 - - BnNH2 - Carbamate 
5
1
 (R,R)-Trost(4) [Pd2(dba)3]·CHCl3 BnNH2 - Carbamate 
Reaction condition: Pd catalyst (0.08 eq.), ligand (0.24 eq.), nucleophile (2 eq.), CH2Cl2, rt; 
1 in toluene; 2 (1 eq.) 
 
 
 
Scheme 67: Allylic substitution on racemo-ester (compound 156) 
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3.5.3 Meso dibenzylether compound 
The ester functionality on the system could have an undesired effect due to acidity of γ-
protons inducing elimination or destabilizing the product otherwise. To overcome this effect, 
benzylethers were introduced as a functional group instead of the ester moiety, as it was 
already done in previous experiments (see Chapter 3.1 and 3.2). 
 
3.5.3.1 Substrate synthesis 
The desired compound was synthesized starting from 142 as common intermediate (scheme 
68). Reduction with LiAlH4
106
 to the alcohol product 161 was achieved in 77% yield. The 
benzylation
107
 of 161 afforded compound 162 in 65% yield. The obtained benzylated product 
162 was deprotected with HCl to afford 163 in 88% yield. Protection of 163 with trisphogene 
afforded the cyclic carbonate compound 164 in 97% yield. 
 
Scheme 68: Synthesis of meso dibenzylether substrate (compound 164) 
 
3.5.3.2 Allylic subsitutions on meso dibenzylether (compound 164) 
Compound 164 turned out to be a more stable substrate. Allylic substitutions under different 
reaction conditions (table 21) mostly led to recovery of starting material but also to some side 
products which decomposed during chromatography.  
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Table 21: Allylic substitutions on meso dibenzylether (compound 164) 
Entry Ligand Pd source Nucleophile Base Solvent Comments 
1 - - BnNH2 EDIPA
1
 THF SM recovery  
Some  carbamate 
2 PPh3 [Pd(allyl)Cl]2 BnNH2 EDIPA
1
 MED SM recovery  
Some product  
 but not stable 
3 PPh3 [Pd(allyl)Cl]2 BnNH2 - MED Some product 
but not stable 
4 Trost(4) [Pd(allyl)Cl]2 BnNH2 EDIPA
1
 THF rt→60°C 
SM recovery 
5 Trost(2) [Pd(allyl)Cl]2 potassium 
phtalimide 
- MED SM recovery  
Reaction condition: Pd catalyst (0.08 eq.), ligand (0.24 eq.), nucleophile (2 eq.), rt; 1 1 eq. 
 
 
3.5.4 Racemo dibenzyl ether compound 
 
3.5.4.1 Substrate synthesis 
The racemo benzyl ether compound 171 was synthesized from commercially available (-)-
dimethyl 2,3-O-isopropylidene-L-tartrate (165) (scheme 69). Reduction with DIBAL followed 
by Horner-Wardsworth-Emmons reaction afforded compound 167 in 60% yield. Reduction 
with LiAlH4 to the alcohol product 168 was achieved in 60% yield. The benzylation of 168 
afforded 169 in 54% yield. 169 was deprotected with HCl to obtain 170 in 91% yield. 
Protection of 170 with trisphogene afforded the cyclic carbonate compound 171 in 
quantitative yield. 
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Scheme 69: Synthesis of racemo dibenzylether substrate (compound 171) 
 
3.5.4.2 Allylic substitution on racemo dibenzylether (compound 171) 
Reactions of enantiomerically pure compound 171 (>95% ee) with (R,R)-Trost ANDEN (0.24 
eq.), [Pd(allyl)Cl]2 (0.08 eq.), BnNH2 (2 eq.), EDIPA (1 eq.), toluene and at rt afforded the 
product 172 in 38% yield with recovery of starting material (scheme 70). In this case, the 
nucleophilic attack did not occur at the position of the leaving group but on the other termini 
of the η3-allyl palladium complex.  Nevertheless, this result confirmed our previous 
hypothesis that a stabilized structure without the possibility to undergo β-hydride elimination 
could indeed afford the product from the allylic substitution. The low yields are not 
satisfactory but further improvement may be feasible. One way to prevent β-hydride 
elimination would be to add an additive which would coordinate to palladium such as a 
hydride ion as described by Keinan and Roth
108
. It is notewothy to mention that although a 
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chiral ligand is not necassary in this case, the chiral ligand was used to ensure comparability 
of the reaction conditions between the racemo and meso-substrates. The absolute 
configuration at the center of the substitution in compound 172 was presumed based on the 
common mechanism of the allylic substitution. The configuration was not determined by 
spectroscopical methods. 
 
 
Scheme 70: Allylic substitution on racemo dibenzylether substrate (compound 171) 
 
 
3.5.5 Cyclic bi-lactone substrate 
From the synthesis described above, we came up with the idea of another interesting substrate 
for allylic substitution: Cyclic bilactone substrate 173 (scheme 71).  
 
 
Scheme 71: Cyclic bilactone substrate (compound 173) 
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3.5.5.1 Substrate synthesis 
The synthesis included the same pathway starting from meso-dimethyl 2,3-O-isopropylidene-
tartrate 140 with DIBAL reduction and Wittig olefination with methyl 
triphenylphosphonoanylidene acetate
102
, affording a mixture of cis/cis 174 and cis/trans 175 
product (scheme 72). Without purification of the crude, MeSO3H was added to the crude 
affording the cyclisation
109
 of the cis/cis 174 product into the bilactone 173 in 7% yield.  
 
 
Scheme 72: Synthesis of meso bislactone (compound 173) 
 
3.5.5.2 Allylic substitution on bi-lactone compound 
An allylic substitution on 173 with Pd(allyl)Cl]2 (0.08 eq.), (R,R)-Trost ANDEN (0.24 eq.), 
EDIPA (1 eq.), BnNH2 (2 eq.), THF at rt was performed but instead of the reaction to the 
desired product (scheme 73), only decomposition was observed. Poor yield in the synthesis of 
the substrate as well as decomposition during allylic substitution made this substrate 
unsuitable. 
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Scheme 73: Allylic substitution on cyclic bilactone substrate (compound 173) 
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3.6 Derivatization and application of chiral allylic amines and ethers 
 
The synthesis of a wide range of interesting compounds is possible with our chiral products 
since all centers are chemoselectively different. Amino sugars or phenol-sugars are of interest 
and important compounds in many syntheses. Phenol sugars are particularly interesting due to 
their difficult synthesis
110
. 
Herein, different compounds were synthesized showing the use of our substitution product. 
 
3.6.1 Synthesis of oxazolidinone derivatives 
Starting from our chiral substitution product 80 (88% ee), the amine was protected with a Boc 
group
111
 in 87% yield to obtain compound 177 (scheme 74). Interesting transformations are 
possible with N-Boc protecting groups as it was shown in 2002 by Agami
112
 who published a 
review highlighting the different observed reactions. In our case, reaction of our product with 
m-CPBA resulted in an intramolecular cyclization affording oxazolidinone 178 and 179 in 
80% yield (scheme 74). The two diastereoisomers could be separated on column 
chromatography in a 1:1 ratio. Their configuration was determined by NMR experiments. 
Diastereoisomer 178 displays a cis configuration in the 5-ring and an anti configuration 
relative to the exocyclic stereogenic center. Diastereoisomer 179 exhibit a trans configuration 
in the 5-ring. In that case, the exocyclic stereogenic center could not be determined by NMR. 
178 and 179 are separable by HPLC on a chiral stationary phase and both diastereoisomers 
display the same ee (88% ee) as the starting compound 80 (figure 6). 
In the literature several examples of N-alkylated N-Boc groups are known where the carboxyl 
oxygen reacts as a nucleophile with a neighbouring group, an effect related to the Thorpe-
Ingold effect. For example, Ueda et al.
113 
reported the synthesis of N-methyl-2-oxazolidinones 
in a stereo- and regioselective fashion proceeding through a 6-(N-tert-butoxycarbonyl)amino-
3-oxo-4-hexenoates. Some calculations were performed by the Agami group
114 
and showed 
the difference between HN-Boc and MeN-Boc group where a compression of the internal C-
N=C angle (122.0 and 117.7° for N-H and N-Me moiety, respectively) was observed, in 
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agreement with a Thorpe-Ingold effect. This effect could explain our results and could imply 
a concerted mechanism such as shown in scheme 75.  
Furthermore, the same reaction with an excess of m-CPBA was made with an N-Acetyl 
protected amine 183 (scheme 76). 183 was synthesized from 80 with acetylchloride, DMAP 
and Et3N
115
 in 71% yield. The goal of the reaction with m-CPBA was to observe the 
formation of an epoxide since cyclization with N-Acetyl compounds is not possible. However, 
no reaction was observed and the starting material was recovered. Other epoxidation reagents 
were tried such as urea-hydrogen peroxide (with Na2HPO4, TFA) or Oxone/NaHCO3 but 
none of them were successful and starting material was recovered. This indicates a 
surprisingly unreactive double bond and could be seen as an indication of the concerted 
mechanism with the N-Boc compound. However, we still do not have a satisfactory 
explanation for the lack of reactivity of the acetyl protected compound 183 towards 
epoxidation. 
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Scheme 74: Boc protection of amine product and cyclization to oxazolidinones 
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Figure 6: Chromatogram of a 1:1 (w/w) mixture of 178 and 179 
 
Scheme 75: Concerted reaction mechanism for cyclization to oxazolidinone derivative 
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Scheme 76: Acetyl protection of amine followed by attempt on epoxidation 
 
 
3.6.2 Selective benzyl deprotection and functionalization 
Another interesting set of compounds could be synthesized starting from our benzylamine 
product 80 (scheme 77) with selective deprotection of one benzylether using Ac2O, AcOH, 
HBr (33% in AcOH)
116
 followed by in situ protection of the alcohol as well as the amine 
affording compound 185 in 81% yield. Hydrolysis of the ether group was performed with 
K2CO3
117
 affording compound 186 in 41% yield. Such compounds could be further 
functionalized by epoxidation or dihydroxylation of the double bond. A possible application 
of our substrate would be the synthesis of different amino-riboses.  
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Scheme 77: Selective benzyl ether deprotection and functionalization starting from compound 80 
 
 
3.6.3 Epoxidation of phenol product 114 
Functionalization of phenol compound 114 to afford phenol sugars is of interest since such 
compounds are difficult to obtain.  
Epoxidation of compound 114 with m-CPBA afforded 187 in 40% yield (scheme 78). m-
CPBA is a strong epoxidation reagent and the use of another reagent could possibly improve 
the yield by suppressing side reactions. The diastereoisomeric ratio was established by HPLC 
on chiral stationary phase and was determined to be 64:36.   
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Scheme 78: Epoxidation of phenol product (compound 114) 
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4. Summary and Conclusion 
 
In the first part of the thesis, enantioselective palladium catalyzed allylic substitutions were 
developed on substrates which proceed via symmetrical η3-allyl complexes. These substrates 
were designed with two identical functional groups on each end of the allyl system which 
allowed the derivatization of the resulting chiral products into attractive compounds. 
Furthermore, the advantage of a symmetrical substrate-palladium complex enabled an 
enantioselective attack of the nucleophile, resulting in a true enantioselective conversion. 
The synthesis of di-ester substrates of this type encountered several issues. The coupling of 
ethyl propiolate to ethyl glyoxalate did not succeed due to the polymerization of ethyl 
glyoxalate at low tempereature. Several attempts to reduce dimethyl 2-oxoglutaconate 
remained unsuccessful. Allylic bromination on diethylglutaconate with NBS provided a 
mixture of 75:25 vinyl:allyl monobromide. The same vinyl/allyl ratio was observed after the 
elimination reaction of diethyl 2,3-dibromopentanedioate indicating a possible dynamic 
equilibrium. Therefore an allylic substitution on the vinyl/allyl monobromide mixture was 
performed but unfortunately a mixture of byproducts was observed. A quantum mechanic 
study was performed to determine the energies of the isomers. In all cases, the vinyl form was 
found thermodynamically more favorable than the allyl form. Furthermore, a keto-enol 
tautomerization could be imagined where the more thermodynamically stable keto form 
would be formed, preventing a possible allylic substitution (scheme 27). 
  
 
Scheme 27: Keto-enol tautomerization 
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In contrast, the synthesis of di-benzylether substrates was straightforward and enabled the 
study of these substrates in allylic substitutions (scheme 79).  
 
 
 
Scheme 79: Enantioselective allylic substitutions study on compound 61 
 
Different parameters can influence the reaction such as the leaving group, ligand, solvent, 
base, catalyst and nucleophile. Therefore several screenings were performed to optimize the 
reaction. Ethylcarbonate-, methylcarbonate, benzylcarbamate and chloracetates were chosen 
as leaving groups. The (E)-chloracetate substrate was found to give the best results and was 
chosen as a standard. It was observed that E/Z isomerization occurred, producing the same 
E/Z ratio, either starting from (Z) or (E)-ethylcarbonate substrates and (Z) or (E)-
methylcarbonate substrates. An explanation for these results was given by the π-σ-π 
isomerization. Two classes of ligands were selected and compared on our substrate: PHOX 
and Trost ligands. From the results obtained, (R,R)-Trost ANDEN showed minimized E/Z 
isomerization as well as a good yield and ee. The choice of a good solvent is important and 
the screening showed three reliable solvents for our substrate: CH2Cl2, toluene, CF3Ph. The 
addition of a base improved the ee and the yield. When different bases were screened, the best 
results were obtained from the addition of 1eq. EDIPA. With (E)-chloracetate, [Pd(allyl)Cl]2 
was the best suited catalyst. The catalyst loading was lowered down to 1 mol% but 
unfortunately lowering the catalyst loading also decreased the yield. Therefore 8 mol% of 
catalyst was chosen as a standard. With these optimized reaction conditions, a broad range of 
nucleophiles was tested on our substrate. Primary aryl amine nucleophiles were found to be 
excellent nucleophiles in our system with ee’s up to 97% and yields up to 93%. Good results 
were also obtained from not commonly used phenol nucleophiles with ee’s up to 92% and 
yields up to 83%.  The absolute configuration was determined by derivatization of the 
substitution product (E)-N-benzyl-1,5-bis(benzyloxy)pent-3-en-2-amine into N-(1,5-
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dihydroxypenta-2-yl)benzamide. Optical activity as well as the assignment of the HPLC 
peaks on chiral stationary phase of the enantiomers allowed determination of the absolute 
configuration to be (R).  
 
The second part of the thesis was focused on the study of dimeric substrates possessing a 
cyclic carbonate as leaving group (scheme 80). The following substrates were synthesized: 
meso diethylester (compound 144), meso dibenzylether (compound 164), racemo 
dimethylester (compound 156) and racemo dibenzylether (compound 171).  
 
 
Scheme 80: Meso diethylester- and dibenzylether substrates and racemo dimethylester- and 
dibenzylether substrates 
 
Allylic substitutions on the meso-diethylester substrate (compound 144) were performed 
using different reaction conditions. The desired substitution could not be obtained and instead 
the elimination product 145 (scheme 62) was isolated which appeared to be unstable over 
time. This product showed that β-hydride elimination took place during the reaction.  
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Scheme 62: Elimination product 145 
From racemo-dimethylester substrate (compound 156), no product could be isolated and 
decomposition was observed. The more stable dibenzylether substrates provided better 
results. No reaction but also no β-hydride elimination was observed from meso-dibenzylether 
substrate (compound 164). On the other hand, the product 172 (scheme 81) could be isolated 
from the racemo-dibenzylether substrate (compound 171). Even though the yield was low 
(38%), the reaction was proven to be feasible and further improvements may be possible. 
 
 
Scheme 81: Product 172 from the allylic substitution on racemo dibenzylether substrate 171 
 
The third part of the thesis focused on the derivatization of the chiral products to give 
potentially useful compounds. Oxazolidinone products 178 and 179 were synthesized from 
177 in a 1:1 diastereoisomeric ratio separable by column chromatography (scheme 82). From 
these products, the synthesis of various compounds could be imagined such as 2-
aminopentoses.  
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Scheme 82: Oxazolidinone products 178 and 179 
 
Another polyfunctionalized compound 186 was synthesized from (E)-N-benzyl-1,5-
bis(benzyloxy)pent-3-en-2-amine (scheme 83). This compound offers many possibilities for 
further transformations such as selective epoxidation or dihydroxylation.  
At last, epoxidation of chiral phenol ether succeeded to afford 187 (scheme 83). Further 
derivatization to afford uncommon phenol sugars can be envisaged.  
 
 
Scheme 83: Derivatized products 186 and 187
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5. Experimental part 
5.1 General Informations 
Work conditions: All reactions were performed under an argon (all allylic substitutions) or 
nitrogen atmosphere with oven-dried glassware using standard Schlenk or vacuum line 
techniques. The following mixture were used for cooled bath: ice/water (0°C), ice/MeOH (-
20°C), Dry ice/i-PrOH (-78°C). Silicon oil was used for heating reactions.  
Chemicals: The cellflock was produced from the production site in Novartis. Commercially 
available reagents were purchased from Acros, Aldrich, Alfa-Aesar or Fluka unless otherwise 
described and used without further purification.  
Solvents: Solvents were purchased from Aldrich of Fluka in septum-sealed bottles over 
molecular sieves.  
Chromatography: Flash column chromatography was performed using silica gel 60 (0.040-
0.063 mm) von Merck (Art. Nr. 1.09385.1000). The eluents employed are reported as volume 
: volume percentages. 
Thin-layer chromatography (TLC): HPTLC Silica gel 60 F254 or TLC Silica gel 60 F254 
were used to monitor reaction progress. Iodine or potassium permanganate was used to 
visualize the spots. 
Melting points: Metling points were determined on Büchi 535 apparatus. 
Optical rotations ([α]20D): Optical rotations were measured on a Perkin Elmer Polarimeter 
341 (serie nr. 7322) in a cuvette (l = 1 dm) at 20°C. The concentration (c) is given in g/100 
mL. 
NMR: The NMR sample was prepared by dissolving X in ca 40 µl DMSO-d6. Most NMR 
spectra (
1
H, 
13
C, 2D) were measured at 300 K on a Bruker AVANCE I spectrometer (600 
MHz proton frequency) equipped with a 1.7 mm 
1
H{
13
C,
15N} CryoProbe™ or on a Bruker 
BioSpin spectrometer (150 MHz proton frequency). 
1
H and 
13
C shifts were referenced to the 
solvent signals at 2.49 ppm and 39.5 ppm, respectively. Data for 
1
H NMR are recorded as 
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follows: chemical shift (δ, ppm), multiplicity [s (singlet), br. s (broad singlet), d (doublet), t 
(triplet), q (quartet), and m (multiplet)], coupling constant [Hz], integration. Data for 
13
C 
NMR are reported in terms of chemical shift (δ, ppm). Some NMR spectra (1H, 13C, 2D) 
were measured on a Bruker AVANCE II spectrometer (400 MHz proton frequency). These 
NMR had 
1
H and 
13
C shifts referenced to the solvent signals at 7.27 ppm and 77.00 ppm 
(CDCl3). 
IR: The infrared spectrum was acquired as a solid film on a Vertex 70 or Tensor 27 FT-IR 
spectrometer (Bruker Optics, Fällanden, Switzerland) coupled with a Bruker FT-IR 
microscope Hyperion 2000 over a wave number range of 4000-600 cm
-1
 with a resolution of 2 
cm
-1
.  
The FT Raman spectrum was recorded with a RFS 100 FT Raman spectrometer (Bruker 
Optics, Fällanden, Switzerland) equipped with liquid nitrogen cooled germanium detector. 
The resolution was 4 cm
-1
 and 150 scans were accumulated using a laser output of 700 mW. 
The spectrum was corrected for instrumental response. 
MS: Mass spectral determination was made on high resolution mass spectrometer (HR-MS) 
LTQ Orbitrap XL (Thermo Scientific, USA). UPLC-MS was made on a Waters Acquity 
UPLC (colum: Acquity HSS T3 2.1x50mm 1.7µ) and a Waters SQD mass spectrometer. 
HPLC: Agilent technologies 1200 Series HPLC (columns: Merck, Chromolith Performance 
RP18, 100 x 4.6 mm or Ascentis® Express C18, 5 cm x 2.1 mm, 2.7 µm; eluent: 0.1% (V/V) 
H3PO4/MeCN; 5mL/min; 40°C) was used to monitor reaction progress. 
HPLC-Method for the enantiomeric excess determination: Analysis of enantiomeric 
excess was performed using a Hewlett Packard Series 1050 HPLC and Chiralpak AD-H chiral 
stationary phase column (0.46cm ø х 25cm), Chiracel OD-H chiral stationary phase column 
(0.46cm ø х 25cm), Chiralpak AD-RH chiral stationary phase column (150 х 4.6 mm). The 
temperature was set at 30°C, the flow at 1.0 mL min
-1
 and the wavelength at 210 nm for all 
measurements unless otherwise described. For all enantioselective allylic substitution 
products, a comparison with the retention time of the racemic product was performed. 
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C-HPLC 1 Chiralpak AD-H, n-Hexan : iPrOH = 99.5 : 0.5 (w/w) 
C-HPLC 2 Chiralpak AD-H, n-Hexan : iPrOH = 99 : 1 (w/w) 
C-HPLC 3 Chiralpak AD-H, n-Hexan : iPrOH = 94 : 6 (w/w) 
C-HPLC 4  Chiralpak AD-H, n-Hexan : iPrOH = 90 : 10 (w/w) 
C-HPLC 5  Chiralpak AD-H, n-Hexan : iPrOH = 85 : 15 (w/w) 
C-HPLC 6  Chiracel OD-H, n-Hexan : iPrOH = 98 : 2 (w/w) 
C-HPLC 7 Chiracel OD-H, n-Hexan : iPrOH = 85 : 15 (w/w) 
C-HPLC 8 Chiralpak AD-RH, 0.01N Na2HPO4 in CH3CN 
C-HPLC 9 Chiralpak AD-H, heptan : ethanol = 75 : 25 (w/w) 
Z/E determination: Z/E isomerisms were determined by 
1
H NMR as well as with a Hewlett 
Packard Series 1050 HPLC and Chiralpak AD-H chiral stationary phase column (0.46cm ø х 
25cm) or Chiracel OD-H chiral stationary phase column (0.46cm ø х 25cm) or Chiralpak AD-
RH chiral stationary phase column (150 х 4.6 mm). 
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5.2 Synthesis of the compounds 
  
(Z)-diethyl 2-bromopent-2-enedioate and (E)-diethyl 4-bromopent-2-enedioate (50 and 
51) 
 
Diethylglutaconate (1.86g, 10mmol, 1 eq.) was put in solution in CCl4 at rt. N-
Bromsuccinimide (1.78g, 10mmol, 1 eq.) was then added to the solution at rt. The reaction 
mixture was put at reflux. Afer 48h, the reaction mixture was cooled down at rt, filtered 
through Büchner and washed with CH2Cl2. The filtrate was evaporated under reduced 
pressure. The crude was purified by flash chromatography (2:8 ESTP : HPTF) to afford the 
mixture of products (0.3084g, 12% yield). 
 
1
H NMR (400 MHz, CDCl3-d)  ppm 1.28 - 1.32 (m, 4 H) 1.33 - 1.38 (m, 4 H) 3.39 (d, 
J=6.53 Hz, 2 H vinyl) 4.18 - 4.26 (m, 3 H) 4.26 - 4.35 (m, 3 H) 4.87 (dd, J=9.54, 0.75 Hz, 1 H 
allyl) 6.08 (dd, J=15.56, 0.75 Hz, 1 H allyl) 7.10 (dd, J=15.56, 9.29 Hz, 1 H allyl) 7.54 (t, 
J=6.53 Hz, 1 H vinyl)  
HR-MS: calculated: 265.00700 [M+H]
+
; 282.03355 [M+NH4]
+
; found: 265.00696 [M+H]
+
; 
282.03354 [M+NH4]
+, Δm =0.1ppm  (the isomers are not separable on LC-MS) 
FTIR: 2984 (υ(CH) aliph. CH), 2940 (υ(CH) aliph. CH), 1737 (υ(C=O) ester), 1635 
(υ(C=C)), 1254 (υ(C-O ester)), 1182 (υ(C-O ester)), 1042 (υ(C-O ester)), 1028 (υ(C-O ester)) 
cm
-1
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Diethyl 2,3-dibromopentanedioate (52) 
 
  
 
Diethylglutaconate (3.72g, 20mmol, 1 eq.) was put in solution in 20mL CH2Cl2 and the 
solution was cooled down at 0°C. Br2 (3.19g, 20mmol, 1 eq.) diluted in 10mL CH2Cl2 was 
slowly added to the solution. After end of addition, the reaction mixture was allowed to come 
at rt and left to stir during 17h. The reaction was extracted with Na2S2O3 and the organic 
phase was dried over Na2SO4. The solvent was evaporated under reduced pressure. The crude 
was purified with flash chromatography (95:5 toluene:ethyl acetate) to afford the desired 
product (5.05g, 73% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.23 - 1.34 (m, 6 H) 2.88 - 2.98 (m, 1 H) 3.33 - 3.41 
(m, 1 H) 4.15 - 4.23 (m, 2 H) 4.23 - 4.31 (m, 2 H) 4.57 - 4.62 (m, 1 H) 4.63 - 4.71 (m, 1 H) 
13
C NMR (500 MHz, DMSO-d6) δ ppm 13.71 (C7 or C9) 14.05 (C7 or C9) 40.41 (C4) 46.63 
(C2 or C3) 46.90 (C2 or C3) 60.74 (C6 or C8) 62.22 (C6 or C8) 167.29 (C=O) 169.23 (C=O) 
HR-MS: calculated: 344.93316 [M+H]
+
; 361.95971 [M+NH4]
+
; found: 344.93318 [M+H]
+
; 
361.95979 [M+NH4]
+, Δm =0.1-0.2 ppm 
FTIR: 2984 (υ(CH) aliph. CH), 1744 (υ(C=O) ester), 1466 (δ(C-H)), 1377 (δ(C-H)), 1266 
(υ(C-O) ester), 1153 (υ(C-O) ester), 1024 (υ(C-O) ester) cm-1 
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(2E,2’E)-diethyl 3,3’-(3,5-diethoxy-1,4-dioxine-2,6-diyl)diacrylate (53) 
 
 
 
Diethyl 2,3-dibromopentanedioate 52 (0.559g, 1.615mmol, 1 eq.) was put in solution in 10mL 
THF at rt. Triethylamine (0.16g, 1.615mmol, 1 eq.) was added to the solution and a precipiate 
was formed. After 1h30, the reaction mixutre was filtered through Büchner and washed with 
THF. Solvent of the filtrate was evaporated under reduced pressure and the crude was purified 
with flash chromatography (95:5 toluene: ethyl acetate) to afford the product (0.0155g, 3% 
yield) 
 
1
H NMR (400 MHz, CDCl3-d)  ppm 1.34 (q, J=7.19 Hz, 12 H) 4.24 - 4.29 (m, 4 H) 4.29 - 
4.35 (m, 4 H) 6.27 (d, J=15.81 Hz, 2 H) 7.65 (d, J=15.81 Hz, 2 H) 
HR-MS: calculated: 369.15727 [M+H]
+
; 386.18788 [M+NH4]
+
, 391.13921 [M+Na]
+
; found: 
369.15426 [M+H]
+
; 386.18093 [M+NH4]
+
, 391.13581 [M+Na]
+
 
FTIR: 2983 (υ(CH) aliph. CH), 2937 (υ(C-H) aliph. CH), 1722 (υ(C=O) ester), 1620 
(υ(C=C)), 1261 (υ(C-O)), 1185 (υ(C-O)), 1027 (υ(C-O)), 971 (δ(CH) trans C=C) cm-1 
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1,5-bis(benzyloxy)pent-3-yn-2-ol (67) 
 
Benzyl propagyl ether (18.5g, 126.52 mmol, 1 eq.) was put in solution in 430mL THF and the 
solution was cooled down at -78°C. Commercially available LDA 2M (76 mL, 151.82 mmol, 
1.2 eq.) was slowly added to the solution. Then benzyloxyacetaldehyde (19g, 126.52 mmol, 1 
eq.) diluted in 50mL THF was added at -78°C. 3h later the yellow milky solution was 
quenched with a dropwise addition of HCl 2N (126.5 mL, 253.04 mmol) at -70°C then the 
solution was warmed up at room temperature. The aqueous phase was extracted with 2x 
250mL TBME. The collected organic phases were washed with 2x 250mL H2O and 2x 
250mL NaCl sat. The organic phase was dried over anhydrous magnesium sulfate and 
filtered. The solution was concentrated under reduced pressure. Flash column 
chromatography (4:2 hexane:EtOAC) of the crude gave the corresponding product: light 
orange oil (27g, 72% yield). 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 2.49 (br. s., 1 H) 3.54 - 3.69 (m, 2 H) 4.20 (d, J=1.76 
Hz, 2 H) 4.58 (s, 2 H) 4.59 - 4.65 (m, 3 H) 7.23 - 7.39 (m, 10 H) 
13
C NMR (500 MHz, DMSO-d6) δ ppm 57.0268 (C5) 60.2417 (C2) 70.6141 (C6 or C13) 
72.1829 (C6 or C13) 73.7778 (C1) 80.1519 (C3 or C4) 86.9432 (C3 or C4) 128.2944-127.4290 
(aromatic CH) 137.6761 (C7 or C14) 138.3129 (C7 or C14) 
HR-MS: calculated: 314.17507 [M+NH4]
+
; found: 314.17514 [M+NH4]
+, Δm = 0.2ppm 
FTIR: 3419 (υ(OH)), 3088 (υ(CH) arom. CH), 3063 (υ(CH) arom. CH), 3031 (υ(CH) arom. 
CH), 2903 (υ(CH) aliph. CH), 2862 (υ(CH) aliph. CH), 1605 (benzene ring stretch), 1587 
(benzene ring stretch), 1496 (benzene ring stretch), 1454 (benzene ring stretch), 1074 (υ(C-
O)), 1028 (υ(C-O)), 738 (monosub. benzene), 698 (monosub. benzene) cm-1 
RAMAN: 2276 (C≡C), 2236 (C≡C), 1003 (monosubst. benzene) 
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(E)-1,5-bis(benzyloxy)pent-3-en-2-ol (68) 
 
 
LiAlH4 in pellet form (4.16g, 109.66 mmol, 5 eq.) was put in solution in 150mL THF under 
argon. After the pellets were dissolved, the grey solution was cooled down at -15°C. 
Dropwise addition of 1,5-bis(benzyloxy)pent-3-yn-2-ol 67 (6.5g, 21.93 mmol, 1 eq.) diluted 
in 50mL THF at -10°C. After the end of addition, the solution was allowed to come at rt. 
After 30min, the reaction was finished and cooled down at 0°C. To quench, 20mL of a 10% 
MgSO4 solution was carefully added during 20min. After the end of addition, the grey slurry 
was left to stir during 30min and then filtered through a fine layer of cellflok (washed with 
400mL EtOAc). The solution was concentrated under reduced pressure. Flash column 
chromatography (7:3 hexane:EtOAc) of the crude gave the desired product: colorless oil 
(4.43g, 68% yield). 
 
1
H-NMR (500 MHz, DMSO-d6): δ ppm 3.34 (dd, J=5.87, 2.21 Hz, 2H) 3.97 (d, J=4.12 Hz, 
2H) 4.18 (t, J=5.26 Hz, 1H) 4.44 (s, 2H) 4.49 (s, 2H) 4.98 (d, J=5.04 Hz, 1H) 5.54 (dd, 
J=5.57, 4.50 Hz, 2H) 7.21-7.40 (m, 10H) 
13
C NMR (500MHz, DMSO-d6): δ ppm 69.3323 (C2), 69.6113 (C5), 71.0664 (C6 or C13), 
72.1552 (C6 or C13), 74.3319 (C1), 126.6576 (C3 or C4), 128.2413 - 127.3527 (aromatic CH), 
133.5996 (C3 or C4), 138.4864 (C7 or C14), 138.5284 (C7 or C14) 
HR-MS: calculated: 316.19072 [M+NH4]
+
, 321.14612 [M+Na]
+
; found: 316.19076 
[M+NH4]
+
, 321.14586 [M+Na]
+, Δm = 0.1-0.8 ppm 
IR: 3430 (υ(OH)), 3087 (υ(CH) arom. CH), 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. 
CH), 2856 (υ(CH) aliph. CH), 1604 (υ(phenyl)), 1586 (υ(phenyl)), 1496 (υ(phenyl)), 1454 
(υ(phenyl)), 1102 (υ(C-O)), 1072 (υ(C-O)), 971 (δ(CH) C=C trans), 736 (δ(CH) arom. CH), 
697 (monosub. benzene ring), 609 cm
-1
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(E)-1,5-bis(benzyloxy)pent-3-en-2-yl ethyl carbonate (69) 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-ol 68 (0.52g, 1.743mmol, 1 eq.) was put in solution in 
30mL THF at rt. DMAP (0.426g, 3.485mmol, 2 eq.) and pyridine (0.414g, 5.228mmol, 3 eq.) 
were added. The solution was cooled down at 0°C and ethylchloroformate (0.567g, 
5.228mmol, 3 eq.) diluted in 5mL THF was drop wisely added at +1°C. A white suspension 
was formed and the solution was allowed to come at rt. Because of incomplete reaction, 
addition of pyridine and ethylchloroformate were added 4 more times as followed: pyridine 
(0.414g, 5.228mmol, 3 eq.) was added, the solution cooled down and ethylchloroformate 
(0.567g, 5.228mmol, 3 eq.) diluted in 5mL THF was drop wisely added at +1°C. After each 
portion, the reaction was allowed to come at rt and stirred for 2-16h. After reaction was 
complete, the mixture was poured on a cooled solution (0°C) of 40mL HCl 2N. Extraction 
with 100mL TMBE followed. The organic phase was extracted with 30mL HCl 2N, 100mL 
NaHCO3 sat and 80mL NaCl sat. The organic phase was dried over anhydrous sodium sulfate 
and filtered. The solution was concentrated under reduced pressure. Flash column 
chromatography (4:2 hexane:EtOAC) of the crude gave the corresponding product: colorless 
oil (0.551g, 85% yield). 
 
1
H-NMR: (500 MHz, DMSO-d6) δ ppm 1.19 (t, J=7.10 Hz, 3H) 3.47-3.63 (m, 2H) 3.99 (d, 
J=5.19 Hz, 2H) 4.10 (q, J=7.02 Hz, 2H), 4.44 (s, 2H) 4.45-4.56 (m, 2H) 5.27 (q, J=5.80 Hz, 
1H) 5.68-5.78 (m, 1H) 5.85 (t, J=5.11 Hz, 1H) 7.23-7.39 (m, 10H); 
 3
JH,H = 15.69 Hz 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 14.01 (C8), 63.52 (C7), 68.96 (C5), 70.84 (C1), 71.32 
(C9 or C16), 72.09 (C9 or C16), 75.98 (C2), 126.41 (C3 or C4), 127.38 - 128.19 (aromatic CH), 
130.77(C3 or C4), 138.04 (C10 or C17), 138.24 (C10 or C17), 153.95 (C6) 
HR-MS: calculated: 388.21185 [M+NH4]
+
, 393.16725 [M+Na]
+
; found: 388.21206 
[M+NH4]
+
, 393.16718 [M+Na]
+, Δm = 0.2 – 0.6 ppm 
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IR: 3088 (υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2859 (υ(CH) 
aliph. CH)), 1745 (υ(C=O)) 1604 (υ(Ph)), 1586 (υ(Ph)) 1496 (υ(Ph)), 1454 (υ(Ph)), 1258 
(υ(C-O)), 1100 (υ(C-O)), 970 (δ(CH) C=C trans) 737 (monosub. C-H), 698 (monosub. Ph) 
cm
-1
 
 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-yl methyl carbonate (70) 
 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-ol 68 (2g, 6.703mmol, 1 eq.) was diluted in THF (70mL). 
DMAP (1.64g, 13.41mmol, 2 eq.) and pyridine (1.6mL, 20.108mmol, 3 eq.) were added to the 
solution at room temperature. The solution was cooled down at 0°C and methylchloroformate 
(1.6mL, 20.180mmol, 3 eq.) diluted in 7mL THF was added drop wise (formation of a white 
precipitate). After the addition, the solution was allowed to come at room temperature. Four 
more addition of pyridine (1.6mL, 20.108mmol, 3 eq.) and methylchloroformate (1.6mL, 
20.180mmol, 3 eq.) at 0°C in an interval of 20h, 22h30, 27h30, 48h were made to complete 
the reaction. To quench the reaction, the mixture was poured to a cooled solution (0°C) of 
HCl 2N (150mL). An extraction followed with TBME (250mL). The organic phase was 
extracted with HCl 2N (80mL), NaHCO3 sat (100mL), NaCl sat (100mL). The solution was 
concentrated under reduced pressure. Flash column chromatography (4:2 hexane:EtOAC) of 
the crude gave the corresponding product: colorless oil (1.509g, 4.23mmol, 63% yield) . 
 
1
H-NMR: (500 MHz, DMSO-d6) δ ppm 3.51 - 3.59 (m, 2 H) 3.68 (s, 3 H) 3.98 (d, J=5.04 Hz, 
2 H) 4.44 (s, 2 H) 4.46 - 4.54 (m, 2 H) 5.24 - 5.30 (m, 1 H) 5.70 - 5.77 (m, 1 H) 5.83 - 5.90 
(m, 1 H) 7.24 - 7.36 (m, 10 H) 
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13
C-NMR: (125 MHz, DMSO-d6) δ ppm 54.66 (C7), 68.96 (C5), 70.78 (C1), 71.35 (C8 or C15), 
72.09 (C8 or C15), 76.30 (C2), 126.30 (C3 or C4), 127.43-128.36 (aromatics CH), 130.88 (C3 or 
C4), 137.99 (C9 or C16), 138.32 (C9 or C16), 154.61 (C6) 
HR-MS: calculated: 374.19620 [M+NH4]
+
; found: 374.19602 [M+NH4]
+, Δm = 0.5ppm 
IR: 3088 (υ(CH) arom. CH), 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2955 (υ(CH) 
aliphatic CH), 2857 (υ(CH) aliphatic CH), 1749 (υ(C=O)), 1605 (υ(phenyl)), 1586 
(υ(phenyl)), 1496 (υ(phenyl)), 1453 (υ(phenyl)), 1442 (δ(CH) aliphatic), 1308 (υ(C-O) 
carbonate), 1267 (υ(C-O) carbonate), 1116 (υ(C-O-C)), 738 (δ(C-H monosub.)), 698 
(δ(phenyl)) cm-1 
 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-yl benzylcarbamate (71) 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-ol 68 (0.5g, 1.676 mmol, 1 eq.) was put in solution in 5mL 
toluene at rt. Benzylisocyanate (0.29g, 2.178mmol, 1.3 eq.) was added at rt then the reaction 
was allowed to reflux (Toil bath = 123°C). After 1h, the reaction was finished. The solution was 
cooled down at rt and the solvent evaporated under reduced pressure. Flash column 
chromatography (4:2 hexane:EtOAC) of the crude gave the desired product: white viscous oil 
(0.6g, 83% yield). 
 
1
H-NMR: (500 MHz, DMSO-d6) δ ppm 3.54 (d, J=3.51 Hz, 2H) 3.98 (d, J=4.73 Hz, 2H) 4.18 
(d, J=5.80 Hz, 2H) 4.44 (s, 2H) 4.45-4.56 (m, 2H) 5.32 (d, J=5.04 Hz, 1H) 5.72-5.87 (m, 2H) 
7.17-7.36 (m, 15H) 7.8 (t, J=6.03 Hz, 1H);   
3
JHH = 16.76 Hz 
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13
C-NMR: (500 MHz, DMSO-d6) δ ppm 43.7455 (C7), 69.1951 (C5), 71.2267 (C1), 71.3280 
(C14 or C21), 71.9862 (C2), 72.0923 (C14 or C21), 126.7323 - 128.3848 (aromatic CH), 
129.1552 (C3 or C4), 138.2103 (C8 or C15 or C22), 138.3434 (C8 or C15 or C22), 139.8016 (C8 
or C15 or C22), 155.8950 (C6) 
HR-MS: calculated: 432.21693 [M+H]
+
 454.19888 [M+Na]
+
; found: 432.21680 [M+H]
+ 
454.19866 [M+Na]
+, Δm = 0.3ppm 
IR: 3334 (υ(N-H)), 1721 (υ(C=O)), 1519 (amide) 1497 (υ(Ph)), 1454 (υ(Ph)), 1245 (υ(C-O)), 
1116 (υ(C-O)), 1028 (δip(CH) arom. CH), 970 (δ(CH) C=C trans), 738 (δ(CH) arom. CH), 
698 (δ(Ph)) cm-1 
 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-yl 2-chloroacetate (72) 
 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-ol 68 (4,428g, 14.84 mmol, 1 eq.) was put in solution in 
94mL toluene and 31mL THF (75:25). DMAP (0.363g, 2.968 mmol, 0.2 eq.) and pyridine 
(2.347g, 29.68 mmol, 2 eq.) were added at room temperature. The solution was cooled down 
at 0°C. Chloracetylchloride (3.352g, 29.68mmol, 2 eq.) diluted in 15mL toluene was slowly 
added at +1-2°C. A white precipitate was formed. After 1h, the reaction mixture was poured 
to 150mL H2O and 300mL TBME was added. The organic phase was extracted with 1x 
150mL NaHCO3 sat, 1x 150mL HCl 2N, 2x 150ml H2O, 1x 150mL NaCl sat. and 1x 150mL 
H2O. The organic phase was dried over anhydrous magnesium sulfate and filtered. The 
solution was concentrated under reduced pressure. Flash column chromatography (9:1 
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hexane:EtOAC) of the crude gave the corresponding product: colorless oil (5.228g, 13.919 
mmol, 94% yield). 
 
1
H-NMR: (600 MHz, DMSO-d6) δppm 3.38 (br. s., 1H) 3.55 - 3.62 (m, 2 H) 4.00 (d, J=5.12 
Hz, 2 H) 4.41 (d, 1 H) 4.46 (d, 2 H) 4.50 (d, 1 H) 4.55 (d, J=12.30 Hz, 1 H) 5.53 (dt, J=6.22, 
5.73 Hz, 1 H) 5.77 (dd, J=15.73, 6.22 Hz, 1 H) 5.91 (dt, J=15.73, 5.12 Hz, 1 H) 7.13 - 7.47 
(m, 10 H)
 
13
C-NMR: (150 MHz, DMSO-d6) δ ppm 41.15 (C7), 68.99 (C5), 70.66 (C1) 71.36 (C8 or C15), 
72.12 (C8 or C15), 74.00 (C2), 126.19 (C3 or C4), 127.33 – 128.29 (aromatic CH), 130.64 (C3 
or C4), 138.02 (C9 or C16), 138.22 (C9 or C16), 166.61 (C6)  
HR-MS: calculated: 392.16638 [M+NH4]
+
; found: 392.16248 [M+NH4]
+, Δm = 0.4ppm 
IR: 3088 (υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2859 (υ(CH) 
aliph. CH), 1759 (υ(C=O) ester), 1605 (υ(phenyl)), 1586 (υ(phenyl)), 1496 (υ(phenyl)), 1454 
(υ(phenyl)), 1183 (υ(C-O-C)), 1114 (υ(C-O-C)), 969 (δ(CH) C=C trans) cm-1 
 
 
1,5-bis(benzyloxy)pent-3-yn-2-yl ethyl carbonate (73)  
 
 
Benzyl propagyl ether (2g, 13.68 mmol, 1 eq.) was put in solution in 20mL THF. The light 
yellow solution was cooled down at -78°C. Commercially available LDA 2M (6.84mL, 13.68 
mmol, 1 eq.) was slowly added to the solution during 15min at -75°C. Benzyloxyactaldehyde 
(2.05g, 13.68mmol, 1 eq.) was slowly added at -75°C. After 1h, ethylchloroformate (2.97g, 
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27.36mmol, 2 eq.) was added at -75°C then the solution was allowed to come at rt. Extraction 
followed with 100mL NaHCO3 sat, 100mL ammonium chlorid sat, the aqueous phase was 
washed with 2x 50mL CH2Cl2. The collected organic phases were dried over sodium sulfate 
and filtered. The solution was concentrated under reduced pressure. Flash column 
chromatography (6:1 HXF:ESTP) of the crude gave the desired product (3.432g, 68% yield). 
1
H-NMR: (500 MHz, DMSO-d6) δ ppm 1.21 (t, J=7.10 Hz, 3H) 3.69 (d, J=5.49 Hz, 2H) 4.14 
(q, J=7.02 Hz, 2H) 4.23 (d, J=1.68 Hz, 2H) 4.49 (s, 2H) 4.51-4.59 (m, 2H) 5.48 (tt, J=1.60 
Hz, 1H) 7.22-7.40 (m, 3H) 7.22-7.40 (m, J=8.26, 8.26, 8.05, 1.68 Hz, 7H) 
13
C-NMR: (500 MHz, DMSO-d6) δ ppm 14.0393 (C8), 56.8081 (C5), 64.1613 (C7), 66.4455 
(C2), 70.4967 (C1), 70.8324 (C9 or C16), 72.2059 (C9 or C16), 81.0137 (C3 or C4), 83.4652 (C3 
or C4), 127.5596 - 128.3077 (aromatic CH), 137.4861 (C10 or C17), 137.8506 (C10 or C17), 
153.7194 (C6) 
HR-MS: calculated: 386.20027 [M+NH4]
+
; found: 386.19629 [M+NH4]
+, Δm = 0.2 ppm 
IR: 3088 (υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2865 (υ(CH) 
aliph. CH), 1749 (υ(C=O)), 1497 (benzene rings stretching), 1455 (benzene rings stretching), 
1255 (υ(C-O)), 1093 (υ(C-O)), 1074 (υ(C-O)), 1027 (υ(C-O)), 1008 (υ(C-O)), 738 
(monosubs. benzene), 698 (monosubs. benzene) cm
-1
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1,5-bis(benzyloxy)pent-3-yn-2-yl methyl carbonate (74) 
 
 
1,5-bis(benzyloxy)pent-3-yn-2-ol 67 (4g, 13.497mmol, 1 eq.) was put in solution in 300mL 
THF at rt. DMAP (3.298g, 26.994mmol, 2 eq.) and pyridine (3.203g, 40.491mmol, 3 eq.) 
were added at rt and the solution cooled down at 0°C. Methylchloroformate (3.826g, 40.491, 
3 eq.) diluted in 5mL THF was slowly added. A white precipitate was formed. The solution 
was allowed to come at rt. Because of incomplete reaction, addition of pyridine and 
ethylchloroformate followed 5 more times as followed: pyridine (3.203g, 40.491mmol, 3 eq.) 
was added, the solution cooled down and methylchloroformate (3.826g, 40.491, 3 eq.) diluted 
in 5mL THF was drop wisely added at +1°C. After each portion, the reaction was allowed to 
come at rt and stirred for 2-15h. To quench the reaction, the mixture was poured on a cooled 
solution (0°C) of 300mL HCl 2N. Extraction with 150mL TMBE followed. The organic 
phase was extracted with 200mL NaHCO3 sat and 200mL NaCl sat. The organic phase was 
dried over anhydrous magnesium sulfate and filtered. The solution was concentrated under 
reduced pressure. Flash column chromatography (7:3 hexane:EtOAC) of the crude gave the 
corresponding product: colorless oil (3.325g, 70% yield). 
 
1
H NMR: (400 MHz, DMSO-d6) δ ppm 3.34 (br. s., 1 H) 3.70 (d, J=5.52 Hz, 2 H) 3.73 (s, 3 
H) 4.24 (d, J=1.00 Hz, 2 H) 4.50 (s, 2 H) 4.52 - 4.61 (m, 2 H) 5.48 (t, J=5.40 Hz, 1 H) 7.25 - 
7.38 (m, J=6.90, 6.90, 6.90, 6.65, 6.53 Hz, 10 H) 
13
C-NMR: (500 MHz, DMSO-d6) δ ppm 55.1005 (C7), 56.8167 (C5), 66.3900 (C2), 70.4490 
(C8 or C15), 70.8624 (C1), 72.2130 (C8 or C15), 80.9329 (C3 or C4), 83.5515 (C3 or C4), 
126.6494 - 129.1706 (aromatic CH), 137.4887 (C9 or C16), 137.8420 (C9 or C16), 154.3641 
(C6) 
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HR-MS: calculated: 372.18055 [M+NH4]
+
, 377.13595 [M+Na]
+
; found: 372.18074 
[M+NH4]
+
, 377.13590 [M+Na]
+, Δm = 0.1-0.5 ppm 
IR: 3089 (υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3032 (υ(CH) arom. CH), 2956 (υ(CH) 
aliph. CH), 2865 (υ(CH) aliph. CH), 2203 (υ(C≡C)), 1754 (υ(C=O)), 1605 (υ(Ph)), 1586 
(υ(Ph)), 1497 (υ(Ph)), 1454 (υ(Ph)), 1443 (δ(C-H)), 1266 (υ(C-O)), 1098 (υ(C-O)), 1074 
(υ(C-O)), 742 (monosub. C-H), 699 (monosub. Ph) cm-1 
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(Z)-1,5-bis(benzyloxy)pent-3-en-2-yl ethyl carbonate (75) 
 
 
1,5-bis(benzyloxy)pent-3-yn-2-yl ethyl carbonate 73  (1g, 2.714mmol, 1 eq.) was put in 
solution in 20mL ethanol (ALI) at room temperature and 2,2’-Bipyridyl (0.212g, 1.357mmol, 
0.5 eq.) was added. The air contained in the flask was replaced with argon and Pd on BaSO4 
(0.1g, 10% m/m) was added. The argon was replaced with a balloon of H2(g) at atmospheric 
pressure. After 3h, the suspension was filtered through cellflok and washed with ethanol 
(ALI). The solvent was evaporated under reduced pressure. Flash column chromatography 
(4:2 hexane:EtOAC) of the crude gave the corresponding product: (0.898g, 2.424mmol, 89% 
yield). 
 
1
H-NMR: (500 MHz, DMSO-d6) δ 1H NMR (500 MHz, DMSO-d6) δ ppm 1.18 (t, J=7.10 
Hz, 3 H) 3.46 - 3.59 (m, 2 H) 4.08 (d, J=7.02 Hz, 2 H) 4.12 (td, J=3.05, 1.37 Hz, 2 H) 4.45 (s, 
2 H) 4.45 - 4.52 (m, 2 H) 5.46 - 5.55 (m, 2 H) 5.78 (ddd, J=10.19, 6.18, 6.07 Hz, 1 H) 7.24 - 
7.36 (m, 10 H);    
3
JHH (cis) = 10 Hz 
13
C-NMR: (100 MHz, DMSO-d6) δ ppm 14.0672 (C8), 63.6160 (C7), 65.6984 (C5), 70.6972 
(C1), 71.5097 (C9 or C16), 72.1017 C9 or C16), 72.7366 (C2), 126.7877 (C3 or C4), 127.4363 - 
128.2638 (aromatic CH), 131.7887 (C3 or C4), 138.0393 (C10 or C17), 138.2329 (C10 or C17), 
153.9841 (C6) 
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HR-MS: calculated: 388.21185 [M+NH4]
+
, 393.16725 [M+Na]
+ 
409.14118 [M+K]
+
; found:  
388.21214 [M+NH4]
+
, 393.16709 [M+Na]
+
,
 
 409.14112 [M+K]
+, Δm = 0.1-0.7 ppm 
IR: 3088(υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2983 (υ(CH) 
aliph. CH), 2861 (υ(CH) aliph. CH), 1744 (υ(C=O)), 1586 (υ(Ph)), 1496 (υ(Ph)), 1454 
(υ(Ph)), 1260 (υ(C-O) carbonate), 737 (monosub. C-H), 698 (monosub. Ph) cm-1 
 
 
(Z)-1,5-bis(benzyloxy)pent-3-en-2-yl methyl carbonate (76) 
 
 
1,5-bis(benzyloxy)pent-3-yn-2-yl methyl carbonate 74 (500mg, 1.411mmol, 1 eq.) was put in 
solution in ethanol (20mL) ALI at room temperature. 2,2’-Bipyridyl (110mg, 0.705mmol, 0.5 
eq.) was added and air was replaced with argon. Lindlar catalyst (0.075g, 15% w/w) was 
added and argon was replaced with H2(g) (atmospheric pressure). After 15min, the reaction 
was stopped in replacing the H2(g) with argon, filtered through a spritzenfilter and washed 
with ethanol (25mL). The solution was concentrated under reduced pressure. Flash column 
chromatography (4:2 hexane:EtOAC) of the crude gave the corresponding product: colorless 
oil (502mg, 1.408mmol, 99% yield). 
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1
H-NMR: 
1
H NMR (400 MHz, CDCl3-d) δ ppm 3.49 - 3.64 (m, 2 H) 3.76 (s, 3 H) 4.17 - 4.21 
(m, 2 H) 4.50 (d, J=1.26 Hz, 2 H) 4.53 (d, J=3.26 Hz, 2 H) 5.49 - 5.61 (m, 2 H) 5.85 (ddd, 
J=10.16, 6.15, 6.02 Hz, 1 H) 7.24 - 7.37 (m, 10 H);    
3
JHH = 10.1 Hz 
13
C-NMR: (125 MHz, DMSO-d6) δ ppm 54.66 (C7), 65.67 (C5), 70.62 (C1), 71.49 (C8 or C15), 
72.08 (C8 or C15), 73.00 (C2), 126.68 (C3 or C4), 127.41 - 128.24 (aromatic CH), 131.84 (C3 
or C4), 137.98 (C9 or C16), 138.00 (C9 or C16), 154.60 (C6) 
HR-MS: calculated 357.16966 [M+H]
+
, 374.20027 [M+NH4]
+
, 379.15159 [M+Na]
+
, 
395.12553 [M+K]
+
, found: 357.16986 [M+H]
+
, 374.19635 [M+NH4]
+
, 379.15158 [M+Na]
+
,
 
395.12558 [M+K]
+, Δm = 0.1-0.6 ppm 
IR: 3088 (υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2955 (υ(CH) 
aliph. CH), 2860 (υ(CH) aliph. CH), 1748 (υ(C=O)), 1605 (arom. rings stretch), 1586 (arom. 
rings stretch), 1496 (arom. rings stretch), 1269 (υ(C-O) carbonate), 1093 (υ(C-O)), 939 (υ(C-
O)), 738 (monosub. benzolring), 699 (monosub. benzolring) cm
-1
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(E)-N-benyzl-1,5-bis(benzyloxy)pent-3-en-2-amine (80) 
 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 1.89 (br. s., 1 H) 3.39 - 3.54 (m, 3 H) 3.60 - 3.90 (m, 2 
H) 4.03 (dd, J=5.90, 1.38 Hz, 2 H) 4.49 (d, J=2.01 Hz, 2 H) 4.51 (s, 2 H) 5.55 - 5.65 (m, 1 H) 
5.83 (dt, J=15.50, 5.68 Hz, 1 H) 7.20 - 7.40 (m, 15 H) 
13
C-NMR: (100MHz, DMSO-d6): δ ppm 50.16 (C6), 58.30 (C2), 69.62 (C5), 70.93 (C13 or 
C20), 71.99 (C13 or C20), 72.94 (C1), 126.44-128.18 (aromatic CH), 128.73 (C3 or C4), 132.89 
(C3 or C4), 138.37 (C7 or C14 or C21), 138.44 (C7 or C14 or C21), 140.92 (C7 or C14 or C21) 
HR-MS: calculated: 388.22711 [M+H]
 +
; found: 388.22733 [M+H]
+, Δm = 0.6 ppm 
IR: 3327 (υ(N-H)), 3086 (υ(CH) arom. CH), 3063 (υ(CH) arom. CH), 3029 (υ(CH) arom. 
CH), 2854 (υ(CH) aliph. CH), 1604 (arom. rings stretch), 1586 (arom. rings stretch), 1496 
(arom. rings stretch), 1094 (υ(C-O) ether), 974 (δ(CH) C=C trans) 736 (monosub. C-H), 698 
(monosub. Ph) cm
-1
 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 7.5 min ((Z)-80), tR = 8.4 min ((E)-80), tR = 8.9 
min ((Z)-ent-80), tR = 10.5 min ((E)-ent-80) 
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(E)-dimethyl 2-(1,5-bis(benzyloxy)pent-3-en-2-yl)malonate (94) 
 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H NMR: (600 MHz, DMSO-d6) δ ppm 3.06 - 3.12 (m, 1 H) 3.51 (d, J=6.22 Hz, 2 H) 3.61 (d, 
J=2.20 Hz, 6 H) 3.70 (d, J=8.42 Hz, 1 H) 3.94 (d, J=4.02 Hz, 2 H) 4.44 (d, J=11.71 Hz, 4 H) 
5.68 - 5.72 (m, 2 H) 7.26 - 7.38 (m, 10 H) 
13
C NMR: (151 MHz, DMSO-d6) δ ppm 42.00 (C2), 51.91 (C3’), 52.04 (C3’), 52.75 (C1’), 
69.40 (C5), 70.58 (C1), 70.71 (C6 or C7), 72.04 (C6 or C7), 126.88-128.27 (aromatic CH), 
129.61 (C3 or C4), 129.83 (C3 or C4), 138.04 (quaternary C), 138.31 (quaternary C), 167.90 
(C=O), 168.01 (C=O) 
HR-MS: calculated: [M+H]
+
 = 413.19587; found: [M+H]
+
 = 413.19577 
IR: 3088 (υ(CH) arom. CH), 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 3006 (υ(CH) 
arom. CH), 2952 (υ(CH) aliph. C-H), 2857 (υ(CH) aliph. C-H), 1736 (υ(C=O)), 1605 (arom. 
rings stretching), 1586 (arom. rings stretching), 1496 (arom. rings stretching), 1454 (arom. 
rings stretching), 1246 (υ(C-O)), 1099 (υ(C-O-C)), 1027 (υ(C-O)), 975 (δ(CH) C=C trans), 
738 (δ(C-H) monosubst.), 698 (δ(Ph) monosubst.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 14.8 min ((E)-94), tR = 17.1 min ((E)-ent-94) 
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(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)aniline (95) 
 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 3.45 - 3.55 (m, 2 H) 3.94 (d, J=5.18 Hz, 2 H) 4.06 - 
4.14 (m, J=6.38, 6.38, 6.25, 6.00 Hz, 1 H) 4.37 (s, 2 H) 4.50 (d, J=1.14 Hz, 2 H) 5.53 (d, 
J=7.71 Hz, 1 H) 5.62 - 5.70 (m, 1 H) 5.72 - 5.81 (m, 1 H) 6.48 (t, J=7.20 Hz, 1 H) 6.58 (d, 
J=8.46 Hz, 2 H) 7.01 (t, J=7.52 Hz, 2 H) 7.19 - 7.37 (m, 10 H) 
13
C-NMR: (100 MHz, DMSO-d6) δ ppm 53.50 (C2), 69.37 (C5), 70.74 (C1 or C12 or C19), 
71.93 (C1 or C12 or C19), 72.07 (C1 or C12 or C19), 112.45 (aromatic CH aniline), 115.50 
(aromatic CH aniline), 127.06 - 127.86 (aromatic CH), 128.41 (aromatic CH aniline), 131.80 
(C3 or C4), 138.00 (C13 or C20), 174.52 (C6) 
HR-MS: calculated: 374.21146 [M+H]
+
; found: 374.21137 [M+H]
+, Δm = 0.2 ppm 
IR: 3395 (υ(N-H)), 3087(υ(CH) arom. CH), 3029(υ(CH) arom. CH), 2856 (υ(CH) aliph. CH), 
1602 (benzene rings stretch), 1504 (benzene rings stretch), 1100 (υ(C-O)), 1074 (υ(C-O)), 
972 (δ(CH) C=C trans), 748 (monosubst. benzene), 695 (monosubst. benzene), 605 cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 10.1 min ((E)-95), tR = 10.7 min ((E)-ent-95) 
 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 127 - 
 
(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-4-methoxyaniline (96) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 3.43 - 3.53 (m, 2 H) 3.60 (s, 3 H) 3.94 (d, J=5.43 Hz, 
2 H) 3.97 - 4.05 (m, 1 H) 4.36 (s, 2 H) 4.50 (d, J=2.27 Hz, 2 H) 5.09 (d, J=7.83 Hz, 1 H) 5.60 
- 5.69 (m, 1 H) 5.70 - 5.79 (m, 1 H) 6.50 - 6.58 (m, 2 H) 6.61 - 6.68 (m, 2 H) 7.20 - 7.34 (m, 
10 H)
 
13
C-NMR: (100 MHz, DMSO-d6) δ ppm 54.33 (C2), 55.19 (C12), 69.40 (C5), 70.67 (C13 or 
C20), 71.93 (C13 or C20), 72.19 (C1), 113.72 (aromatic CH methoxyphenyl), 114.17 (aromatic 
CH methoxyphenyl), 127.85 - 127.05 (aromatic CH and C3 or C4), 132.28 (C3 or C4), 137.99 
(C14 or C21), 141.66 (C6), 150.36 (C9) 
HR-MS: calculated: 404.22202 [M+H]
+
; found: 404.22223 [M+H]
+, Δm = 0.5 ppm 
IR: 3382 (υ(N-H)), 3087 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2856 (υ(CH) aliph. 
CH), 1618 (υ(Ph)), 1512 (υ(Ph)), 1454 (υ(Ph)), 1100 (υ(C-O)), 1074 (υ(C-O)), 1039 (υ(C-O)), 
973 (δ(CH) C=C trans), 820 (paradisub. C-H), 737 (monosub. C-H), 698 (monosub. Ph) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 17.1 min ((Z)-96), tR = 18.6 min ((E)-96), tR = 
23.1 min ((E)-ent-96), tR = 25.3 min ((Z)-ent-96) 
 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 128 - 
 
(E)-1-(1,5-bis(benzyloxy)pent-3-en-2-yl)piperidine (97) 
 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (600 MHz, DMSO-d6 - 1.36 (m, 2 H) 1.41 - 1.48 (m, 4 H) 2.38 - 2.48 
(m, 4 H) 3.11 (t, J=5.85 Hz, 1 H) 3.48 (dd, J=9.51, 6.59 Hz, 1 H) 3.58 (dd, J=9.88, 5.85 Hz, 1 
H) 3.99 (d, J=4.03 Hz, 2 H) 4.45 (s, 2 H) 4.46 (s, 2 H) 5.63 - 5.73 (m, 2 H) 7.22 - 7.38 (m, 10 
H)
 
13
C-NMR: (150 MHz, DMSO-d6 37 (C8), 26.03 (C6 and C10 or C7 and C9), 50.49 
(C6 and C10 or C7 and C9), 65.58 (C2), 69.76 (C5), 70.95 (C11 or C18), 72.04 (C11 or C18), 
126.98-128.42 (aromatic CH), 129.29 (C3 or C4), 130.53 (C3 or C4), 138.45 (C12 or C19), 
138.52 (C12 or C19) 
HR-MS: calculated: 366.24276 [M+H]
+
; found: 366.24297 [M+H]
+, Δm = 0.6 ppm 
IR: 3087 (υ(C-H) arom. CH), 3063 (υ(C-H) arom. CH), 3030 (υ(C-H) arom. CH), 2932 
(υas(CH2)), 2853 (υs(CH2)), 2798 (N-CH), 2751 (N-CH), 1605 (υ(Ph)), 1586 (υ(Ph)), 1496 
(υ(Ph)), 1454 (υ(Ph)), 1102 (υ(C-O-C)), 1028 (δ(C-H) monosub.), 975 (δ (C-H) C=C trans), 
736 (δ(C-H) monosub.), 698 (δ(C-H) monosub.) cm-1 
HPLC: C-HPLC 8 (1 mL/min, 40°C), tR = 14.5 min ((E)-97), tR = 14.8 min ((E)-ent-97) 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 129 - 
 
(E)-1,5-bis(benzyloxy)-N-butylpent-3-en-2-amine (98) 
 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (600 MHz, DMSO-d6 - 0.89 (m, 3 H) 1.21 - 1.32 (m, 2 H) 1.32 - 1.42 
(m, 2 H) 2.36 - 2.57 (m, 2 H) 3.29 (dd, J=7.50, 6.59 Hz, 1 H) 3.33 - 3.41 (m, 2 H) 3.98 (d, 
J=5.85 Hz, 2 H) 4.45 (s, 2 H) 4.49 (s, 2 H) 5.52 (dd, J=15.55, 7.50 Hz, 1 H) 5.74 (dd, 
J=15.55, 5.85 Hz, 1 H) 7.24 - 7.39 (m, 10 H) 
13
C-NMR: (150 MHz, DMSO-d6) δ ppm 13.83 (C9), 19.96 (C6 or C7 or C8), 31.90 (C6 or C7 
or C8), 46.44 (C6 or C7 or C8), 59.43 (C2), 69.67(C5), 70.95 (C10 or C17), 72.09 (C10 or C17),  
73.04 (C1), 127.32-128.26 (aromatic CH), 128.34 (C3 or C4), 133.30 (C3 or C4), 138.40 (C11 
and C18) 
HR-MS: calculated: 354.24276 [M+H]
+
; found: 354.24297 [M+H]
+, Δm = 0.6 ppm 
IR: 3326 (υ(N-H)), 3088 (υ(C-H) arom. CH), 3064 (υ(C-H) arom. CH), 3030 (υ(C-H) arom. 
CH), 2956 (υ(C-H) aliph. CH), 2928 (υ(C-H) aliph. CH), 2857 (υ(C-H) aliph. CH), 1605 
(υ(Ph)), 1496 (υ(Ph)), 1455 (υ(Ph)),  1097 (υ(C-O-C), 1028 (δip(C-H) monosub.), 974 (δoop(C-
H) C=C), 736 (δ(C-H) monosub.) 698 (δ(Ph) monosub.) cm-1 
HPLC: C-HPLC 8 (1 mL/min, 40°C), tR = 13.6 min ((Z)-98), tR = 13.8 min ((Z)-ent-98), tR = 
14.4 min ((E)-98), tR = 14.6 min ((E)-ent-98) 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 130 - 
 
(E)-1,5-bis(benzyloxy)-N,N-diethylpent-3-en-2-amine (99) 
 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (600 MHz, DMSO-d6) δ ppm 0.90 - 0.99 (m, 6 H) 2.34 - 2.46 (m, 2 H) 2.49 - 2.61 
(m, 2 H) 3.37 - 3.42 (m, 1 H) 3.46 - 3.60 (m, 2 H) 3.99 (d, J=4.39 Hz, 2 H) 4.45 (s, 2 H) 4.48 
(s, 2 H) 5.68 - 5.72 (m, 2 H) 7.24 - 7.37 (m, 10 H) 
13
C-NMR: (150 MHz, DMSO-d6 7 and C9), 43.69 (C6 and C8), 60.63 (C2), 
69.84 (C5), 70.89 (C10 or C17), 71.31 (C1), 72.10 (C10 or C17), 127.24-128.11 (aromatic CH), 
129.00 (C3 or C4), 130.99 (C3 or C4), 138.46 (C11 or C18) 
HR-MS: calculated: 354.24276 [M+H]
+
; found: 354.24301 [M+H]
+, Δm = 0.7 ppm 
IR: 3088 (υ(CH) arom. CH), 3064 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2968 (υ(C-H) 
aliph. CH), 2930 (υ(C-H) aliph. CH), 2854 (υ(C-H) aliph. CH), 1605 (υ(phenyl)), 1587 
(υ(phenyl)), 1496 (υ(phenyl)), 1454 (υ(phenyl)), 1100 (υ(C-O-C)), 1075 (υ(C-O-C)), 1028 
(δip(C-H) monosub.) 974 (δ(CH) C=C trans), 736 (δ(C-H) monosub.), 698 (δ(Ph) monosub.) 
cm
-1
 
HPLC: C-HPLC 6 (1 mL/min, 30°C), tR = 9.7 min ((Z)-99), tR = 13.6 min ((E)-99), tR = 14.9 
min ((Z)-ent-99), tR = 16.1 min ((E)-ent-99) 
 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 131 - 
 
 
(E)-1,5-bis(benzyloxy)pent-3-en-2-yl 2-(piperidin-1-yl)acetate (100) 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 1.29 - 1.38 (m, 2 H) 1.46 (quin, J=5.40 Hz, 4 H) 2.44 
(br. s., 4 H) 3.21 (br. s., 2 H) 3.50 - 3.60 (m, 2 H) 3.99 (d, J=5.02 Hz, 2 H) 4.44 (s, 2 H) 4.46 - 
4.56 (m, 2 H) 5.48 (q, J=5.35 Hz, 1 H) 5.70 - 5.78 (m, 1 H) 5.80 - 5.89 (m, 1 H) 7.25 - 7.38 
(m, 10 H) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 23.46 (C10) 25.37 (C9 + C11) 53.14 (C8 + C12) 59.51 
(C7) 69.05 (C5) 70.91 (C1) 71.26 (C13) 72.04 (C2 + C20) 127.01 (C3) 127.43 - 128.24 (aromatic 
CH) 130.09 (C4) 138.11 (quaternary C) 138.28 (quaternary C) 
HR-MS: calculated 424.24824 [M+H]
+
, 446.23018 [M+Na]
+
, found: 424.24805 [M+H]
+
, 
446.23007 [M+Na]
+
,
 Δm = 0.2-0.4 ppm 
IR:3087 (υ(CH) arom. CH + olefinic CH), 3063 (υ(CH) arom. CH + olefinic CH), 3030 
(υ(CH) arom. CH + olefinic CH), 2934 (υ(CH) aliph. CH), 2854 (υ(CH) aliph. CH), 1747 
(υ(C=O) ester), 1650 (υ(C=C)), 1606 (υ(Ph)), 1496 (υ(Ph)), 1454 (υ(Ph)), 1113 (υ(C-O)), 
1028 (δip(CH) mono-sub.), 968 (δoop(CH) olefinic CH), 738 (δoop(CH) mono-sub.), 698 (δ(Ph) 
mono-sub.) cm
-1
 
 
 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 132 - 
 
(E)-N-(1,5-bis(benzyloxy)pent-3-ene-2-yl)-3’-methoxyaniline (101) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.53 - 3.66 (m, 2 H) 3.75 (s, 3 H) 4.03 (d, J=5.77 Hz, 
2 H) 4.08 (q, J=5.27 Hz, 1 H) 4.21 (br. s., 1 H) 4.48 (d, J=1.51 Hz, 2 H) 4.52 - 4.61 (m, 2 H) 
5.75 (dt, J=15.60 Hz, 1 H) 5.85 - 5.94 (m, 1 H) 6.20 - 6.23 (m, 1 H) 6.24 - 6.31 (m, 2 H) 7.06 
(t, J=8.16 Hz, 1 H) 7.28 - 7.39 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 54.81 (C2) 55.04 (Me) 70.11 (C1 or C5) 71.93 (C6 or 
C13) 72.47 (C1 or C5) 73.13 (C6 or C13) 99.79 (C2’ or C4’ or C5’ or C6’) 102.83 (C2’ or C4’ or C5’ 
or C6’) 106.86 (C2’ or C4’ or C5’ or C6’) 127.56-128.46 (aromatic CH) 128.78 (C3 or C4) 129.82 
(C2’ or C4’ or C5’ or C6’) 132.23 (C3 or C4) 137.86 (quaternary C) 138.24 (quaternary C) 
148.88 (quaternary C) 160.68 (quaternary C) 
HR-MS: calculated: 404.22202 [M+H]
+
; found: 404.22202 [M+H]
+, Δm < 0.1 ppm 
IR: 3395 (υ(NH)), 3062 (υ(CH) arom. CH), 3029 (υ(CH) arom. CH), 2902 (υ(CH) aliph. 
CH), 2856 (υ(CH) aliph. CH), 1614 (aromatic rings stretching), 1508 (aromatic rings 
stretching), 1496 (aromatic rings stretching), 1454 (aromatic rings stretching), 1210 (various 
C-O), 1163 (various C-O), 1101 (various C-O), 972 (δ(CH) C=C trans), 739 (δ(CH) mono-
sub.), 698 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 20.2 min ((Z)-101), tR = 24.8 min ((E)-101), tR = 
27.8 min ((Z)-ent-101), tR = 30.4 min ((E)-ent-101) 
 Experimental part 
___________________________________________________________________________ 
- 133 - 
 
(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-3’,5’-dimethoxyaniline (102) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.53 - 3.66 (m, 2 H) 3.73 (s, 6 H) 4.04 (d, J=6.27 Hz, 
2 H) 4.05 - 4.10 (m, 1 H) 4.21 (br. s., 1 H) 4.44 - 4.51 (m, 2 H) 4.52 - 4.61 (m, 2 H) 5.74 (dt, 
J=15.60 Hz, 1 H) 5.84 (d, J=2.01 Hz, 2 H) 5.85 - 5.93 (m, 1 H) 5.88 - 5.89 (m, 1 H) 7.27 - 
7.40 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 54.82 (C2) 55.12 (2x Me) 70.12 (C1 or C5) 71.94 (C6 
or C13) 72.46 (C1 or C5) 73.14 (C6 or C13) 90.07 (C4’) 92.62 (C2’ and C6’) 127.56 (quaternary 
C) 127.74-128.46 (aromatic CH) 128.79 (C3 or C4) 132.25 (C3 or C4) 137.86 (quaternary C) 
138.25 (quaternary C) 149.41 (quaternary C) 161.58 (quaternary C) 
HR-MS: calculated: 434.23259 [M+H]
+
; found: 434.23254 [M+H]
+, Δm = 0.1 ppm 
IR: 3394 (υ(NH)), 3062 (υ(CH)), 3030 (υ(CH)), 2934 (υ(CH) aliph. CH), 2904 (υ(CH) aliph. 
CH), 2855 (υ(CH) aliph. CH), 1616 (aromatic rings stretching), 1512 (aromatic rings 
stretching), 1454 (aromatic rings stretching), 1205 (various C-O), 1152 (various C-O), 1101 
(various C-O), 1069 (various C-O), 973 (δ(CH) C=C trans), 738 (δ(CH) mono-sub.), 699 
(δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 4 (1 mL/min, 30°C), tR =  21.6 min ((Z)-102), tR = 25.7 min ((E)-102), tR =  
29.7 min ((Z)-ent-102), tR = 36.1 min ((E)-ent-102) 
 
 
 Experimental part 
___________________________________________________________________________ 
- 134 - 
 
(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-2’,6’-dimethoxyaniline (103) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.61 - 3.73 (m, 2 H) 3.82 (s, 6 H) 3.86 - 4.03 (m, 2 H) 
4.26 (d, J=7.78 Hz, 2 H) 4.44 - 4.50 (m, 1 H) 4.58 (d, J=2.26 Hz, 2 H) 5.68 (dt, J=15.60 Hz, 1 
H) 5.80 (dt, J=15.30 Hz, 1 H) 6.53 (d, J=8.53 Hz, 2 H) 6.82 (t, J=8.28 Hz, 1 H) 7.21 - 7.39 
(m, 10 H)
  
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 55.84 (Me) 70.18 (C1 or C5) 70.95 (C6 or C13) 73.11 
(C1 or C5) 73.24 (C6 or C13) 104.57 (C3’ and C5’) 127.42 (C3 or C4) 127.44 (C3 or C4) 127.76 - 
128.40 (aromatic CH) 138.41 (quaternary C) 138.48 (quaternary C) 151.29 (quaternary C)  
HR-MS: calculated: 434.23259 [M+H]
+
; found: 434.23264 [M+H]
+, Δm = 0.1 ppm 
IR: 3362 (υ(NH)), 3062 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 3000 (υ(CH) arom. 
CH), 2837 (υs(OCH3)), 1599 (υ(Ph)), 1492 (υ(Ph)), 1464 (υ(Ph)), 1430 (υ(Ph)), 1248 (Ph-O), 
1229 (Ph-O), 1109 (υ(C-O-C)), 972 (δ(CH) C=C  trans), 735 (δ(CH) mono-sub.), 698 (δ(Ph) 
mono-sub.) cm
-1
 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 18.7 min ((E)-103), tR = 20.1 min ((Z)-103), tR = 
23.8 min ((Z)-ent-103), tR = 26.2 min ((E)-ent-103) 
 Experimental part 
___________________________________________________________________________ 
- 135 - 
 
(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)benzo[d][1,3]dioxol-5-amine (104) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.51 - 3.66 (m, 2 H) 3.95 - 4.01 (m, 1 H) 4.03 (d, 
J=5.52 Hz, 2 H) 4.47 (s, 2 H) 4.56 (d, J=2.26 Hz, 2 H) 5.73 (dt, J=15.60 Hz, 1 H) 5.83 - 5.85 
(m, 2 H) 5.85 - 5.92 (m, 1 H) 6.11 (dd, J=8.28, 2.26 Hz, 1 H) 6.30 (d, J=2.26 Hz, 1 H) 6.64 
(d, J=8.53 Hz, 1 H) 7.27 - 7.39 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 56.08 (C2’) 70.08 (C1’ or C5’) 71.94 (CH2 ether) 72.41 
(C1’ or C5’) 73.16 (CH2 ether) 97.21 (C3 or C4 or C6) 100.56 (CH2 dioxo) 106.06 (C3 or C4 or 
C6) 108.47 (C3 or C4 or C6) 127.58-128.41 (aromatic CH) 129.04 (C3’ or C4’) 132.16 (C3’ or 
C4’) 137.83 (quaternary C) 138.21 (quaternary C) 139.95 (quaternary C) 142.88 (quaternary 
C) 148.16 (quaternary C) 
HR-MS: calculated: 418.20129 [M+H]
+
; found: 418.20132 [M+H]
+, Δm = 0.1 ppm 
IR: 3387 (υ(NH)), 3030 (υ(CH) arom. CH), 2858 (υ(CH) aliph. CH), 1634 (υ(Ph)), 1503 
(υ(Ph)), 1490 (υ(Ph)), 1453 (υ(Ph)), 1202 (υ(C-O)), 1095 (υ(C-O)), 1039 (υ(C-O)), 972 
(δ(CH) C=C (trans)), 738 (δ(CH) arom. CH), 699 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 24.6 min ((Z)-104), tR = 29.0 min ((E)-104), tR = 
39.5 min ((Z)-ent-104), tR = 42.8 min ((E)-ent-104) 
 
 Experimental part 
___________________________________________________________________________ 
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(E)-N-(1,5-bis(benzyloxy)pent-3-en-2yl)-3’,4’,5’-trimethoxyaniline (105) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.55 - 3.67 (m, 2 H) 3.76 (s, 3 H) 3.78 (s, 6 H) 4.02 - 
4.07 (m, 3 H) 4.48 (s, 2 H) 4.57 (d, J=2.01 Hz, 2 H) 5.76 (dt, J=15.60 Hz, 1 H) 5.87 - 5.93 (m, 
1 H) 5.93 (s, 2 H) 7.28 - 7.40 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 55.49 (C2) 55.89 (CH3O-C3‘ and -C5‘) 61.05 (CH3O-
C4’) 70.10 (C5) 72.07 (C6 or C13) 72.56 (C1) 73.19 (C6 or C13) 91.51 (C2’ and C6’) 127.61 - 
128.46 (aromatic CH) 128.95 (C3 or C4) 130.29 (quaternay C) 132.49 (C3 or C4) 137.82 
(quaternay C) 138.15 (quaternay C) 144.27 (quaternay C) 153.77 (quaternay C) 
HR-MS: calculated: 464.24315 [M+H]
+
; found: 434.24316 [M+H]
+, Δm < 0.1 ppm 
IR: 3382 (υ(NH)), 3062 (υ(CH) arom. CH), 3029 (υ(CH) arom. CH), 2995 (υ(CH) aliph. 
CH), 2933 (υ(CH) aliph. CH), 2855 (υ(CH) aliph. CH), 1610 (aromatic rings stretching), 1509 
(aromatic rings stretching), 1453 (aromatic rings stretching), 1412 (aromatic rings stretching), 
1237 (various C-O), 1127 (various C-O), 1014 (various C-O), 974 (δ(CH) C=C trans), 739 
(δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 5 (1 mL/min, 30°C), tR = 25.5 min ((E)-105), tR = 27.2 min ((E)-ent-105) 
 Experimental part 
___________________________________________________________________________ 
- 137 - 
 
 (E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-2’,3’,4’-trimethoxyaniline (106) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.55 - 3.66 (m, 2 H) 3.78 (s, 3 H) 3.86 (s, 3 H) 3.89 (s, 
3 H) 3.96 - 4.01 (m, 1 H) 4.03 (dd, J=5.65, 0.88 Hz, 2 H) 4.47 (s, 2 H) 4.52 (s, 1 H) 4.53 - 
4.62 (m, 2 H) 5.75 (m, 1 H) 5.89 (ddt, J=15.80 Hz, 1 H) 6.34 (d, J=9.03 Hz, 1 H) 6.53 (d, 
J=8.78 Hz, 1 H) 7.28 - 7.38 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 55.56 (C2) 56.63 (CH3) 60.42 (CH3) 60.85 (CH3) 
70.16 (C5) 71.90 (C6 or C13) 72.58 (C1) 73.06 (C6 or C13) 106.42 (C5’ or C6’) 107.98 (C5’ or 
C6’) 127.58 - 128.40 (aromatic CH) 128.53 (C4) 132.74 (C3) 136.04 (quaternary C) 137.72 - 
138.28 (quaternary C) 138.28 - 138.66 (quaternary C) 141.38 (quaternary C) 142.82 
(quaternary C) 145.32 (quaternary C) 
HR-MS: calculated: 464.24315 [M+H]
+
; found: 464.24319 [M+H]
+, Δm = 0.1 ppm 
IR: 3387 (υ(NH)), 3062 (υ(CH) arom.), 3030 (υ(CH) arom.), 2935 (υ(CH) aliph. CH), 2855 
(υs(OCH3), 1644 (υ(C=C)), 1500 (υ(Ph)), 1453 (υ(Ph)), 1268 (Ph-O), 1095 (υ(C-O)), 971 
(δ(CH) C=C (trans)), 788 (δ(CH) arom. CH), 737 (δ(CH) mono-sub.), 698 (δ(Ph) mono-sub.) 
cm
-1
 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 19.6 min ((E)-106), tR = 41.1 min ((E)-ent-106) 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 138 - 
 
(E)-N-(1,5-bis(benzyloxy)pent-3-en-2yl)-2’-(tert-butoxy)aniline (107) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 1.38 (s, 9 H) 3.57 - 3.68 (m, 2 H) 4.03 (dd, J=5.65, 
0.88 Hz, 2 H) 4.04 - 4.09 (m, 1 H) 4.46 (s, 2 H) 4.53 - 4.62 (m, 2 H) 4.90 (br. s., 1 H) 5.72 - 
5.80 (m, 1 H) 5.88 (dtt, J=15.30 Hz, 1 H) 6.59 (td, J=7.59, 1.63 Hz, 1 H) 6.63 (dd, J=8.03, 
1.51 Hz, 1 H) 6.91 (td, J=7.72, 1.38 Hz, 1 H) 6.95 (dd, J=7.78, 1.51 Hz, 1 H) 7.27 - 7.39 (m, 
10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 28.97 (CH3-
t
Bu) 54.73 (C2) 70.11 (C1) 71.78 (C6 or 
C13) 72.80 (C5) 73.15 (C6 or C13) 79.51 (quaternary C of 
t
Bu) 111.83 (C3’ or C6’) 116.16 (C4’ 
or C5’) 121.88 (C3’ or C6’) 123.60 (C4’ or C5’) 127.40 - 128.70 (aromatic CH and C3 or C4) 
132.66 (C3 or C4) 137.96 (quaternary C) 138.25 (quaternary C) 142.14 (quaternary C) 142.86 
(quaternary C) 
HR-MS: calculated: 446.26897 [M+H]
+
; 468.25092 [M+Na]
+
; found: 446.26895 [M+H]
+
, 
468.25073 [M+Na]
+
 
IR: 3425 (υ(NH)), 3063 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2977 (υ(CH) aliph. 
CH), 2929 (υ(CH) aliph. CH), 2856 (υ(CH) aliph. CH), 1599 (υ(Ph)), 1508 (υ(Ph)), 1454 
(υ(Ph)), 1366 (δ(CH3)3), 1256 (Ph-O), 1161 (υ(C-O) t-butoxy), 1100 (υ(C-O-C)), 740 (δ(CH) 
ortho-disub. + mono-sub.) 698 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 7.4 min ((E)-107), tR = 8.1 min ((E)-ent-107) 
 
 Experimental part 
___________________________________________________________________________ 
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(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-2’(tert-butyl)aniline (108) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 1.43 (s, 9 H) 3.60 - 3.76 (m, 2 H) 4.02 (d, J=6.02 Hz, 
2 H) 4.12 - 4.19 (m, 1 H) 4.42 - 4.51 (m, 2 H) 4.54 - 4.63 (m, 2 H) 4.68 (d, J=4.77 Hz, 1 H) 
5.72 - 5.80 (m, 1 H) 5.89 (ddt, J=15.60 Hz, 1 H) 6.63 - 6.72 (m, 2 H) 7.05 - 7.11 (m, 1 H) 
7.23 - 7.26 (m, 1 H) 7.27 - 7.38 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 29.88 (
t
Bu) 34.19 (quaternary C of 
t
Bu) 55.00 (C2) 
70.10 (C5) 71.85 (C6 or C13) 72.83 (C1) 73.13 (C6 or C13) 112.89 (aromatic CH of amine) 
117.07 (aromatic CH of amine) 126.16 (aromatic CH of amine) 126.86 (aromatic CH of 
amine) 127.56 - 128.39 (aromatic CH) 128.82 (C4) 132.55 (C3) 133.63 (quaternary C) 137.78 
(quaternary C) 138.24 (quaternary C) 145.45 (quaternary C) 
HR-MS: calculated: 430.27406 [M+H]
+
; found: 430.27411 [M+H]
+, Δm = 0.1 ppm 
IR: 3454 (υ(NH)), 3062 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2956 (υ(CH) aliph. 
CH), 2858 (υ(CH) aliph. CH), 1671 (υ(C=C)), 1600 (υ(Ph)), 1578 (υ(Ph)), 1507 (υ(Ph)), 1450 
(υ(Ph)), 1396 (δ(CH3)3), 1100 (υ(C-O-C)), 1028 (δip(CH) mono-sub.), 972 (δ(CH) C=C 
(trans)), 743 (δ(CH) arom. CH), 698 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 2 (1 mL/min, 30°C), tR = 14.4 min ((E)-108), tR = 17.3 min ((E)-ent-108) 
 
 Experimental part 
___________________________________________________________________________ 
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(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-2’,6’-diisopropylaniline (109) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR:
 
(400 MHz, CDCl3-d) δ ppm 1.16 - 1.22 (m, 12 H) 3.32 (quin, J=6.84 Hz, 2 H) 3.57 
- 3.68 (m, 3 H) 3.96 - 4.01 (m, 2 H) 4.37 (s, 2 H) 4.57 (q, J=11.96 Hz, 2 H) 5.70 (dt, J=16.06, 
15.31 Hz, 1 H) 5.82 - 5.92 (m, 1 H) 6.99 - 7.10 (m, 3 H) 7.28 - 7.37 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 24.09 (CH3-iPr) 24.23 (CH3-iPr) 27.48 (CH-iPr) 
61.61 (C2) 70.34 (C5) 71.74 (C6 or C13) 72.63 (C1) 73.34 (C6 or C13) 123.37 (C3’ and C5’) 
123.41 (C4’) 127.41 - 127.89 (aromatic CH) 128.12 (C4) 128.33 (aromatic CH) 132.93 (C3) 
138.21 (quaternary C) 138.32 (quaternary C) 141.30 (quaternary C) 142.46 (quaternary C) 
HR-MS: calculated: 458.30536 [M+H]
+
; found: 458.30521 [M+H]
+, Δm = 0.3 ppm 
IR: 3387 (υ(NH)), 3063 (υ(CH) aom. CH), 3030 (υ(CH) aom. CH), 2960 (υ(CH) aliph. CH), 
2926 (υ(CH) aliph. CH), 2864 (υ(CH) aliph. CH), 1588 (υ(Ph)), 1495 (υ(Ph)), 1454 (υ(Ph)), 
1113 (υ(C-O)), 1075 (υ(C-O)), 973 (δ(CH) C=C (trans)), 800 (δ(CH) arom. CH), 735 (δ(CH) 
arom. CH), 698 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 1 (1 mL/min, 30°C), tR = 11.1 min ((E)-109), tR = 12.1 min ((E)-ent-109) 
 
 
 
 
 Experimental part 
___________________________________________________________________________ 
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(E)-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)-2’,6’-dimethylaniline (110) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 2.27 (s, 6 H) 3.57 - 3.68 (m, 2 H) 3.87 (dt, J=6.71, 
3.54 Hz, 1 H) 3.91 - 4.06 (m, 2 H) 4.31 - 4.40 (m, 2 H) 4.51 - 4.62 (m, 2 H) 5.74 (dt, J=15.81, 
1 H) 5.82 - 5.89 (m, 1 H) 6.78 - 6.84 (m, 1 H) 6.97 (d, J=7.53 Hz, 2 H) 7.27 - 7.39 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 18.83 (CH3) 58.51 (C2) 70.13 (C1 or C5) 71.45 (C6 or 
C13) 72.83 (C1 or C5) 73.41 (C6 or C13) 121.73 (C4’) 127.50 (quaternary C) 127.59-128.37 
(aromatic CH) 127.64 (quaternary C) 128.77 (C3 or C4) 129.48 (C3’ and C5’) 133.06 (C3 or C4) 
138.08 (quaternary C) 138.34 (quaternary C) 
HR-MS: calculated: 402.24276 [M+H]
+
; found: 402.24258 [M+H]
+, Δm = 0.4 ppm 
IR: 3380(υ(NH)), 3062 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2924 (υ(CH) aliph. CH), 
2855 (υ(CH) aliph. CH), 1594 (υ(Ph)), 1495 (υ(Ph)), 1474 (υ(Ph)), 1453 (υ(Ph)), 1097 (υ(C-
O)), 972 (δ(CH) C=C (trans)), 765 (δ(CH) arom. CH), 736 (δ(CH) arom. CH), 698 (δ(Ph) 
mono-sub.) cm
-1
 
HPLC: C-HPLC 7 (1 mL/min, 30°C), tR = 8.5 min ((E)-110), tR = 9.8 min ((E)-ent-110) 
 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 142 - 
 
N-allyl-3,4,5-trimethoxyaniline (111) 
 
 
 
1
H NMR: (400 MHz, CDCl3-d)  ppm 3.76 (t, J=1.63 Hz, 2 H) 3.77 - 3.79 (m, 3 H) 3.83 (s, 6 
H) 5.17 - 5.35 (m, 2 H) 5.90 (s, 2 H) 5.92 - 6.03 (m, 1 H) 
LC-MS: M = 223 
 
 
 Experimental part 
___________________________________________________________________________ 
- 143 - 
 
(E)-1-(1‘,5‘-bis(benzyloxy)pent-3‘-en-2‘-yl)-1H-benzo[d]imidazole (112) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (600 MHz, DMSO-d6) δ ppm 3.92 (dd, J=10.43, 4.57 Hz, 1 H) 3.98 (d, J=5.12 Hz, 
2 H) 4.05 (dd, J=10.43, 8.23 Hz, 1 H) 4.42 (s, 2 H) 4.46 - 4.54 (m, 2 H) 5.44 (dd, J=11.89, 
6.04 Hz, 1 H) 5.73 - 5.79 (m, 1 H) 6.06 (dd, J=15.37, 6.59 Hz, 1 H) 7.17 (d, J=6.59 Hz, 1 H) 
7.21 (dd, J=8.23, 6.40 Hz, 1 H) 7.23 - 7.35 (m, 10 H) 7.60 (d, J=8.05 Hz, 1 H) 7.66 (d, J=7.32 
Hz, 1 H) 8.31 (s, 1 H) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 56.31 (C2‘) 69.01 (C5‘) 70.21 (C1‘) 71.30 (C6‘) 71.98 
(C7‘) 111.07 (C6) 119.48 (C9) 122.19 (C7) 127.41 - 128.23 (aromatic CH + C8 + C3’) 130.68 
(C4‘) 133.47 (quaternary C) 137.85 (quaternary C) 138.22 (quaternary C) 142.74 (C2) 143.36 
(quaternary C) 
HR-MS: calculated: 399.2073 [M+H]
+
;found: 399.2066 [M+H]
+
 
IR: 3087 (υ(CH) arom. CH), 3061 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 1613 
(aromatic rings stretching), 1493 (aromatic rings stretching), 1455 (aromatic rings stretching), 
1110 (υ(C-O-C)), 972 (δ(CH) C=C trans), 743 (δ(CH) arom. CH), 699 (δ(Ph) mono-sub.)    
cm
-1
 
HPLC: C-HPLC 5 (1 mL/min, 30°C), tR = 19.9 min ((Z)-112), tR = 23.6 min ((Z)-ent-112), tR 
= 27.2 min ((E)-112), tR = 30.1 min ((E)-ent-112) 
 
 
 
 Experimental part 
___________________________________________________________________________ 
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(E)-1,5-bis(benzyloxy)pent-3-en-2-yl 2-(1H-benzo[d]imidazol-1-yl)acetate (113) 
 
 
 
1
H-NMR: (600 MHz, DMSO-d6) δ ppm 3.53 - 3.62 (m, 2 H) 3.99 (d, J=5.12 Hz, 2 H) 4.45 (s, 
2 H) 4.46 - 4.52 (m, 2 H) 5.27 - 5.39 (m, 2 H) 5.51 - 5.55 (m, 1 H) 5.76 (dd, J=15.92, 6.04 
Hz, 1 H) 5.85 - 5.90 (m, 1 H) 7.16 - 7.23 (m, 2 H) 7.24 - 7.38 (m, 10 H) 7.45 (d, J=7.32 Hz, 1 
H) 7.66 (d, J=8.05 Hz, 1 H) 8.20 (s, 1 H) 
HR-MS: calculated 457.21218 [M+H]
+
, 479.19413 [M+Na]
+
, found: 457.21231 [M+H]
+
, 
479.19413 [M+Na]
+
,
 Δm = 0.1-0.3 ppm 
IR: 3061 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 1753 (υ(C=O) ester), 1616 (aromatic 
rings stretching), 1497 (aromatic rings stretching), 1458 (aromatic rings stretching), 1205 
(υ(C-O) ester), 1114 (υ(C-O-C)), 971 (δ(C-H) C=C (trans)), 744 (δ(CH) arom. CH), 699 
(δ(Ph) mono-sub.) cm-1 
 
 Experimental part 
___________________________________________________________________________ 
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(E)-(((4-(4-methoxyphenoxy)pent-2-ene-1,5-diyl)bis(oxy))bis(methylene))dibenzene (114) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H NMR: (600 MHz, DMSO-d6) δ ppm 3.59 - 3.67 (m, 2 H) 3.68 (s, 3 H) 3.94 - 4.01 (m, 2 
H) 4.39 (s, 2 H) 4.56 (s, 2 H) 4.89 - 4.94 (m, 1 H) 5.75 (dd, J=15.73, 6.22 Hz, 1 H) 5.85 - 5.91 
(m, 1 H) 6.83 (d, J=9.15 Hz, 2 H) 6.90 (d, J=9.15 Hz, 2 H) 7.25 - 7.31 (m, 4 H) 7.31 - 7.36 
(m, 6 H) 
13
C NMR: (151 MHz, DMSO-d6) δ ppm 55.36 (C7’) 69.23 (C1) 71.10 (C7) 72.21 (C5) 72.31 
(C6) 77.30 (C4) 114.53 (C3’
 
and C5’) 117.14 (C2’ and C6’) 127.47 - 128.27 (aromatic CH) 
129.14 (C3) 130.15 (C2) 138.33 (quaternary C) 151.64 (quaternary C) 153.57 (quaternary C) 
HR-MS: calculated: [M+NH4]
+
 = 422.23259, [M+Na]
+
 = 427.18798; found: [M+NH4]
+
 = 
422.23291; [M+Na]
+
 = 427.18785; Δm = 0.3-0.8 ppm 
IR: 3087 (υ(C-H) arom. CH), 3063 (υ(C-H) arom. CH), 3030 (υ(C-H) arom. CH),3003 (υ(C-
H) arom. CH), 2906 (υ(C-H) aliph. CH), 2856 (υ(C-H) aliph. CH), 1605 (υ(Ph)), 1590 
(υ(Ph)), 1506 (υ(Ph)), 1454 (υ(Ph)), 1105 (C-O-C), 1037 (H3C-O), 971 (δ(CH) C=C trans), 
911, 825 (δ(CH) paradisubst.), 737 (δ(CH) monosubst.) 698 (δ(CH) monosubst.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 13.4 min ((E)-114), tR = 14.9 min ((E)-ent-114) 
 Experimental part 
___________________________________________________________________________ 
- 146 - 
 
(E)-(((4-(2’,5’-dimethoxyphenoxy)pent-2-ene-1,5-diyl)bis(oxy))bis(methylene))dibenzene 
(115) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.67 - 3.84 (m, 2 H) 3.71 (s, 3 H) 3.81 (s, 3 H) 4.03 
(dd, J=5.40, 1.13 Hz, 2 H) 4.44 (s, 2 H) 4.60 - 4.70 (m, 2 H) 4.86 - 4.92 (m, 1 H) 5.80 - 5.88 
(m, 1 H) 5.93 (dt, J=15.60 Hz, 1 H) 6.44 (dd, J=8.78, 2.76 Hz, 1 H) 6.60 (d, J=3.01 Hz, 1 H) 
6.81 (d, J=9.03 Hz, 1 H) 7.27 - 7.38 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 55.62 (CH3) 56.88 (Me) 69.81 (C1 or C5) 71.86 (C6 or 
C13) 72.49 (C1 or C5) 73.43 (C6 or C13) 79.07 (C4) 104.92 (C3’ or C4’ or C6’) 105.04 (C3’ or C4’ 
or C6’) 113.34 (C3’ or C4’ or C6’) 127.43 - 127.97 (aromatic CH) 128.34 (aromatic CH) 129.40 
(C2 or C3) 130.49 (C2 or C3) 138.19 (quaternary C) 144.73 (quaternary C) 148.36 (quaternary 
C) 154.09 (quaternary C) 
HR-MS: calculated: 452.24315 [M+NH4]
+
; 457.19855 [M+Na]
+
; found: 452.24326 
[M+NH4]
+
, 457.19839 [M+Na]
+;  Δm = 0.2-0.3 ppm 
IR: 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 3001 (υ(CH) arom. CH), 2857 (υs 
(OCH3)), 1609 (υ(Ph)), 1509 (υ(Ph)), 1454 (υ(Ph)), 1228 (Ph-O), 1118 (υ(C-O-C)), 1046 
(υ(C-O)), 971 (δ(CH) C=C trans), 738 (δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 5 (1 mL/min, 30°C), tR = 14.4 min ((E)-115), tR = 17.1 min ((E)-ent-115) 
 
 Experimental part 
___________________________________________________________________________ 
- 147 - 
 
(E)-(((4-(3’,4’-dimethoxyphenoxy)pent-2-ene-1,5-diyl)bis(oxy))bis(methylene))dibenzene 
(116) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.63 - 3.75 (m, 2 H) 3.82 (d, J=1.00 Hz, 6 H) 4.03 (d, 
J=5.52 Hz, 2 H) 4.47 (s, 2 H) 4.63 (d, J=5.77 Hz, 2 H) 4.77 - 4.83 (m, 1 H) 5.81 (dt, J=16.10 
Hz, 1 H) 5.92 (dtt, J=15.60 Hz, 1 H) 6.45 (dd, J=8.78, 2.76 Hz, 1 H) 6.60 (d, J=2.76 Hz, 1 H) 
6.74 (d, J=8.53 Hz, 1 H) 7.28 - 7.38 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 55.80 (CH3) 56.36 (CH3) 69.84 (C1) 72.05 (C6 or C13) 
72.63 (C5) 73.49 (C6 or C13) 78.36 (C4) 102.47 (C2’ or C5’ or C6’) 106.42 (C2’ or C5’ or C6’) 
111.61 (C2’ or C5’ or C6’) 127.57 - 127.83 (aromatic CH) 128.37 (aromatic CH) 129.51 (C3) 
130.15 (C2) 138.08 (quaternary C) 143.74 (quaternary C) 149.67 (quaternary C) 152.55 
(quaternary C) 
HR-MS: calculated: 435.21660 [M+H]
+
, 452.24315 [M+NH4]
+
, 457.19855 [M+Na]
+
; found: 
435.21671 [M+H]
+
, 452.24319 [M+NH4]
+
, 457.19843 [M+Na]
+
;  Δm = 0.1-0.3 ppm 
IR: 3062 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 3002 (υ(CH) arom. CH), 2932 (υ(CH) 
aliph. CH), 2856 (υ(CH) aliph. CH), 1596 (υ(Ph)), 1510 (υ(Ph)), 1453 (υ(Ph)), 1229 (various 
C-O), 1198 (various C-O), 1121 (various C-O), 1028 (various C-O), 970 (δ(CH) C=C trans), 
835 (δ(CH) arom. CH), 738 (δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 5 (1 mL/min, 30°C), tR = 15.2 min ((E)-116), tR = 18.8 min ((E)-ent-116) 
 Experimental part 
___________________________________________________________________________ 
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(E)-(((4-(3’,5’-dimethoxyphenoxy)pent-2-ene-1,5-diyl)bis(oxy))bis(methylene))dibenzene 
(117) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.63 - 3.74 (m, 2 H) 3.75 (s, 6 H) 4.04 (d, J=5.52 Hz, 
2 H) 4.47 (s, 2 H) 4.63 (d, J=4.52 Hz, 2 H) 4.87 (qd, J=5.48, 0.88 Hz, 1 H) 5.80 (dt, J=15.80 
Hz, 1 H) 5.92 (dtt, J=15.80 Hz, 1 H) 6.07 - 6.11 (m, 1 H) 6.15 (d, J=2.26 Hz, 2 H) 7.27 - 7.38 
(m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 55.30 (Me) 69.81 (C1) 72.01 (C6 or C13) 72.48 (C5) 
73.44 (C6 or C13) 77.38 (C4) 93.38 (C4’) 94.96 (C2’ and C6’) 127.60-128.36 (aromatic CH) 
129.16 (C2 or C3) 130.15 (C2 or C3) 138.05 (quaternary C) 138.12 (quaternary C) 159.88 
(quaternary C) 161.36 (quaternary C) 
HR-MS: calculated: 435.21660 [M+H]
+
, 452.24315 [M+NH4]
+
; 457.19855 [M+Na]
+
; found: 
435.21667 [M+H]
+
, 452.24307 [M+NH4]
+
; 457.19827 [M+Na]
+, Δm = 0.2-0.6 ppm 
IR: 3030 (υ(CH) arom. CH), 3003 (υ(CH) arom. CH), 2936 (υ(CH) aliph. CH), 2856 (υ(CH) 
aliph. CH), 1600 (aromatic rings stretching), 1474 (aromatic rings stretching), 1455 (aromatic 
rings stretching), 1362 (δ(CH3)), 1205 (various C-O), 1153 (various C-O), 1119 (various C-
O), 1068 (various C-O), 971 (δ(CH) C=C trans), 738 (δ(CH) monosub.), 698 (δ(Ph) 
monosub.) cm
-1
 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 18.5 min ((E)-117), tR = 20.2 min ((E)-ent-117) 
 Experimental part 
___________________________________________________________________________ 
- 149 - 
 
(E)-(((4-(2’,6’-dimethoxyphenoxy)pent-2-ene-1,5-diyl)bis(oxy))bis(methylene))dibenzene 
(118) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.70 - 3.89 (m, 2 H) 3.79 - 3.82 (m, 6 H) 3.99 (ddd, 
J=12.17, 5.77, 1.13 Hz, 2 H) 4.33 (s, 2 H) 4.64 (s, 2 H) 4.84 (dt, J=7.72, 5.55 Hz, 1 H) 5.76 
(dt, J=16.10 Hz, 1 H) 5.93 (ddt, J=16.10 Hz, 1 H) 6.55 (d, J=8.28 Hz, 2 H) 6.97 (t, J=8.41 Hz, 
1 H) 7.27 - 7.39 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 56.01 (CH3) 69.95 (C1) 71.36 (C6 or C13) 72.66 (C5) 
73.32 (C6 or C13) 81.08 (C4) 105.23 (C3’ and C5’) 123.61 (C4’) 127.43 – 128.45 (aromatic CH) 
130.85 (C2 and C3) 135.60 (quaternary C) 138.35 (quaternary C) 138.48 (quaternary C) 
153.83 (quaternary C) 
HR-MS: calculated: 452.24315 [M+NH4]
+
, 457.19855 [M+Na]
+
; found: 452.24329 
[M+NH4]
+
, 457.19843 [M+Na]
+; Δm = 0.3 ppm 
IR: 3062 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 3003 (υ(CH) arom. CH), 2935 (υ(CH) 
aliph. CH), 2855 (υ(CH) aliph. CH), 1596 (υ(Ph)), 1493 (υ(Ph)), 1477 (υ(Ph)), 1454 (υ(Ph)), 
1253 (Ph-O), 1112 (υ(C-O-C)), 971 (δ(CH) C=C (trans)), 772 (δ(CH) arom. CH), 736 (δ(CH) 
arom. CH), 699 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 7 (1 mL/min, 30°C), tR = 14.5 min ((E)-118), tR = 18.6 min ((E)-ent-118) 
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(E)-5-((1’,5’-bis(benzyloxy)pent-3’-en-2’-yl)oxy)benzo[d][1,3]dioxole (119) 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 3.61 - 3.74 (m, 2 H) 4.01 - 4.06 (m, 2 H) 4.47 (s, 2 H) 
4.59 - 4.67 (m, 2 H) 4.71 - 4.78 (m, 1 H) 5.79 (dt, J=15.80 Hz, 1 H) 5.85 - 5.94 (m, 1 H) 5.90 
- 5.91 (m, 2 H) 6.40 (dd, J=8.53, 2.51 Hz, 1 H) 6.55 (d, J=2.51 Hz, 1 H) 6.68 (d, J=8.53 Hz, 1 
H) 7.27 - 7.38 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 69.79 (C1’ or C5’) 72.04 (CH2 ether) 72.56 (C1’ or C5’) 
73.46 (CH2 ether) 78.99 (C2’) 99.86 (C3 or C4 or C6) 101.10 (CH2 dioxo) 107.87 (C3 or C4 or 
C6) 108.36 (C3 or C4 or C6) 127.29 - 128.78 (aromatic CH) 129.28 (C3’ or C4’) 130.26 (C3’ or 
C4’) 138.08 (quaternary C) 141.94 (quaternary C) 148.05 (quaternary C) 153.44 (quaternary 
C) 
HR-MS: calculated: 436.21185 [M+NH4]
+
; 441.16725 [M+Na]
+
;found: 436.21198 
[M+NH4]
+
; 441.16718 [M+Na]
+, Δm =0.3 ppm 
IR: 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2858 (υ(CH) aliph. CH), 1631 (υ(Ph)), 
1501 (υ(Ph)), 1484 (υ(Ph)), 1453 (υ(Ph)), 1242 (υ(C-O)), 1185 (υ(C-O)), 1099 (υ(C-O)), 
1038 (υ(C-O)), 970 (δ(CH) C=C (trans)), 816 (δ(CH) arom. CH), 737 (δ(CH) arom. CH), 698 
(δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 5 (1 mL/min, 30°C), tR = 8.6 min ((Z)-119), tR = 9.4 min ((Z)-ent-119), tR = 
11.6 min ((E)-119), tR = 12.3 min ((E)-ent-119) 
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(E)-(((4-(2‘-(tert-butyl)-4‘-methoxyphenoxy)pent-2-ene-1,5-
diyl)bis(oxy))bis(methylene))dibenzene (120) 
 
 
For the procedures on racemic and enantioselective substitutions see section 5.3. 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 1.42 (s, 9 H) 3.65 - 3.83 (m, 2 H) 3.73 - 3.76 (m, 3 H) 
4.00 - 4.04 (m, 2 H) 4.45 (s, 2 H) 4.60 (d, J=1.51 Hz, 2 H) 4.92 (q, J=5.52 Hz, 1 H) 5.81 (dt, 
J=15.60 Hz, 1 H) 5.89 (td, J=16.56, 15.56 Hz, 1 H) 6.59 - 6.64 (m, 1 H) 6.74 (d, J=9.03 Hz, 1 
H) 6.90 (d, J=3.01 Hz, 1 H) 7.28 - 7.37 (m, 10 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 29.80 (
t
Bu) 35.03 (quaternary C of 
t
Bu) 55.58 (CH3O) 
69.83 (C1) 71.93 (C6 or C13) 73.08 (C5) 73.39 (C6 or C13) 76.40 (C4) 109.57 (C3’ or C5’ or C6’) 
113.47 (C3’ or C5’ or C6’) 114.37 (C3’ or C5’ or C6’) 127.68 - 128.36 (aromatic CH) 129.87 (C2 
or C3) 130.07 (C2 or C3) 
HR-MS: calculated: 478.29519 [M+NH4]
+
; 483.25058 [M+Na]
+
; found: 478.29514 
[M+NH4]
+
; 483.25037 [M+Na]
+, Δm = 0.1-0.4 ppm 
IR: 3063 (υ(NH)), 2952 (υ(CH) aliph. CH), 2861 (υ(CH) aliph. CH), 1583 (aromatic rings 
strechting), 1485 (aromatic rings strechting), 1454 (aromatic rings strechting), 1362 
(δ(CH3)3), 1216 (Ph-O), 1107 (υ(C-O)), 1054 (υ(C-O)), 971 (δ(CH) C=C (trans)), 800 (δ(CH) 
arom. CH), 737 (δ(CH) arom. CH), 698 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), tR = 7.8 min ((E)-120), tR = 10.7 min ((E)-ent-120) 
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2-(allyloxy)-1,4-dimethoxybenzene (123) 
 
 
 
1
H NMR: (400 MHz, CDCl3-d)  ppm 3.77 (s, 3 H) 3.84 (s, 3 H) 4.60 (dt, J=5.52, 1.51 Hz, 2 
H) 5.27 - 5.45 (m, 2 H) 6.09 (ddt, J=17.32, 10.60, 5.36, 5.36 Hz, 1 H) 6.42 (dd, J=8.78, 2.76 
Hz, 1 H) 6.54 (d, J=2.76 Hz, 1 H) 6.81 (d, J=8.78 Hz, 1 H) 
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2-aminopentane-1,5-diol (124) 
 
 
(E)-N-benyzl-1,5-bis(benzyloxy)pent-3-en-2-amine 80 (product from enantioselective allylic 
substitution with (R,R)-Trost ANDEN ligand) (0.95g, 2.451 mmol, 1 eq.) was put in solution 
in 200mL EtOH (98%) at rt. The flask was put under a flush of argon and Pd/C 10% (0.19g, 
20% m/m) was added. Argon was then replaced by H2(g) (atmospheric pressure) at rt. After 
48h, the Pd/C was filtered through a spritzenfilter and washed with 30mL EtOH (98%). The 
flask was put under a flush of argon and Pd/C 10% (0.19g, 20% m/m) was added. After 4 
days, the Pd/C was filtered through a spritzenfilter and washed with 30mL ALI. The solvent 
was evaporated under reduced pressure. Flash chromatography column (15% MeOH, 2% 
ammonia sol (25%) in MED) of the crude gave the corresponding product (oil, 0.1222g, 
42%). 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 1.25 - 1.38 (m, 1 H) 1.62 - 1.79 (m, 3 H) 1.96 (br. s., 2 
H) 2.79 - 2.88 (m, 1 H) 3.37 (dd, J=10.54, 7.78 Hz, 1 H) 3.58 - 3.72 (m, 3 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 30.27 (C3 or C4) 32.09 (C3 or C4) 52.94 (C2) 62.79 
(C1 or C5) 67.80 (C1 or C5) 
HR-MS: calculated 120.10191 [M+H]
+
; found: 120.10202 [M+H]
+, Δm = 1 ppm 
IR: 3355 (υ(OH)), 2943 (υ(CH)), 2877 (υ(CH)), 1058 (υ(C-OH)) cm-1 
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(R)-N-(1,5-dihydroxypentan-2-yl)benzamide (125) 
 
 
2-aminopentane-1,5-diol 124 (0.04g, 0.336mmol, 1 eq.) was put in solution in 4mL THF and 
cooled down at 0°C with an ice/water bath. 2mL of a solution of saturated aqueous sodium 
carbonate was slowly added at 0°C (white suspension). 0.99mL of a solution of 0.524g 
benzoyl chlorid in 10mL THF (0.052g, 0.369mmol, 1.1 eq.) was slowly added at 0°C during 
10min. After 1h, the solution was allowed to come at rt and the solvents were evaporated 
under reduced pressure (the benzoyl product is soluble in water). 6mL of a solution of 20% 
MeOH in MED was added to the crude (white solid) and left to stir during 1h. The white 
precipitate was filtered and the filtrate was evaporated under reduced pressure. Flash 
chromatography of the evaporated filtrate (10% MeOH in MED) gave the corresponding 
product (0.045g, 60%, white crystals) 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 1.36 - 1.55 (m, 3 H) 1.59 - 1.73 (m, 1 H) 3.33 - 3.49 
(m, 4 H) 3.89 - 4.00 (m, 1 H) 4.36 (t, J=5.14 Hz, 1 H) 4.66 (t, J=5.77 Hz, 1 H) 7.41 - 7.55 (m, 
3 H) 7.80 - 7.89 (m, 2 H) 8.00 (d, J=8.53 Hz, 1 H) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 27.30 (C3 or C4) 29.28 (C3 or C4) 51.34 (C2) 60.78 
(C1
 
or C5) 63.48 (C1
 
or C5) 127.24 (aromatic CH) 128.10 (aromatic CH) 130.91 (C10) 134.86 
(C7) 166.09 (C6) 
HR-MS: calculated 224.12812 [M+H]
+
, 246.11007 [M+Na]
+
, found: 224.12801 [M+H]
+
, 
246.10985 [M+Na]
+
,
 Δm = 0.5 - 0.9 ppm 
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IR: 3355 (υ(NH) + υ(OH)), 3284 (υ(NH) + υ(OH)), 3082 (υ(CH) arom. CH), 2954 (υ(CH) 
aliph. CH), 2923 (υ(CH) aliph. CH), 2860 (υ(CH) aliph. CH), 1638 (υ(C=O) amide), 1605 
(υ(Ph)), 1579 (υ(Ph)), 1541 (amide II), 1488 (υ(Ph)), 1451 (υ(Ph)), 1099 (υ(C-OH)), 1072 
(υ(C-OH)), 1031 (υ(C-OH)), 704 (δ(Ph) mono-sub.) cm-1 
Optical activity: [α]20D = +27 (c = 0.01, MeOH) 
mp: 104.4 - 106.2 °C 
HPLC:  C-HPLC 9 (1 mL/min, 30°C), ee = 90%, tR = 5.7 min ((S)-125), tR = 6.6 min ((R)-
125). Major enantiomer is the (R)-enantiomer. 
 
 
(R)-dimethyl 2-benzamidopentanedioate (127) 
 
 
 
H-D-glu(OMe)-OMe·HCl (5g, 23.624mmol, 1 eq.) was put in solution in 100mL THF at rt. 
The white suspension was then cooled down at 0°C with an ice/water bath. A solution of 
saturated sodium carbonate (90mL) was slowly added at 0°C. At 0°C, Benzoyl chloride 
(4.317g, 30.711mmol, 1.3 eq.) was slowly added with adjustment of the pH with a solution of 
saturated sodium carbonate (pH=9.6). After 30min, the reaction was allowed to come at rt. 
After 1h30, the solvents were evaporated under reduced pressure. To dissolve the salt, 100mL 
water were added, then 250mL ethyl acetate were added and the phase separated. The organic 
 Experimental part 
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phase was extracted with 3x 50mL NaHCO3 sat, 3x 50mL KHSO4 sat and 3x 50mL NaCl sat 
and then dried over MgSO4. The solvents were evaporated under reduced pressure. Flash 
chromatography column (1:1 Hexane:Ethyl acetate) of the crude gave the corresponding 
product (6.16g, 93% yield, white crystals) 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 1.96 - 2.20 (m, 2 H) 2.42 - 2.49 (m, 2 H) 3.59 (s, 3 
H) 3.65 (s, 3 H) 4.48 (ddd, J=9.54, 7.53, 5.27 Hz, 1 H) 7.44 - 7.52 (m, 2 H) 7.52 - 7.59 (m, 1 
H) 7.84 - 7.93 (m, 2 H) 8.76 (d, J=7.53 Hz, 1 H) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 25.70 (C3 or C4) 29.94 (C3 or C4) 51.36 (C13 or C14) 
51.92 (C13 or C14 or C2) 51.93 (C13 or C14 or C2) 127.46 (aromatic CH) 128.28 (aromatic CH) 
131.52 (C10) 133.61 (C7) 166.66 (C6) 172.23 (C1 or C5) 172.68 (C1 or C5) 
HR-MS: calculated 280.11795 [M+H]
+
, 302.09990 [M+Na]
+
, found: 280.11798 [M+H]
+
, 
302.09973 [M+Na]
+
,
 Δm = 0.1-0.5 ppm 
IR: 3285 (υ(NH)), 3072 (υ(CH) arom. CH), 3029 (υ(CH) arom. CH), 3001 (υ(CH) arom. 
CH), 2955 (υ(CH) aliph. CH), 2852 (υ(CH) aliph. CH), 1748 (υ(C=O) ester), 1733 (υ(C=O) 
ester),  1638 (υ(C=O) amide), 1602 (υ(Ph)), 1578 (υ(Ph)), 1542 (amide II), 1491 (υ(Ph)), 
1274 (υ(C-O) ester), 1197 (υ(C-O) ester), 1174 (υ(C-O) ester), 781 (δ(CH) mono-sub.), 702 
(δ(Ph) mono-sub.) cm-1 
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(R)-N-(1,5-dihydroxypentan-2-yl)benzamide (128) 
 
 
Pellet of LiAlH4 (0.815g, 21.483 mmol, 3 eq.) were dissolved in 40mL THF at rt. The grey 
suspension was then cooled down at 0°C with an ice/water bath. (R)-dimethyl 2-
benzamidopentanedioate 127 (2g, 7.161 mmol, 1 eq.) was dissolved in 20mL THF and  
slowly added at 0°C to the suspension of LiAlH4. After the end of the addition, the solution 
was allowed to come at rt. After 20min, the reaction was finished, cooled down at 0°C and 
20mL of water were slowly added .The reaction mixture was then allowed to come at rt. The 
grey gel was filtered though a short pad of cellflock and washed with 250mL THF. The 
solvent (filtrate) was evaporated under reduced pressure. A white solid crystallized from the 
crude. 8mL of TBME was added to the crystals, cooled down at 0°C and stirred during 
30min. The obtained white powder was filtered, washed with a minimum of TBME and dried 
in the oven. Then a recrystallisation was done. Ethyl acetate (40mL) was added to the crystals 
and heated until a clear solution was obtained. A hot filtration was done and then slowly 
cooled to rt. Crystals were formed in the filtrate which were filtered, washed with a minimum 
of TBME and dried in the oven to give the corresponding desired product (1.0086g, 63% 
yield, white crystals) 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 1.36 - 1.55 (m, 3 H) 1.59 - 1.72 (m, 1 H) 3.33 - 3.42 
(m, 3 H) 3.42 - 3.49 (m, 1 H) 3.89 - 4.00 (m, 1 H) 4.36 (t, J=5.14 Hz, 1 H) 4.65 (t, J=5.77 Hz, 
1 H) 7.41 - 7.48 (m, 2 H) 7.48 - 7.54 (m, 1 H) 7.83 - 7.87 (m, 2 H) 8.00 (d, J=8.53 Hz, 1 H) 
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13
C-NMR: (101 MHz, DMSO-d6) δ ppm 27.32 (C3 or C4) 29.30 (C3 or C4) 51.36 (C2) 60.80 
(C1
 
or C5) 63.51 (C1
 
or C5) 127.27 (aromatic CH) 128.11 (aromatic CH) 130.93 (C10) 134.88 
(C7) 166.13 (C6) 
HR-MS: calculated 224.12812 [M+H]
+
, 246.11007 [M+Na]
+
, found: 224.12816 [M+H]
+
, 
246.10991 [M+Na]
+
,
 Δm = 0.1-0.2 ppm 
IR: 3356 (υ(NH) + υ(OH)), 3284 (υ(NH) + υ(OH)), 3084 (υ(CH) arom. CH), 3033 (υ(CH) 
arom. CH), 2954 (υ(CH) aliph. CH), 2923 (υ(CH) aliph. CH), 2860 (υ(CH) aliph. CH), 1637 
(υ(C=O) amide), 1605 (υ(Ph)), 1579 (υ(Ph)), 1540 (amide II), 1490 (υ(Ph)), 1452 (υ(Ph)), 
1098 (υ(C-OH)), 1072 (υ(C-OH)), 1031 (υ(C-OH)), 704 (δ(Ph) mono-sub.) cm-1 
Optical activity: (recrystallized) [α]20D = +33 (c = 0.01, MeOH) 
mp: 106.4 – 109.4 °C 
HPLC: C-HPLC 9 (1 mL/min, 30°C), tR = 6.6 min ((R)-128) 
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(S)-dimethyl 2-benzamidopentanedioate (130) 
 
 
Same procedure as for (R)-dimethyl 2-benzamidopentanedioate 127 (yield of 130 = 93%, 
white crystals) 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 2.11 - 2.22 (m, 1 H) 2.34 (dtd, J=14.24, 7.06, 7.06, 
5.02 Hz, 1 H) 2.41 - 2.59 (m, 2 H) 3.66 (s, 3 H) 3.79 (s, 3 H) 4.80 - 4.88 (m, 1 H) 7.02 (d, 
J=7.53 Hz, 1 H) 7.42 - 7.49 (m, 2 H) 7.50 - 7.56 (m, 1 H) 7.80 - 7.86 (m, 2 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 27.20 (C3) 30.19 (C4) 51.89 (CH3) 52.25 (C2) 52.60 
(CH3) 127.08 (aromatic CH, 2C) 128.59 (aromatic CH, 2C) 131.83 (aromatic CH, 1C) 133.57 
(quaternary C) 167.08 (quaternary C) 172.39 (quaternary C) 173.64 (quaternary C) 
HR-MS: calculated 280.11795 [M+H]
+
, 302.09990 [M+Na]
+
, found: 280.11807 [M+H]
+
, 
302.09976 [M+Na]
+
,
 Δm = 0.4 ppm 
IR: 3285 (υ(NH)), 3072 (υ(CH) arom. CH), 2955 (υ(CH) aliph. CH), 1750 (υ(C=O) ester), 
1733 (υ(C=O) ester), 1577 (υ(Ph)), 1542 (amide II), 1491 (υ(Ph)), 1273 (υ(C-O) ester), 701 
(δ(Ph) mono-sub.) cm-1 
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(S)-N-(1,5-dihydroxypentan-2-yl)benzamide (131) 
 
 
Pellet of LiAlH4 (1.08g, 28.465 mmol, 3 eq.) were dissolved in 40mL THF at rt. The grey 
suspension was then cooled down at 0°C with an ice/water bath. (S)-dimethyl 2-
benzamidopentanedioate (2.65g, 9.488 mmol, 1 eq.) was dissolved in 20mL THF and  slowly 
added at 0°C to the suspension of LiAlH4. After the end of the addition, the solution was 
allowed to come at rt. After 15h, the solution was heated to 40°C with an oil bath during 6h. 
Then, the solution was cooled down at rt and 60mL of diethyl ether were added. After 18h, 
the reaction mixture was cooled down at 0°C and 20mL of water were slowly added .The 
reaction mixture was then allowed to come at rt and left to stir during 30min. The grey gel 
was filtered though a short pad of cellflock and washed with 300mL THF. The solvent was 
evaporated under reduced pressure. A white solid crystallized from the crude and was filtered 
with a minimum of TBME. The crystals were dried in the oven (m=0.7424g). Then a 
recrystallisation was done. Ethyl acetate (40mL) was added to the crystals and heated until a 
clear solution was obtained. A hot filtration was done and then slowly cooled to rt. Crystals 
were formed in the filtrate which were filtered, washed with a minimum of TBME and dried 
in the oven to give the corresponding desired product (0.443g, 21% yield, white crystals) 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 1.35 - 1.55 (m, 3 H) 1.59 - 1.72 (m, 1 H) 3.34 - 3.50 
(m, 4 H) 3.89 - 4.00 (m, 1 H) 4.36 (t, J=5.14 Hz, 1 H) 4.66 (t, J=5.77 Hz, 1 H) 7.41 - 7.54 (m, 
3 H) 7.82 - 7.88 (m, 2 H) 8.00 (d, J=8.53 Hz, 1 H) 
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13
C-NMR: (101 MHz, DMSO-d6) δ ppm 27.30 (C3 or C4) 29.28 (C3 or C4) 51.34 (C2) 60.78 
(C5) 63.48 (C1) 127.24 (C12 and C8) 128.09 (C9 and C11) 130.91 (C10) 134.86 (C7) 166.10 (C6) 
HR-MS: calculated 224.12812 [M+H]
+
, 246.11007 [M+Na]
+
, found: 224.12804 [M+H]
+
, 
246.10991 [M+Na]
+
,
 Δm = 0.4-0.6 ppm 
IR: 3359 (υ(NH) + υ(OH)), 3301 (υ(NH) + υ(OH)), 3284 (υ(NH) + υ(OH)), 3085 (υ(CH) 
arom. CH), 2953 (υ(CH) aliph. CH), 2924 (υ(CH) aliph. CH), 2860 (υ(CH) aliph. CH), 1637 
(υ(C=O) amide), 1537(amide II), 1072 (υ(C-OH)), 702 (δ(Ph) mono-sub.) cm-1 
Optical activity: (recrystallized) [α]20D = -34.5 (c = 0.01, MeOH) 
mp: 106.5 – 107.4 °C 
HPLC: C-HPLC 9 (1 mL/min, 30°C), tR = 5.7 min 
 
 
 
 Experimental part 
___________________________________________________________________________ 
- 162 - 
 
(2R,3S)-dimethyl 2,3-dihydroxysuccinate (139) 
 
Meso-tartaric acid monohydrate (10g, 66.63mmol, 1 eq.) was put in solution in 270mL 
MeOH. Amberlyst 15 (H
+
-form 20-50 mesh, 120g) was added portion wise (addition of 
Amberlyst heat up the solution) and left under soft shaking (no stirring) for 96h. The reaction 
mixture was filtered through Büchner and washed with 400mL MeOH. The solvent was 
evaporated under reduced pressure and the product crystallized during the process. The brawn 
crystals were dissolved in MED/ESTP and 1g of activated charcoal was added. After 30min, 
the mixture was filtered through a disposable bottle-top filter (Zapcap
®
-CR) and the solvent 
was evaporated under reduced pressure to afford white crystals (10.95g, 92% yield). 
 
1
H NMR (400 MHz, DMSO-d6)  ppm 3.62 (s, 6 H) 4.28 (s, 2 H) 5.80 (br. s., 2 H) 
13
C NMR (101 MHz, DMSO-d6)  ppm 51.60 (CH3) 72.87 (C2 and C3) 171.51 (C=O) 
HR-MS: calculated 179.05502 [M+H]
+
, 196.08157 [M+NH4]
+
; found 179.05506 [M+H]
+
, 
196.08162 [M+NH4]
+; Δm =0.3 ppm 
IR: 3427 (υ(OH)), 2960 (υ(CH)), 1743 (υ(C=O)), 1444 (δ(CH)), 1229 (υ(C-O)), 1125 (υ(C-
O)) cm
-1
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(4S,5R)-dimethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic (140) 
 
(2R,3S)-dimethyl 2,3-dihydroxysuccinate 139 (6g, 33.68mmol, 1 eq.) was put in solution in 
4mL CH2Cl2 at rt. p-toluenesulfonic acid monohydrate (3.2g, 16.84mmol, 0.5 eq.) was added 
to the solution followed by addition of  2,2-dimethoxypropane (27mL, 6.5 eq.). Molecular 
sieves (3Å) were added to the mixture. After 24h, the reaction was filtered through Büchner 
and washed with CH2Cl2. The solvent was evaporated under reduced pressure. 200mL H2O 
was added to the crude and extracted with 2x 200mL ESTP. The organic layer was dried over 
MgSO4 and the solvent evaporated under reduced pressure. Flash chromatography of the 
crude (9:1 HXF:ESTP) afforded the desired product (yellow oil, 5.941g, 81% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.43 (s, 3 H) 1.67 (s, 3 H) 3.77 (s, 6 H) 4.85 (s, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 25.78 (CH3-C2) 26.61 (CH3-C2) 52.47 (CH3 ester) 
113.12 (C4 and C5) 168.66 (C=O) 
HR-MS: calculated 219.08632 [M+H]
+
, 236.11287 [M+NH4]
+
, 241.06826 [M+Na]
+
; found 
219.08626 [M+H]
+
, 236.11275 [M+NH4]
+
, 241.06806 [M+Na]
+; Δm = 0.2-0.8 ppm 
FTIR: 2991 (υ(CH)), 2956 (υ(CH)), 2853 (υ(CH)), 1768 (υ(C=O) ester), 1439 (δ(CH)), 1385 
(δ (CH)), 1213 (C-O ester), 1108 (C-O) cm-1 
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(2E,2’E)-diethyl 3,3’-[(4’’R,5’’S)-2’’,2’’-dimethyl-1’’,3’’-dioxolane-4’’,5’’-diyl]diacrylate 
(142) 
 
(4S,5R)-dimethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic 140 (4g, 18.33mmol, 1 eq.) 
was put in solution in 120mL toluene and the solution was cooled down at -78°C. DIBAL 
(1M in toluene, 37mL, 36.66mmol, 2 eq.) was slowly added to the solution at -78°C during 
30min and left to react during 2h30. Meanwhile, a solution of sodio triethyl phosphonoacetate 
was prepared by dissolving sodium hydrid (55-65% in mineral oil, 2g, 45.83mmol, 2.5 eq.) in 
20mL DME at 0°C and adding triethyl phosphonoacetate diluted in 10mL DME at 0°C. After 
end of addition, the white suspension was allowed to come at rt and the mixture was stirred to 
react during 20min at rt. The solution of sodio triethyl phosphonoacetate was added to the 
reaction mixture at -70°C during 15min. After the end of addition, the solution was allowed to 
come at rt. After 4h, the reaction mixture was cooled at 0°C and 50mL H2O was slowly 
added. A grey gel was formed which was filtered through a small pad of cellflock and washed 
with TBME. The filtrate was transferred into a separatory funnel and extracted with 3x 50mL 
H2O. The solvent was evaporated under reduced pressure. Flash chromatography of the crude 
(8:2 HXF:ESTP) afforded the desired product (yellow oil, 3.22g, 59% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.28 (t, J=7.15 Hz, 6 H) 1.42 (s, 3 H) 1.57 (s, 3 H) 4.19 
(q, J=7.03 Hz, 4 H) 4.85 (dt, J=2.45, 1.16 Hz, 2 H) 6.04 - 6.12 (m, 2 H) 6.67 - 6.76 (m, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 14.16 (CH3 ethyl) 25.35 (CH3-C2’’) 27.67 (CH3-C2’’) 
60.57 (CH2 ethyl) 77.42 (C4’’ and C5’’) 110.25 (C2’’) 123.72 (C2 and C2’
 
or C3 and C3’) 141.86 
(C2 and C2’ or C3 and C3’) 165.55 (C1 and C1’) 
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HR-MS: calculated 299.14892 [M+H]
+
, 316.17547 [M+NH4]
+
; found 299.14881 [M+H]
+
, 
316.17531 [M+NH4]
+; Δm = 0.3-05 ppm 
FTIR: 2987 (υ(CH) aliph. CH), 2940 (υ(CH) aliph. CH), 2907 (υ(CH) aliph. CH), 1723 
(υ(C=O) ester), 1663 (υ (C=C)), 1465, 1372, 1308, 1262 (C-O), 1180 (C-O), 1123 (C-O), 
1042 (C-O), 981 (δ(CH) CH=CH trans), 859cm-1 
 
 
(2E,4R,5S,6E)-diethyl 4,5-dihydroxyocta-2,6-dienedioate (143) 
 
 
(2E,2’E)-diethyl 3,3’-((4R,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)diacrylate 142 (3g, 
10.056mmol, 1 eq.) was put in solution in 60mL THF and 60mL H2O at rt. HCl (fuming 37%, 
24mL) was slowly added to the solution. After 4h, the reaction was quenched with a dropwise 
addition of 40mL K2CO3 10N. 40mL NaCl sat was then added and followed by extraction 
with 3x 60ml TBME. The organic layer was dried over MgSO4 and the solvent evaporated 
under reduced pressure. Flash chromatography of the crude (1:1 HXF:ESTP) afforded the 
desired product (white crystals, 2.073g, 80% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.30 (t, J=7.15 Hz, 6 H) 2.42 (br. s., 2 H) 4.22 (q, 
J=7.03 Hz, 4 H) 4.45 - 4.52 (m, 2 H) 6.15 (dt, J=15.69, 0.69 Hz, 2 H) 6.88 - 6.97 (m, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 14.18 (CH3-ethyl) 60.69 (CH2-ethyl) 73.50 (C4 or C5) 
123.47 (C2 and C7) 144.06 (C3 and C6) 165.90 (C1 and C8)  
HR-MS: calculated 259.11762 [M+H]
+
, 276.14417 [M+NH4]
+
, 281.09956 [M+Na]
+
; found 
259.11749 [M+H]
+
, 276.14404 [M+NH4]
+
, 281.09940 [M+Na]
+
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FTIR: 3439 (υ(OH)), 2991 (υ(CH) aliph. CH), 2942 (υ(CH) aliph. CH), 2914 (υ(CH) aliph. 
CH), 1694 (υ(C=O) ester), 1660 (υ(C=C)), 1480 (δ(CH)), 1458 (δ(CH)), 1445 (δ(CH)), 1398 
(δ(CH)), 1310, 1283 (υ(C-O)), 1273 (υ(C-O)), 1189 (υ(C-O)), 1096 (υ(C-O)), 1033 (υ(C-O)), 
987 (δ(CH) CH=CH trans)  cm-1 
 
 
(2E,2’E)-diethyl 3,3’-[(4R’’,5S’’)-2’’-oxo-1’’,3’’-dioxolane-4’’,5’’-diyl]diacrylate (144) 
 
(2E,4R,5S,6E)-diethyl 4,5-dihydroxyocta-2,6-dienedioate 143 (1.95g, 7.55mmol, 1 eq.) was 
put in solution in 75mL CH2Cl2 at rt. Pyridine (3.062g, 38.72mmol, 5.1 eq.) was added at rt 
and then the reaction was cooled down at 0°C. Trisphosgen (3.447g, 11.616mmol, 1.5 eq.) 
diluted in 35mL CH2Cl2 was slowly added to the reaction mixture at 0°C during 15min. After 
15min, the reaction was finished and 100mL NH4Cl sat was added at 0°C to quench the 
reaction. The solution was then allowed to come at rt. The organic phase was separated and 
the aqueous phase was extracted with 2x 70mL TBME. The organic phases were put together 
and extracted with 1x 100mL NaHCO3 sat, 1x 100mL NaCl sat and dried over MgSO4. The 
solvent was evaporated under reduced pressure. Flash chromatography of the crude (6:4 
HXF:ESTP) afforded the desired product (2.123g, 99% yield). 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.31 (t, J=7.03 Hz, 6 H) 4.24 (q, J=7.03 Hz, 4 H) 5.37 - 
5.43 (m, 2 H) 6.19 - 6.25 (m, 2 H) 6.66 - 6.75 (m, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 14.10 (CH3 ethyl) 61.21 (CH2 ethyl) 126.47 (C2 and 
C2’ or C3 and C3’) 136.28 (C2 and C2’
 
or C3 and C3’) 152.65 (C2’’) 164.43 (C1 and C1‘) 
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HR-MS: calculated 285.09688 [M+H]
+
, 302.12343 [M+NH4]
+
, 307.07883 [M+Na]
+
; found 
285.09665 [M+H]
+
, 302.12317 [M+NH4]
+
, 307.07858 [M+Na]
+; Δm = 0.8-0.9 ppm 
FTIR: 3072 (υ(CH) arom.), 3042 (υ(CH) arom.), 2984 ((υ(CH) aliph.), 2936 (υ(CH) aliph.), 
1818 (υ(C=O) carbonate), 1718 (υ(C=O) ester), 1662 (υ(C=C)), 1370, 1309, 1262, 1177 (υ(C-
O)), 1051 (υ(C-O))  cm-1 
 
 
(2E,4E,6E)-diethyl 4-hxdroxyocta-2,4,6-trienedioate (145) 
 
 
1
H NMR (600 MHz, DMSO-d6)  ppm 1.22 (q, J=6.95 Hz, 6 H) 4.14 (dq, J=17.93, 7.20 Hz, 
4 H) 5.88 - 5.93 (m, 2 H) 6.31 (d, J=15.73 Hz, 1 H) 7.04 (d, J=15.37 Hz, 1 H) 7.78 (dd, 
J=15.00, 12.07 Hz, 1 H) 10.07 (s, 1 H) 
HR-MS: found 195.06511 [M-HOC2H5]
+
, 241.10692 [M+H]
+
, 263.08880 [M+Na]
+
 
HSQC, COSY, ROESY and HMBC spectras available. 
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(2E,2’E)-dimethyl 3,3’-[(4R’’,5R’’)-2’’,2’’-dimethyl-1’’,3’’-dioxolane 
4’’,5’’diyl]diacrylate (154) 
 
 
Dimethyl (4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate (3g, 13.75mmol, 1 eq.) was 
put in solution in 60mL toluene and the solution was cooled down at -78°C. DIBAL (1M in 
toluene, 3.91g, 27.5mmol, 2 eq.) was slowly added to the solution during 30min and left to 
react during 2h (inner temperature went up to-70°C during addition). In the meantime, a 
solution of sodio methyl diethylphosphonate was prepared by dissolving NaH (55-65% in 
mineral oil, 1.5g, 34.37mmol, 2.5 eq.) in 20mL DME. The mixture was cooled down at 0°C 
and methyl diethylphosphonoacetate (7.22g, 34.37mmol, 2.5 eq.) diluted in 15mL DME was 
slowly added to the NaH mixture at 0°C. After the end of addition, the white suspension was 
allowed to come at rt and was stirred to react during 20min at rt. Sodio methyl 
diethylphosphonate was added to the DIBAL solution during 20min (inner temperature went 
up to -65°C during reaction). After the end of addition, the clear solution was allowed to come 
at rt. After 4h, the reaction mixture was slowly quenched with 50mL H2O. The formed gel 
was filtered through a thin pad of cellflock then poured to 150mL TBME and extracted. The 
organic phase was washed 3x 50mL H2O and dried over MgSO4. The solvent was evaporated 
under reduced pressure. Flash chromatography of the crude (9:1 HXF:ESTP) afforded the 
desired product (colorless oil, 2.317g, 62%). 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.48 (s, 6 H) 3.78 (s, 6 H) 4.30 (ddd, J=2.95, 1.32, 1.00 
Hz, 2 H) 6.16 (d, J=15.81 Hz, 2 H) 6.85 - 6.92 (m, 2 H) 
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13
C NMR (400 MHz, CDCl3-d) δ ppm 26.78(CH3-C2’’) 51.82 (CH3 ester) 79.72 (C4’’ and C5’’) 
110.94 (C2’’) 123.27 (C2 and C2’ or C3 and C3’) 142.15 (C2 and C2’ or C3 and C3’) 166.06 (C1 
and C1’) 
HR-MS: calculated 271.11762 [M+H]
+
, 288.14417 [M+NH4]
+
; found: 271.11750 [M+H]
+
, 
288.14402 [M+NH4]
+, Δm = 0.4-0.5 ppm 
FTIR: 2990 (γ(CH), aliph. CH), 2954 (γ(CH), aliph. CH), 2883 (γs(OCH3)), 1729 (γ(C=O) 
ester), 1666 (γ(C=C)), 1438 (δ(C-H)), 1375 (δ(C-H)), 1307 (C-O), 1279 (C-O), 1167 (C-O), 
979 (δ(CH) trans C=C) cm-1 
 
 
(2E,4R,5R,6E)-dimethyl 4,5-dihydroxyocta-2,6-dienedioate (155) 
 
 
(2E,2’E)-dimethyl 3,3’-((4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)diacrylate 154 (1g, 
3.7mmol, 1 eq.) was put in solution in 20mL THF and 20mL H2O at rt. HCl (fuming 37%, 
5mL was added to the solution (inner temperature raised up to 30°C). Afte 2h, another 5mL of 
HCl (fuming 37%) was slowly added to the solution. After 4h, the reaction was quenched 
with addition of 20mL10N K2CO3. The resulting mixture was saturated with 20mL NaCl and 
extracted with 3x 50mL TBME. The organic phases were put together and dried over MgSO4. 
The solvent was evaporated under reduced pressure. Product crystallized by addition of a 
minimum of CH2Cl2. The white solid was filtered, washed with hexane and put in the oven to 
dry to afford the desired product (white solid, 0.7506g, 88% yield). 
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1
H NMR (600 MHz, DMSO-d6) δ ppm 3.65 (s, 6 H) 4.31 (br. s., 2 H) 5.55 (d, J=4.02 Hz, 2 
H) 5.99 (dd, J=15.73, 1.10 Hz, 2 H) 6.90 (dd, J=15.73, 3.66 Hz, 2 H) 
13
C NMR (151 MHz, DMSO-d6) δ ppm 51.33 (CH3) 72.29 (C4 and C5) 120.27 (C2 and C7) 
148.54 (C3 and C6) 166.00 (C1 and C8) 
HR-MS: calculated 231.08632 [M+H]
+
, 248.11287 [M+NH4]
+
, 253.06826 [M+Na]
+
; found 
231.08623 [M+H]
+
, 248.11275 [M+NH4]
+
, 253.06811 [M+Na]
+; Δm = 0.4-0.6 ppm 
FTIR: 3390 (OH), 3279 (OH), 2997 (CH), 2955(CH), 2916 (CH), 2855 (CH), 1714 (C=O 
ester), 1666 (C=C), 1445, 1318 (C-O), 1279 (C-O), 1201 (C-O), 1178 (C-O), 1020 (C-O), 982 
(δ CH trans C=C) cm-1 
mp: 88.5-90.5 °C 
 
 
(2E,2’E)-dimethyl 3,3’-[(4’’R,5’’R)-2’’-oxo-1’’,3’’-dioxolane-4’’,5’’-diyl]diacrylate (156) 
 
(2E,4R,5R,6E)-dimethyl 4,5-dihydroxyocta-2,6-dienedioate 155 (0.4g, 1.737mmol, 1 eq.) was 
put in solution in 15mL CH2Cl2 at rt. Pyridine (0.7mL, 8.685mmol, 5 eq.) was added at rt and 
the reaction mixture was cooled down at 0°C. Trisphosgen (0.773g, 2.606mmol, 1.5 eq.) 
diluted in 7mL CH2Cl2 was slowly added to the mixture during 10min (inner temperature +1-
2°C). After 1h, the reaction was quenched with 40mL NH4Cl at 0°C and was allowed to come 
at rt. The organic phase was separated and the aqueous phase was extracted with 3x 30mL 
TBME. The organic phases were put together and extracted with 1x 100mL NaHCO3 sat., 1x 
100mL NaCl sat. and dried over MgSO4. The solvent was evaporated under reduced pressure. 
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Flash chromatography of the crude (1:1 HXF : ESTP) afforded the desired product (white 
powder, 0.423g, 95% yield) 
1
H NMR (400 MHz, DMSO-d6) δ ppm 3.71 (s, 6 H) 5.30 - 5.36 (m, 2 H) 6.24 (d, J=15.81 
Hz, 2 H) 6.94 - 7.04 (m, 2 H) 
13
C NMR (101 MHz, DMSO-d6) δ ppm 51.80 (CH3) 78.54 (C4’’ and C5’’) 124.68 (C2 and C2’ 
or C3 and C3’) 140.09 (C2 and C2’ or C3 and C3’) 153.01 (C=O) 164.99 (C=O) 
HR-MS: calculated 257.06558 [M+H]
+
, 274.09213 [M+NH4]
+
, 279.04753 [M+Na]
+
; found 
257.06558 [M+H]
+
, 274.09201 [M+NH4]
+
, 279.04745 [M+Na]
+; Δm: < 0.1-0.4 ppm 
IR: 3073 (υ(CH) arom. olef. CH), 3001 (υ(CH) arom. olef. CH), 2956 (υas(CH3)), 2849 
(υs(CH3)), 1822 (υ(C=O) carbonate), 1720 (υ(C=O) ester), 1670 (υ(C=C)), 1436 (δ(CH)), 
1389 (δ(CH)), 1327, 1271 (υ(C-O)), 1201 (υ(C-O)), 1063 (C-O), 989 (δ(CH) CH=CH trans), 
746 cm
-1
 
mp: 78.8-79.9°C 
 
 
(2E,4R,5R,6E)-dimethyl 4-((benzylcarbamoyl)oxy)-5-hydroxyocta-2,6-dienedioate (157) 
 
1
H NMR (400 MHz, CDCl3-d)  ppm 3.74 (s, 6 H) 4.35 (m, 3H) 4.50 (br. s., 1 H) 5.45 (m, 1 
H) 5.51 - 5.57 (m, 1 H) 6.04 - 6.21 (m, 2 H) 6.92 (dt, J=15.75, 4.55 Hz, 2 H) 7.23 - 7.38 (m, 5 
H) 
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13
C NMR (101 MHz, CDCl3-d)  ppm 45.13 (CH2 amide) 51.72 (CH3) 51.79 (CH3) 71.63 (C4 
or C5) 74.82 (C4 or C5) 122.65 (C2 or C3 or C6 or C7) 123.26 (C2 or C3 or C6 or C7) 127.41 - 
128.69 (aromatic CH) 137.76 (quaternary C) 141.88 (C2 or C3 or C6 or C7) 144.79 (C2 or C3 
or C6 or C7) 155.21 (C=O) 166.13 (C=O) 166.46 (C=O) 
HR-MS: calculated 364.13908 [M+H]
+
, 381.16563 [M+NH4]
+
, 386.12103 [M+Na]
+
; found 
364.13925 [M+H]
+
, 381.16590 [M+NH4]
+
, 386.12101 [M+Na]
+; Δm: < 0.1-0.7 ppm 
IR: 3437 (γ(NH) + γ(OH)), 3420 (γ(NH) + γ(OH)), 3032 (γ(CH) arom. CH), 1721 (γ(C=O)), 
1700 (γ(C=O)), 1660 (γ(C=O)), 1515 (amide II) cm-1 
 
 
(2E,2’E)-3,3’-[(4’’R,5’’S)-2’’,2’’-dimethyl-1’’,3’’-dioxolane-4’’,5’’-diyl]bis(prop-2-en-1-
ol) (161) 
 
 
LiAlH4 (pellet, 0.043g, 1.133mmol, 3.4 eq.) was put in solution in 4mL THF at rt and the 
solution was cooled down at -78°C. n-BuBr (0.155g, 1.133mmol, 3.4 eq.) diluted in 1mL 
THF was slowly added and after the end of addition, the mixture was allowed to come at rt to 
react. After16h, the mixture was cooled down at -78°C and (2E,2’E)-diethyl 3,3’-((4R,5S)-
2,2-dimethyl-1,3-dioxolane-4,5-diyl)diacrylate 142 (0.1g, 0.335mmol, 1 eq.) was added 
dropwise during 15min. After 3h, the reaction mixture was allowed to come at 0°C. After 1h 
at 0°C, the reaction was finished and 0.07mL NaOH 1M was slowly added at 0°C and left to 
stir for 15min. A grey gel was formed which is filtered through a short pad of cellflock and 
washed with 40mL ESTP. The solvent was evaporated under reduced pressure. Flash 
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chromatography of the crude (eluent: ESTP) afforded the desired product (0.055g, 77% 
yield). 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.41 (s, 3 H) 1.54 (s, 3 H) 1.80 (br. s., 2 H) 4.16 (dd, 
J=5.02, 1.51 Hz, 4 H) 4.63 - 4.71 (m, 2 H) 5.61 - 5.71 (m, 2 H) 5.91 (dt, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 25.41 (CH3-C2’’) 27.95 (CH3-C2’’) 62.61 (C1 and C1’) 
78.88 (C4’’
 
and C5’’) 108.86 (C2’’) 127.24 (C3 and C3’) 133.33 (C2 and C2’) 
HR-MS: calculated 215.12779 [M+H]
+
, 232.15434 [M+NH4]
+
; found 215.12772 [M+H]
+
, 
232.15425 [M+NH4]
+; Δm = 0.3-0.4 ppm 
FTIR: 3381 (υ(OH)), 2988 (υ(CH) aliph. CH), 2934 (υ(CH) aliph. CH), 2871 (υ(CH) aliph. 
CH), 1676 (υ(C=C)), 1456 (δ(CH)), 1381 (δ(CH)), 1372 (δ(CH)), 1247 (υ(C-O)), 1217 (υ(C-
O)), 1165 (υ(C-O)), 1094 (υ(C-O)), 1041 (υ(C-O)), 974 (δoop(CH), trans CH=CH) cm
-1
 
 
 
(4R,5S)-4,5-bis-[(E)-3’-(benzyloxy)prop-1’-en-1’-yl]-2,2-dimethyl-1,3-dioxolane (162) 
 
 
 
NaH (55-65% in mineral oil, 0.367g, 8.4mmol, 3 eq.) was put in solution in 15mL THF at rt 
forming a white/grey suspension. (2E,2’E)-3,3’-((4R,5S)-2,2-dimethyl-1,3-dioxolane-4,5-
diyl)bis(prop-2-en-1-ol) 161 (0.6g, 2.8mmol, 1 eq.) diluted in 15mL THF was slowly added to 
the suspension during 10min. 3mL of DMF was added to the reaction mixture followed by 
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BnBr (1.149g, 6.72mmol, 2.4 eq.). After 3h30, the reaction was quenched with 10mL 
ammonium chloride sat and 5mL water. The water phase was extracted with 2x 40mL ESTP. 
The organic phases were put together, washed with 50mL NaCl sat and dried over MgSO4. 
The solvent was evaporated under reduced pressure. Flash chromatography of the crude (8:2 
HXF:ESTP) afforded the desired product (0.723g, 65% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.41 (s, 3 H) 1.54 (s, 3 H) 4.04 (d, J=5.52 Hz, 4 H) 
4.48 (s, 4 H) 4.64 - 4.70 (m, 2 H) 5.65 - 5.75 (m, 2 H) 5.84 - 5.93 (m, 2 H) 7.25 - 7.36 (m, 10 
H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 25.49 (CH3) 28.02 (CH3) 69.72 (C3’) 71.95 (C4’) 79.01 
(C4 and C5) 108.86 (C2) 127.59 – 128.69 (aromatic CH + C1’ or C2’) 130.86 (C1’ or C2’) 
138.17 (quaternary C, 2 C) 
HR-MS: calculated 412.24824 [M+NH4]
+
, 417.20363 [M+Na]
+
, 433.17757 [M+K]
+
; found  
412.24850 [M+NH4]
+
, 417.20355 [M+Na]
+
, 433.17755 [M+K]
+; Δm = 0.6-0.7 ppm 
FTIR: 3325 (υ(OH)), 3063 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2988 (υ(CH) aliph. 
CH)), 2934 (υ(CH) aliph. CH)), 2858 (υ(CH) aliph. CH)), 1605 (υ(Ph)), 1496 (υ(Ph)), 1454 
(υ(Ph)), 1371 (δ(CH)), 1247 (υ(C-O)), 1216 (υ(C-O)), 1115 (υ(C-O)), 1042 (υ(C-O)), 972 
(δ(CH) C=C trans), 739 (δ(CH) arom. CH), 699 (δ(Ph)) cm-1 
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(2E,4R,5S,6E)-1,8-bis-(benzyloxy)octa-2,6-diene-4,5-diol (163) 
 
  
 
(4R,5S)-4,5-bis((E)-3-(benzyloxy)prop-1-en-1yl)-2,2-dimethyl-1,3-dioxolane 162 (0.688g, 
1.744mmol, 1 eq.) was put in solution in 40mL THF and 15mL water at rt. HCl (fuming 37%, 
5mL) was slowly added to the solution. After 3h, the reaction was quenched with 10mL 
K2CO3 10N and 20mL NaCl sat. The water phase was extracted with 3x 50mL TBME and the 
organic phase was dried over MgSO4. The solvent was evaporated under reduced pressure. 
Flash chromatography of the crude (1:1 HXF:ESTP) afforded the desired product (0.545g, 
88% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.69 (br. s., 2 H) 4.05 (d, J=5.27 Hz, 4 H) 4.21 - 4.26 
(m, 2 H) 4.52 (s, 4 H) 5.76 - 5.84 (m, 2 H) 5.88 - 5.97 (m, 2 H) 7.28 - 7.38 (m, 10 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 69.91 (C1 and C8) 72.27 (CH2 ether) 74.66 (C4 and C5) 
127.67 (aromatic CH) 127.74 (aromatic CH) 128.40 (aromatic CH) 130.10 (C2 and C7 or C3 
and C6) 130.45 (C2 and C7 or C3 and C6) 138.12 (aromatic quaternary C) 
HR-MS: calculated 355.19039 [M+H]
+
, 372.21694 [M+NH4]
+
, 377.17233 [M+Na]
+
; found 
372.21686 [M+NH4]
+
, 377.17209 [M+Na]
+; Δm = 0.2 ppm 
FTIR: 3063 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2861 (υ(CH) aliph. CH), 1586 
(υ(Ph)), 1496 (υ(Ph)), 1454 (υ(Ph)), 1101 (υ(C-O)), 1068 (υ(C-O)), 974 (δ(CH) C=C trans) 
741 (δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) cm-1 
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(4R,5S)-4,5-bis-[(E)-3’-(benzyloxy)-prop-1’-en-1’-yl]-1,3-dioxolan-2-one (164) 
 
 
 
(2E,4R,5S,6E)-1,8-bis-(benzyloxy)octa-2,6-diene-4,5-diol 163 (0.52g, 1.47mmol, 1 eq.) was 
put in solution in 40mL CH2Cl2 at rt,  pyridine (0.61mL, 7.48mmol, 5.1 eq.) was added at rt 
and then cooled down at 0°C. Trisphosgen (0.653g, 2.2mmol, 1.5 eq.) diluted in 10mL 
CH2Cl2 was slowly added to the reaction mixture during 15min. After 15min, the reaction was 
quenched with 20mL ammonium chloride sat and extracted with 3x 60mL CH2Cl2. The 
collected organic phases was extracted with 1x 60mL NaHCO3 sat and 1x 60mL NaCl sat. 
The solvent was evaporated under reduced pressure. Flash chromatography of the crude (6:4 
HXF:ESTP) afforded the desired product (0.543g, 97% yield). 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 4.07 (dd, 4 H) 4.51 (s, 4 H) 5.16 - 5.23 (m, 2 H) 5.70 - 
5.81 (m, J=15.53, 5.49, 1.78, 1.78, 1.78 Hz, 2 H) 6.02 (dt, J=15.81, 4.89 Hz, 2 H) 7.27 - 7.39 
(m, 10 H) 
13
C NMR  (101 MHz, CDCl3-d) δ ppm 68.90 (C3’) 72.50 (CH2 ether) 79.71 (C4 and C5) 
123.10 (C1’) 127.65 (aromatic CH) 127.81 (aromatic CH) 128.46 (aromatic CH) 134.43 (C2’) 
137.77 (aromatic quaternary C) 154.07 (C2) 
HR-MS: calculated 398.19620 [M+NH4]
+
, 403.15160 [M+Na]
+
, 419.12553 [M+K]
+
; found 
398.19629 [M+NH4]
+
, 403.15147 [M+Na]
+
, 419.12540 [M+K]
+,; Δm = 0.2-0.3 ppm 
FTIR: 3088 (υ(CH) arom. CH), 3063 (υ(CH) arom. CH), 3031 (υ(CH) arom. CH), 2855 
(υ(CH) aliph. CH), 1800 (υ(C=O) carbonate), 1678 (υ(C=C)), 1605 (υ(Ph)), 1496 (υ(Ph)), 
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1454 (υ(Ph)), 1176 (υ(C-O)), 1115 (υ(C-O)), 1040 (υ(C-O)), 968 (δ(CH) CH=CH trans), 739 
(δ(CH) Ph), 699 (δ(Ph)) cm-1 
 
 
(2E,2'E)-diethyl 3,3'-[(4''S, 5''S)-2''-2''-dimethyl-1’’,3’’-dioxolane-4’’,5’’diyl]diacrylate 
(167) 
 
(-)-Dimethyl 2,3-O-isopropylidene-L-tartrate (21g, 96.237mmol, 1 eq.) was put in solution in 
400mL toluene and the solution was cooled down at -78°C. DIBAL (1M in toluene, 193mL, 
193 mmol, 2 eq.) was slowly added to the reaction mixture during 30min and left to react 
during 3h (inner temperature went up to -70°C). In the meantime, sodio triethyl 
phosphonoacetate was prepared by dissolving NaH (55-65% in mineral oil, 10.5g, 240.6 
mmol, 2.5 eq.) in 70mL DME. The mixture was cooled down at 0°C and triethyl 
phosphonoacetate (53.94g, 240.6, 2.5 eq.) diluted in 30mL DME was added at 0°C. After the 
end of addition, the yellow solution with some white suspension was allowed to come at rt 
and the mixture was stirred during 45min at rt. The sodio triethyl phosphonoacetate was 
added to the DIBAL solution during 15min (inner temperature -70°C) and was then allowed 
to come at rt. After 3h, the reaction was quenched with 200mL H2O. The formed grey gel was 
filtered through a small pad of cellflock and washed with ESTP. The filtrate was extracted 
with 2x 200mL H2O and the organic phase was dried over MgSO4. The solvent was 
evaporated under reduced pressure. Flash chromatography of the crude (9:1 HXF:ESTP) 
afforded the desired product (colorless oil, 17.291g, 60%). 
 
 Experimental part 
___________________________________________________________________________ 
- 178 - 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.31 (t, J=7.15 Hz, 6 H) 1.48 (s, 6 H) 4.22 (q, J=7.28 
Hz, 4 H) 4.27 - 4.33 (m, 2 H) 6.12 - 6.18 (m, 2 H) 6.83 - 6.91 (m, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 14.17 (CH3 ethyl) 26.77 (CH3-C2‘‘) 60.72 (CH2 ethyl) 
79.70 (C4’’ and C5’’) 110.81 (C2’’) 123.70 (C2 and C2’’) 141.78 (C3 and C3’’) 165.64 (C1 and 
C1’’)  
HR-MS: calculated 299.14892 [M+H]
+
, 316.17547 [M+NH4]
+
; found 299.14887 [M+H]
+
, 
316.17551 [M+NH4]
+
  
FTIR: 2986 (υ(CH) aliph. CH), 2939 (υ(CH) aliph. CH), 1724 (υ(C=O)), 1664 (υ(C=C)), 
1448 (δ(CH)), 1180 (υ(C-O)), 1165 (υ(C-O)), 979 (δ(CH) C=C trans) cm-1 
 
 
(2E,2’E)-3,3’-[(4S’’, 5S’’)-2’’,2’’-dimethyl-1’’,3’’-dioxolane-4’’,5’’-diyl]bis(prop-2-en-1-
ol) (168) 
  
LiAlH4 (pellets, 7.63g, 201.12mmol, 6 eq.) was put in solution in 350mL THF and stirred to 
dissolve the pellets. The grey suspension was then cooled down at -78°C. n-BuBr (27.56g, 
201.12, 6 eq.) was added to the grey suspension (inner temperature -70°C). After the end of 
addition, the reaction mixture was allowed to come at rt. After 16h, the reaction mixture was 
cooled down at -78°C and (2E,2’E)-diethyl 3,3’-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-
diyl)diacrylate 167 (10g, 33.52mmol, 1 eq.) diluted in 40mL THF was slowly added during 
15min. 1h30 after the end of addition, the reaction mixture was allowed to come at 0°C after 
30min at 0°C, the reaction was finished. The mixture was slowly quenched with 20mL NaOH 
(1M) at 0°C and left to stir for 1h. The grey gel formed was filtered through a small pad of 
cellflock and washed with ESTP (500mL). The solvent was evaporated under reduced 
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pressure. Flash chromatography (eluent: ESTP) afforded the desired product (oil, 4.29g, 60% 
yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.45 (s, 6 H) 1.92 (s, 2 H) 4.14 (dd, J=4.89, 1.88 Hz, 2 
H) 4.17 (dd, J=5.14, 1.63 Hz, 4 H) 5.67 - 5.74 (m, 2 H) 5.98 (dt, J=15.69, 4.96 Hz, 2 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 26.99 (CH3-C2’’) 62.59 (C1 and C1’) 81.34 (C4’’ and 
C5’’) 109.10 (C2’’) 126.47 (C3 and C3’) 134.39 (C2 and C2’)  
HR-MS: calculated 259.11842 [M+HCOO
-
]; found 259.11865 [M+HCOO
-
] 
FTIR: 3397 (υ(OH)), 2987 (υ(CH) aliph. CH), 2934 (υ(CH) aliph. CH), 2872 (υ(CH) aliph. 
CH), 1683 (υ(C=C)), 1455 (δ(CH) aliph. CH), 1373 (δ(CH) aliph. CH), 1236 (υ(C-O)), 1054 
(υ(C-OH)), 971 (δ(CH) C=C trans) cm-1 
 
 
(4S,5S)-4,5-bis[(E)-3’-(benzyloxy)prop-1’-en-1’-yl]-2,2-dimethyl-1,3-dioxolane (169) 
 
 
NaH (55-65% in mineral oil, 0.754g, 17.268mmol, 3.7 eq.) was put in solution in 50mL THF 
at rt. (2E,2’E)-3,3’-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(prop-2-en-1-ol) 168 (1g, 
4.667mmol, 1 eq.) diluted in 20mL THF was slowly added during 5min at rt. Afer 1h30, 
10mL DMF and BnBr (1.92g, 11.2mmol, 2.4 eq.) were added to the brawn solution. After 3h, 
the reaction was quenched with 20mL ammonium chloride sat. and 20mL H2O. The water 
phase was extracted with 2x 40mL ESTP and the collected organic phases were dried over 
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MgSO4. The solvent was evaporated under reduced pressure. Flash chromatography of the 
crude (8:2 HXF:ESTP) afforded the desired product (0.999g, 54% yield) 
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 1.46 (s, 6 H) 4.06 (dd, J=5.27, 1.51 Hz, 4 H) 4.12 - 
4.19 (m, 2 H) 4.52 (s, 4 H) 5.70 - 5.80 (m, 2 H) 5.94 (dt, 2 H) 7.27 - 7.38 (m, 10 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 27.01 (CH3-C2) 69.72 (C3’) 72.22 (CH2 benzyloxy) 
81.40 (C4 and C5) 109.09 (C2) 127.64 (aromatic CH, 2C) 127.71 (aromatic CH, 4C) 128.12 
(C1’) 128.40 (aromatic CH, 4C) 131.47 (C2’) 138.10 (aromatic quaternary C, 2C) 
HR-MS: calculated 412.24824 [M+NH4]
+
, 417.20363 [M+Na]
+
; found 412.24830 [M+NH4]
+
, 
417.20327 [M+Na]
+; Δm = 0.2 ppm  
FTIR: 3088 (υ(C-H) arom. CH), 3031 (υ(C-H) arom. CH), 2986 (υ(C-H) arom. CH), 2933 
(υ(C-H) aliph. CH), 2858 (υ(C-H) aliph. CH), 1605 (υ(Ph)), 1496 (υ(Ph)), 1455 (υ(Ph)), 1239 
(υ(C-O)), 1118 (υ(C-O)), 1054 (υ(C-O)), 970 (δ(CH) C=C trans), 739 (δ(CH) mono-sub.), 
699 (δ(Ph) mono-sub.) cm-1 
 
 
(2E,4S,5S,6E)-1,8-bis(benzyloxy)octa-2,6-diene-4,5-diol (170) 
 
 
(4S,5S)-4,5-bis((E)-3-(benzyloxy)prop-1-en-1-yl)-2,2-dimethyl-1,3-dioxolane 169 (0.429g, 
1.089mmol, 1 eq.) was put in solution in 25mL THF and 9mL H2O at rt. HCl (fuming 37%, 
3.5mL) was slowly added to the solution. After 6h, 1ml HCl fuming was slowly added again 
at rt.  2h after the second addition, the reaction was quenched with 7mL 10N K2CO3 and 
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saturated with 20mL NaCl sat. The aqueous phase was extracted with 3x 50mL TBME and 
the organic phase was dried over MgSO4. The solvent was evaporated under reduced 
pressure. Flash chromatography of the crude (1:1 HXF:ESTP) afforded the desired product 
(0.35g, 91% yield). 
1
H NMR (400 MHz, CDCl3-d) δ ppm 2.14 (br. s., 2 H) 4.05 (dd, J=5.14, 1.13 Hz, 6 H) 4.52 
(s, 4 H) 5.75 - 5.84 (m, 2 H) 5.94 (dt, J=15.80 Hz, 2 H) 7.27 - 7.38 (m, 10 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 69.89 (C1 and C8 or C4 and C5) 72.29 (CH2 benzyloxy) 
74.92 (C1 and C8 or C4 and C5) 127.66 (aromatic CH, 2C) 127.73 (aromatic CH, 4C) 128.39 
(aromatic CH, 4C) 129.86 (C2 and C7 or C3 and C6) 131.07 (C2 and C7 or C3 and C6) 138.11 
(aromatic quaternary C) 
HR-MS: calculated 372.21694 [M+NH4]
+
, 377.17233 [M+Na]
+
; found 372.21712 [M+NH4]
+
, 
377.17216 [M+Na]
+; Δm = 0.5ppm 
FTIR: 3392 (υ(OH)), 3063 (υ(C-H) arom. CH), 3031 (υ(C-H) arom. CH), 2859 (υ(C-H) 
aliph. CH), 1605 (υ(Ph)), 1496 (υ(Ph)), 1454 (υ(Ph)), 1097 (υ(C-O)), 1065 (υ(C-O)), 1028 
(δ(CH) mono-sub.), 973 (δ(CH) C=C trans) 740 (δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) 
cm
-1
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(4S,5S)-4,5-bis[(E)-3’-(benzyloxy)prop-1’-en-1’-yl)]-1,3-dioxolan-2-one (171) 
 
 
(2E,4S,5S,6E)-1,8-bis(benzyloxy)octa-2,6-diene-4,5-diol 170 (0.1g, 0.282mmol, 1 eq.) was 
put in solution in 8mL CH2Cl2 at rt. Pyridine (0.114mL, 1.438mmol, 5.1 eq.) was added to the 
solution at rt and the reaction mixture was cooled down at 0°C. Trisphogen (0.126g, 
0.423mmol, 1.5 eq.) diluted in 2mL CH2Cl2 was slowly added to the reaction mixture. After 
1h, the reaction was quenched with 3.5mL ammonium chloide sat. and 2mL H2O at 0°C. The 
solution was then allowed to come at rt and the aqueous phase was extracted with 3x 10mL 
CH2Cl2. The collected organic phases were extracted with 1x 25mL NaHCO3 sat. and 1x 
25mL NaCl sat. The solvent was evaporated under reduced pressure. Flash chromatography 
of the crude (6:4 HXF:ESTP) afforded the desired product  
 
1
H NMR (400 MHz, CDCl3-d) δ ppm 4.08 (dd, J=4.77, 1.76 Hz, 4 H) 4.55 (s, 4 H) 4.72 - 
4.79 (m, 2 H) 5.78 - 5.88 (m, 2 H) 6.03 (dt, J=15.81 Hz, 2 H) 7.28 - 7.41 (m, 10 H) 
13
C NMR (101 MHz, CDCl3-d) δ ppm 68.87 (C3‘) 72.80 (CH2 benzyloxy) 82.02 (C4 and C5) 
124.14 (C1’) 127.72 (aromatic CH, 4C) 127.87 (aromatic CH, 2C) 128.49 (aromatic CH, 4C) 
134.64 (C2’) 137.66 (aromatic quaternary C) 153.90 (C2) 
HR-MS: calculated 398.19620 [M+NH4]
+
, 403.15160 [M+Na]
+
; found 398.19625 [M+NH4]
+
, 
403.15136 [M+Na]
+
 
FTIR: 3088 (υ(C-H) arom. CH), 3063 (υ(C-H) arom. CH), 3030 (υ(C-H) arom. CH), 2921 
((υ(C-H) aliph. CH), 2854 (υ(C-H) aliph. CH), 1800 (υ(C=O)), 1678 (υ(C=C)), 1605 (υ(Ph)), 
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1496 (υ(Ph)), 1454 (υ(Ph)), 1178 (υ(C-O)), 1114 (υ(C-O)), 1024 (υ(C-O)), 967 (δ(CH) C=C 
trans), 737 (δ(CH) mono subst.), 698 (δ(CH) mono subst.) cm-1 
 
(2E,4R,5E,7R)-7-(benzylamino)-1,8-bis(benzyloxy)octa-2,5-dien-4-ol (172) 
 
 
The empty flask was evacuated and refilled with argon in a cycle of 3x (5min vacuum/5min 
argon). (R,R)-Trost ANDEN (0.01g, 0.0126mmol, 0.24 eq.) diluted in 0.5mL toluene and 
[Pd(ally)Cl]2 (0.0015g, 0.0042mmol, 0.08 eq.) diluted in 0.5mL toluene were added to the 
flask. The unclear yellow solution was left to stir for 15min then (4S,5S)-4,5-bis((E)-3-
(benzyloxy)prop-1-en-1-yl)-1,3-dioxolan-2-one 171 (0.02g, 0.0526mmol, 1 eq.) diluted in 
0.5mL toluene was added. EDIPA (0.0068g, 0.0526mmol, 1 eq.) diluted in 0.5mL toluene and 
BnNH2 (0.0113g, 0.1052mmol, 2eq) were added to the reaction mixture at rt. After 2h, 
BnNH2 (6µL) was added again. After 72h, the reaction mixture was filtered over silica (1.4g) 
and washed with a solution of 80mL TBME and 0.3mL Et3N. The solvents were evaporated 
under reduced pressure. Flash chromatography of the crude (7:3 ESTP:HXF) afforded the 
desired product (0.0088g, 38% yield) 
 
1
H NMR: (600 MHz, CDCl3-d) δ ppm 3.49 - 3.63 (m, 3 H) 3.78 - 4.01 (m, 2 H) 4.06 (d, 
J=5.49 Hz, 2 H) 4.49 - 4.59 (m, 6 H) 4.68 (t, J=5.85 Hz, 1 H) 5.80 (dd, J=14.64, 5.49 Hz, 2 
H) 5.86 (m, J=4.94, 4.94 Hz, 2 H) 7.29 - 7.41 (m, 15 H) 
13
C NMR: (101 MHz, CDCl3-d) δ ppm 51.32 (C11) 59.34 (C5) 70.00 (C1) 72.34 (C9 or C10) 
72.45 (C4) 73.16 (C9 or C10) 73.19 (C8) 126.86 – 128.40 (aromatic CH + 1 C allyl) 130.82 (C2 
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or C3 or C6 or C7) 133.87 (C2 or C3 or C6 or C7) 134.45 (C2 or C3 or C6 or C7) 138.05 
(quaternary C) 138.16 (quaternary C) 140.41 (quaternary C) 
HR-MS: calculated 444.25332 [M+H]
+
; found 444.25327 [M+H]
+, Δm =  0.1ppm 
FTIR: 3327 (υ(NH) + υ(OH)), 3062 (υ(CH) arom. CH), 3029 (υ(CH) arom. CH), 2919 
(υ(CH) aliph. CH), 2853 (υ(CH) aliph. CH), 1604 (υ(Ph)), 1496 (υ(Ph)), 1454 (υ(Ph)), 1097 
(υ(C-O)), 1074 (υ(C-O)), 1028 (δip(CH) mono-sub.), 974 (δ(CH) C=C trans), 738 (δ(CH) 
mono-sub.), 698 (δ(Ph) mono-sub.) cm-1 
 
 
[2,2’-bifuran]-5,5’(2H,2’H)-dione (173) 
 
 
(4S,5R)-dimethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylic (5g, 22.914mmol, 1 eq.) was 
put in solution in 70mL toluene and the solution was cooled down at -78°C. DIBAL (1M in 
toluene, 46mL, 45.827mmol, 2 eq.) was slowly added to the solution during 20min at -70°C. 
Methyl triphenylphosphonoanylidene acetate diluted in 250mL MeOH was added to the 
reaction mixutre during 30min. After end of addition, the solution was allowed to come at rt. 
After 3h, 10mL of water was slowly added to quench the reaction. The formed gel was 
filtered and washed with TBME. The solvents were evaporated under reduced pressure. 40mL 
H2O was added to the crude and extracted with 70mL TBME. The collected organic phases 
were dried over MgSO4 and the solvent was evaporated under reduced pressure. A white 
precipitate was formed which corresponded to triphenylphosphine oxide. To remove it, the 
mixture was stirred with pentane (300mL) and filtered off to afford a crude product (5.254g). 
Ethanol (1.023g, 22.2mmol, 1.2 eq.) and methansulfonic acid (0.711g, 7.4mmol, 0.4 eq.) were 
added to the crude. 270mL DME and 27mL H2O were added to the reaction mixture and put 
at reflux. Afer 6h, the reaction mixture was cooled down at rt and the solvent were evaporated 
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under reduced pressure. Hexane was then added to the crude and left to precipitate during 15h 
in the fridge. The precipitate was then filtered and dried in the oven. ESTP was added the 
precipitate, heated up to dissolve, cooled down at rt. The precipiate was filtered and dried in 
the oven to afford the desired product (0.2769g, 7% yield). 
 
1
H NMR (400 MHz, DMSO-d6) δ ppm 5.58 - 5.65 (m, 2 H) 6.41 (dd, J=5.77, 1.51 Hz, 2 H) 
7.74 (dd, J=5.90, 0.88 Hz, 2 H) 
13
C NMR (101 MHz, DMSO-d6) δ ppm 81.21 (C2 and C2’) 123.05 (C3 and C3’ or C4 and C4’) 
153.21 (C3 and C3’ or C4 and C4’) 172.00 (C5 and C5’) 
HR-MS: found 165.01918 [M-H]
- 
 
FTIR: 3098 (υ(CH)), 2943 (υ(CH)), 1791 (υ(C=O) lactone), 1751 (υ(C=O) lactone), 1600 
(υ(C=C)), 1165 (υ(C-O)), 1097 (υ(C-O)), 1038 (υ(C-O)) cm-1 
 
 
(R,E)-tert-butyl benzyl(1,5-bis(benzyloxy)pent-3-en-2-yl)carbamate (177) 
 
 
 
(E)-N-benyzl-1,5-bis(benzyloxy)pent-3-en-2-amine 80 (product from enantioselective allylic 
substitution with (R,R)-Trost ANDEN ligand) (0.2g, 0.516mmol, 1 eq.) was put in solution in 
3mL CH2Cl2. DMAP (0.0063g, 0.0516mmol, 0.1 eq.) was added to the solution. Di-tert-butyl 
dicarbonate was diluted in 1mL CH2Cl2 and added drop wise to the reaction mixture. The 
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reaction was quenched with 2mL water and the aqueous layer was extracted with 2x 5mL 
CH2Cl2. The combined organic layer was dried over MgSO4 and the solvent was evaporated 
under reduced pressure. Flash chromatography of the crude in 9:1 HXF:ESTP afforded the 
desired product (colorless oil, 0.2213g, 87% yield). 
 
1
H-NMR: (600 MHz, DMSO-d6) δ ppm 1.13 - 1.47 (m, 9 H) 3.49 - 3.68 (m, 2 H) 3.92 (br. s., 
2 H) 4.25 - 4.47 (m, 6 H) 4.79 (m, 1 H) 5.53 - 5.84 (m, 2 H) 7.16 - 7.41 (m, 15 H)  
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 27.91 (CH3 
t
Bu) 48.52 (CH2 benzylamine) 56.64 
(C2) 69.36 (C5) 70.95 (C1) 71.82 (CH2 benzylether) 79.11 (quternary C) 126.62 - 128.20 
(aromatic CH and C3 and C4) 138.19 (quaternary C) 138.36 (quaternary C) 154.88 (C=O) 
Confirmation of rotamers with ROESY 
HR-MS: calculated 488.2801 [M+H]
+
, found: 488.2798 [M+H]
+, Δm = 0.6ppm 
IR: 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2975 (υ(CH) aliph. CH), 2929 (υ(CH) 
aliph. CH), 2858 (υ(CH) aliph. CH), 1692 (υ(C=O)), 1605 (υ(Ph)), 1454 (υ(Ph)), 1404 (C-N), 
1365 (δ(CH3)3), 1167 (υ(C-O) boc), 1104 (υ(C-O-C)), 1028 (δip(CH) arom. CH), 972 (δ(CH) 
C=C trans), 736 (δ(CH) mono-sub.), 698 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 3 (1 mL/min, 30°C), ee = 87%,  tR = 11.1 min ((R)-177), tR = 14.9 min ((S)-
177) 
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(4S,5S)-3-benzyl-5-((R)-2’-(benzyloxy)-1’-hydroxyethyl)-4-
((benzyloxy)methyl)oxazolidin-2-one (178) 
 
 
 
(R,E)-tert-butyl benzyl(1,5-bis(benzyloxy)pent-3-en-2-yl)carbamate 177 (0.12g, 0.246mmol, 
1 eq.) was put in solution in 10mL CH2Cl2 at rt. m-CPBA (70% purity, 0.57g, 2.31mmol, 9.4 
eq.) was added to the solution at rt. After 24h, 10mL CH2Cl2 was added and the reaction 
mixutre was extracted with 1x 15mL Na2S2O3 sat, 1x 15mL NaHCO3 and 1x 15mL H2O. The 
organic phase was dried over MgSO4 and the solvent evaporated under reduced pressure. 
Flash chromatography of the crude (6:4 HXF: ESTP) afforded the desired product (colorless 
oil, 0.0429g, 39% yield) and the second diastereoisomer 179 (colorless oil, 0.0452g, 41% 
yield). 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 2.93 (d, J=5.02 Hz, 1 H) 3.61 - 3.73 (m, 4 H) 3.74 - 
3.80 (m, 1 H) 3.96 (d, J=15.31 Hz, 1 H) 4.10 (dd, J=8.28, 4.02 Hz, 1 H) 4.40 - 4.45 (m, 1 H) 
4.45 - 4.63 (m, 4 H) 4.81 (d, J=15.31 Hz, 1 H) 7.19 (dd, J=7.40, 1.88 Hz, 2 H) 7.28 - 7.42 (m, 
13 H) 
13
C-NMR: (101 MHz, CDCl3-d) δ ppm 46.32 (C6’) 56.08 (C4’) 64.86 (C2’) 67.88 (C1’) 70.77 
(C4) 73.43 (C3’ or C5’) 73.65 (C3’ or C5’) 74.83 (C5) 126.85 - 129.88 (aromatic CH) 136.01 
(quaternary C) 136.95 (quaternary C) 137.59 (quaternary C) 157.60 (C=O) 
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HR-MS: calculated 448.2124 [M+H]
+
, found: 448.2123 [M+H]
+, Δm = 0.2ppm 
IR: 3430 (υ(OH)), 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2923 (υ(CH) aliph. 
CH), 2865 (υ(CH) aliph. CH), 1752 (υ(C=O)), 1586 (υ(Ph)), 1496 (υ(Ph)), 1454 (υ(Ph)), 1421 
(C-N), 1221 (υ(C-O)), 1205 (υ(C-O)), 1090 (υ(C-O)), 1074 (υ(C-O)), 1028 (δip(CH) arom. 
CH), 739 (δ(CH) mono-sub.), 701 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 5 (1 mL/min, 30°C), ee = 88%, tR = 30.8 (major enantiomer), tR =36.6 
(minor enantiomer) 
 
 
(4S,5R))-3-benzyl-5-(2-(benzyloxy)-1-hydroxyethyl)-4-((benzyloxy)methyl)oxazolidin-2-
one (179) 
 
 
The same procedure as for the other diastereoisomer 178 (yield of 179 = 0.0452g, 41% yield). 
 
1
H-NMR: (400 MHz, CDCl3-d) δ ppm 2.49 (d, J=6.02 Hz, 1 H) 3.39 - 3.53 (m, 2 H) 3.56 - 
3.66 (m, 2 H) 3.71 - 3.76 (m, 1 H) 3.76 - 3.80 (m, 1 H) 4.14 (d, J=15.31 Hz, 1 H) 4.30 (dd, 
J=7.28, 5.02 Hz, 1 H) 4.39 - 4.48 (m, 2 H) 4.48 - 4.56 (m, 2 H) 4.74 (d, J=15.06 Hz, 1 H) 7.19 
- 7.24 (m, 2 H) 7.28 - 7.40 (m, 13 H) 
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13
C-NMR: (101 MHz, CDCl3-d) δ ppm 46.47 (C6’) 56.43 (C4) 68.96 (C4’) 69.85 (C2’) 70.83 
(C1’) 73.23 (C3’ or C5’) 73.64 (C3’ or C5’) 75.08 (C5) 127.43 - 128.92 (aromatic CH) 135.96 
(quaternary C) 137.39 (quaternary C, 2 C) 157.70 (C=O) 
HR-MS: calculated 448.2124 [M+H]
+
, found: 448.2124 [M+H]
+, Δm < 0.1 ppm 
IR: 3405 (υ(OH)), 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2921 (υ(CH) aliph. 
CH), 2863 (υ(CH) aliph. CH), 1733 (υ(C=O)), 1586 (υ(Ph)), 1496 (υ(Ph)), 1453 (υ(Ph)), 1253 
(υ(C-O)), 1205 (υ(C-O)), 1099 (υ(C-O)), 1076 (υ(C-O)), 739 (δ(CH) mono-sub.), 700 (δ(Ph) 
mono-sub.) cm
-1
 
HPLC: C-HPLC 5 (1 mL/min, 30°C), ee = 88%, tR = 17.3 (major enantiomer), tR =18.3 
(minor enantiomer) 
 
 
(R, E)-N-benzyl-N-(1,5-bis(benzyloxy)pent-3-en-2-yl)acetamide (183) 
 
 
 
(E)-N-benyzl-1,5-bis(benzyloxy)pent-3-en-2-amine 80 (product from enantioselective allylic 
substitution with (R,R)-Trost ANDEN ligand) (0.2g, 0.516mmol, 1 eq.) was put in solution in 
4mL CH2Cl2 at rt. DMAP (0.0032g, 0.026mmol, 0.05 eq.) and Et3N (0.1566g, 1.548mmol, 3 
eq.) were added to the solution and cooled down at 0°C. Acetylchlorid (70µL, 1.032mmol, 2 
eq.) was slowly added to the reaction mixture. After 15min, the reaction was finished, the 
solvent was evaporated and the crude was purified with flash chromatography (1:1 
ESTP:HXF) to afford the desired product (yellow oil, 0.157g, 71% yield) 
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1
H-NMR: (600 MHz, DMSO-d6) δ ppm 1.92 (s, 3 H) 2.17 (s, 3 H) 3.55 - 3.65 (m, 2 H) 3.92 
(br. s., 2 H) 4.34 - 4.38 (m, 4 H) 4.39 - 4.64 (m, 2 H) 4.71 - 4.78 (m, 1 H) 5.07 - 5.13 (m, 1 H) 
5.65 - 5.81 (m, 2 H) 7.15 - 7.38 (m, 15 H) 
mixture of rotamers (ROESY) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 22.13 (C9) 44.53 (C8) 58.64 (C2) 69.31 (C5) 71.11 
(C1) 71.88 (C6 or C7) 72.02 (C6 or C7) 126.11 - 128.67 (aromatic CH + C3 and C4) 129.82 
(quaternary C) 130.08 (quaternary c) 170.69 (C=O) 
HR-MS: calculated 430.2382 [M+H]
+
, found: 430.2381 [M+H]
+, Δm = -0.2 ppm 
IR: 3062 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2926 (υ(CH) aliph. CH), 2857 (υ(CH) 
aliph. CH), 1648 (υ(C=O) amide), 1496 (υ(Ph)), 1453 (υ(Ph)), 1412 (υ(C-N) amide) 1104 
(υ(C-O)), 1028 (δip(CH) mono-sub.), 975 (δ(CH) C=C trans), 735 (δoop(CH) mono-sub.), 698 
(δ(Ph) mono-sub.) cm-1 
 
 
 (E)-4-(N-benzylacetamido)-5-(benzyloxy)pent-2-en-1yl acetate (185) 
 
 
 
(E)-N-benyzl-1,5-bis(benzyloxy)pent-3-en-2-amine 80 (product from enantioselective allylic 
substitution with (R,R)-Trost ANDEN ligand) (0.3g, 0.774mmol, 1 eq.) was weighted in a 
reaction flask. Acetic acid (12mL) then acetic acid anhydride (12mL) were added at rt. HBr, 
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33% in acetic acid (12mL) was added to the reaction mixture. After 32h, the reaction was 
finished. To quench the reaction, 500mL NaHCO3 sat was cooled down at 0°C then the 
reaction mixture was slowly (drop by drop) added to the this cooled stirring solution at 0°C 
(the amount of NaHCO3 has to be enough to quench the whole reaction). The aqueous phase 
was extracted with 3x 300mL CH2Cl2 and the collected organic phase was dried over MgSO4. 
The solvent was evaporated under reduced pressure and the crude was purified with flash 
chromatography (1:1 HXF:ESTP) to afford the desired product (oil, 0.2377g, 81%) 
 
1
H-NMR: (400 MHz, DMSO-d6) δ ppm 1.95 (s, 3 H) 2.02 (br. s., 3 H) 3.53 - 3.66 (m, 2 H) 
4.36 (d, J=5.14 Hz, 2 H) 4.42 (d, J=4.40 Hz, 2 H) 4.51 (m, J=10.51 Hz, 2 H) 4.81 (br. s., 1 H) 
5.71 (m, J=4.03 Hz, 2 H) 7.14 - 7.33 (m, 10 H) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 20.62 (CH3) 22.10 (CH3) 49.04 (C17) 58.45 (C4) 
63.38 (C1) 69.64 (C5) 71.93 (C6) 125.75 - 130.74 (aromatic CH + C2 and C3) 138.63 
(quaternary C) 139.53 (quaternary C) 169.94 (C=O) 170.74 (C=O) 
HR-MS: calculated 382.2018 [M+H]
+
, found: 382.2022 [M+H]
+, Δm = 1 ppm 
IR: 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2933 (υ(CH) aliph. CH), 2864 (υ(CH) 
aliph. CH), 1739 (υ(C=O)), 1649 (υ(C=O) amide), 1496 (υ(Ph)), 1453 (υ(Ph)), 1413 (C-N 
amide), 1364 (δ(CH3) acetate), 1236 (υ(C-O) acetate), 1100 (υ(C-O-C) ether), 1028 (δip(CH) 
mono-sub.), 974 (δ(CH) C=C trans), 733 (δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) cm-1 
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(E)-N-benzyl-N-(1-(benzyloxy)-5-hydroxypent-3-en-2yl)acetamide (186) 
 
(E)-4-(N-benzylacetamido)-5-(benzyloxy)pent-2-en-1yl acetate 185 (0.2g, 0.524mmol, 1 eq.) 
was put in solution in 15mL MeOH at rt. K2CO3 was added to the solution. After 30min, the 
reaction mixture was filtered through a syringe filter (PTFE, 0.45µm) and washed with 20mL 
MeOH. The solvent was reduced under reduced pressure and the crude was purified with 
flash chromatography (8:2 ESTP: HXF) to afford the desired product (0.0723g, 41%) 
 
1
H-NMR: (600 MHz, DMSO-d6) δ ppm 1.90 (s, 1 H) 2.16 (s, 1 H) 3.42 - 3.64 (m, 2 H) 3.90 
(d, J=4.39 Hz, 5 H) 4.20 - 4.40 (m, 3 H) 4.47 - 4.65 (m, 2 H) 4.70 (br. s., 1 H) 5.09 (br. s., 1 
H) 5.58 - 5.81 (m, 10 H) 
Rotamers (ROESY)
 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 22.24 (C21) 48.87 (C13) 58.73 (C2) 60.82 (C6) 70.04 
(C1) 71.91 (C5) 125.16 (C3 or C4) 125.65 - 129.51 (aromatic CH) 133.96 (C3 or C4) 138.14 
(quaternary C) 139.59 (quaternary C) 170.70 (C=O) 
HR-MS: calculated 340.19072 [M+H]
+
, 362.17267 [M+Na]
+
, found: 340.19067 [M+H]
+
, 
362.17239 [M+Na]
+
 
IR: 3395 (υ(OH)), 3062 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2925 (υ(CH) aliph. 
CH), 2860 (υ(CH) aliph. CH), 1627 (υ(C=O)), 1496 (υ(Ph)), 1452 (C-N), 1417 (C-N), 1099 
(υ(C-O)), 1028 (δip(CH) arom. CH), 976 (δoop(CH) olefinic CH), 732 (δoop(CH) mono-sub.), 
698 (δ(Ph) mono-sub.)  cm-1 
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2-(2-(benzyloxy)-1-(4-methoxyphenoxy)ethyl)-3-((benzyloxy)methyl)oxirane (187) 
 
(E)-(((4-(4-methoxyphenoxy)pent-2-ene-1,5-diyl)bis(oxy))bis(methylene))dibenzene 114 
(product from enantioselective allylic substitution with (R,R)-Trost ANDEN ligand) (0.345g, 
0.853mmol, 1 eq.) was put in solution in 5mL CH2Cl2 at rt. m-CPBA (70%, 0.58g, 
2.352mmol, 2.8 eq.) was added to the solution at rt. After 7h, 10mL of 10% MeOH in CH2Cl2 
was added to the reaction mixture and extracted with 1x 15mL Na2S2O3 sat and 1x 15mL 
NaHCO3 sat and 1x 15mL H2O. The organic phase was dried over MgSO4 and the solvent 
was evaporated under reduced pressure. Flash chromatography of the crude (8:2 HXF:ESTP) 
afforded the desired product (oil, 0.1394g, 40%) 
 
1
H-NMR: (600 MHz, DMSO-d6) δ ppm 3.20 (s, 1 H) 3.37 - 3.43 (m, 1 H) 3.65 - 3.73 (m, 6 
H) 4.23 (q, J=5.49 Hz, 1 H) 4.36 (q, J=4.51 Hz, 1 H) 4.47 - 4.58 (m, 4 H) 6.81 - 6.87 (m, 2 H) 
6.92 - 6.98 (m, 2 H) 7.25 - 7.38 (m, 10 H) 
13
C-NMR: (101 MHz, DMSO-d6) δ ppm 53.88 (C2) 55.30 (C25) 69.27 (C10 or C2’) 69.49 (C10 
or C2’) 72.04 (C11 or C18) 72.35 (C11 or C18) 76.57 (C3) 77.88 (C1’) 114.49 (C6 and C8) 117.18 
(C5 and C9) 127.26 - 128.23 (aromatic CH) 151.62 (quaternary C) 151.78 (quaternary C) 
153.79 (quaternary C) 153.97 (quaternary C) 
HR-MS: calculated 438.22750 [M+H]
+
, 443.18290 [M+Na]
+
, found: 438.22762 [M+H]
+
, 
443.18265 [M+Na]
+, Δm = 0.3-0.6 ppm 
IR: 3063 (υ(CH) arom. CH), 3030 (υ(CH) arom. CH), 2913 (υ(CH) aliph. CH), 2860 (υ(CH) 
aliph. CH), 1506 (υ(Ph)), 1454 (υ(Ph)), 1227 (Ph-O), 1105 (υ(C-O)), 1036 (υ(C-O)), 826 
(δ(CH) para-disub.), 740 (δ(CH) mono-sub.), 699 (δ(Ph) mono-sub.) cm-1 
HPLC: C-HPLC 5 (1 mL/min, 30°C), tR = 19.0 (major diastereoisomer), tR =21.9 (minor 
diastereoisomer) 
 Experimental part 
___________________________________________________________________________ 
- 194 - 
 
5.3 General procedures for allylic substitutions 
 
General procedure for the racemic allylic substitutions 
 
The empty reaction flask was first degassed through 3 cycles of (5 min vacuum/ 5 min argon). 
The chosen solvent (2 mL) was added and again 3 short cycles of vacuum/argon were 
performed. Triphenylphosphine (0.24 eq.) and [Pd(allyl)Cl]2  or [Pd2(dba)3]·CHCl3  (0.08 eq.) 
were added at room temperature and left to stir for 15 min. Substrate (100 mg) diluted in 
0.5mL of the chosen solvent was added and depending on the temperature cooled down or 
heated up.  The chosen nucleophile was then added (2 eq.). The reaction was followed by 
HPLC and after completion, filtered through a short pad of silica (1 g for 0.1 g of substrate) 
and washed with a solution of 80 mL TBME and 0.3 mL Et3N. The solvent was evaporated 
under reduced pressure. Flash column chromatography of the crude gave the corresponding 
product. 
 
General procedure for enantioselective allylic substitutions without addition of a base 
 
The empty reaction flask was degassed through 3x (5 min vacuum/ 5 min argon cycles) then 
the desired solvent (2 mL) was added and again 3 short cycles of vacuum/argon were 
performed. The chosen ligand (0.24 eq.) and [Pd(allyl)Cl]2 or [Pd2(dba)3]CHCl3  (0.08 eq.) 
were added at room temperature and left to stir during 15 min. Substrate (100 mg) diluted in 
0.5 mL of the chosen solvent and then the nucleophile (2 eq.) were added to the reaction 
mixture. The reaction was followed by HPLC and after completion, was filtered through a 
short pad of silica (1 g for 0.1 g of substrate) and washed with a mixture of TBME (80 mL) 
and triethylamine (0.3 mL). The solvent was evaporated under reduced pressure. Flash 
column chromatography of the crude gave the corresponding product.  
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General procedure for enantioselective allylic substitutions with addition of a base 
 
The empty reaction flask was degassed through 3x (5 min vacuum/ 5 min argon cycles) then 
the desired solvent (2 mL) was added and again 3 short cycles of vacuum/argon were 
performed. The chosen ligand (0.24 eq.) and [Pd(allyl)Cl]2 or [Pd2(dba)3]CHCl3  (0.08 eq.) 
were added at room temperature and left to stir during 15 min. Substrate (100 mg) diluted in 
0.5 mL of the chosen solvent and then the base (1 eq.) were added to the reaction mixture. 
The nucleophile (2 eq.) was then added to the reaction mixture. The reaction was followed by 
HPLC and after completion, was filtered through a short pad of silica (1 g for 0.1 g of 
substrate) and washed with a mixture of TBME (80 mL) and triethylamine (0.3 mL). The 
solvent was evaporated under reduced pressure. Flash column chromatography of the crude 
gave the corresponding product. 
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6. Appendix 
6.1 Abbreviations 
 
2,2-DMP 2,2-Dimethoxypropane 
Ac2O Acetic anhydride 
AcOH Acetic acid 
ALI 90% ethanol, 5% iPrOH, 
5% water 
Aliph. Aliphatic 
Arom. Aromatic 
Art.-Nr. Articel number  
Bn Benzyl 
BOC tert-Butyloxycarbonyl 
BSA N, O-bis(trimethylsilyl) 
acetamide 
Cellflock Cellulose 
d Day 
dba Dibenzylidenacetone 
DBU 1,8-diazabicyclo 
[5.4.0]undec-7-ene 
DIBAL Diisobutylaluminium 
hydride 
DIOP O-isopropylidene-2,3-
dihydroxy-1,4-bis 
(diphenylphosphino)butan 
DMAP 4-(dimethylamino)pyridine 
DME Dimethoxyethane 
DMF Dimethylformamide 
DPPBA 2-(diphenylphosphino) 
benzoic acid  
DYKAT  Dynamic Kinetic 
Asymmetric Transformation 
EDIPA Ethyldiisopropylamine 
ee Enantiomeric excess 
eq. Equivalent 
ESTP Ethyl acetat, tech. 
Et3N Triethylamine 
EtOH Ethanol 
FC Flash Chromatography 
h Hours 
HPLC High Pressure Liquid 
Chromatography 
HR High Resolution 
HPTF Heptan fraction, tech. 
HXF Hexan fraction, tech. 
IR Infrared Spectroscopy 
J Coupling constant 
LC Liquid Chromatography 
LDA Lithium Diisopropylamine 
LG Leaving group 
LiAlH4 Lithium Aluminium 
Hydride 
Ln Ligand 
LTMP Lithium-2,2,6,6-
tetramethylpiperidine 
m-CPBA meta-Chloroperoxybenzoic 
acid 
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MED Dichloromethane, tech. 
Min Minute 
mp Melting point 
MS Mass Spectroscopy 
NBS N-Bromsuccinimide 
NMR Nuclear Magnetic 
Resonance 
NuH Nucleophile 
Pd Palladium 
Pd/C Palladium on carbon 
Ph Phenyl 
PHOX Chiral phosphinooxazoline 
Phth Phthalimide 
PMP para-Methoxyphenyl 
PTSA para-Toluenesulfonic acid 
rt Room temperature 
SM Starting material 
TBME  tert-butylmethyl ether 
Tech. Technic 
T Temperature 
TFA Trifluoroacetic acid 
THF  Tetrahydrofuran 
TMP 2,2,6,6-
Tetramethylpiperidine 
UPLC Ultra Performance Liquid 
Chromatography 
UV  Ultraviolet 
β-H  β-Hydride 
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